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The research on conjugated materials (e.g. conjugated polymers and oligomers) is 
of significant theoretical importance and plays a vital role in developing commercially 
applicable materials. In the past two decades, star-shaped donor-acceptor π-conjugated 
oligomers have become very popular not only due to their unique 
structure-two-photon absorption (TPA) properties relationships, but also because 
materials based on them are promising candidates for TPA based applications, e.g. 
two-photon microscopy (TPM) bioimaging. Design and synthesis of novel star-shaped 
donor-acceptor structures provides a platform for structure-TPA properties 
relationships study and yields promising TPA materials. 
Despite the versatility in known star-shaped donor-acceptor structures, more 
studies are still in need to provide new synthetic methodologies and to complement 
current structures. Also, there is a strong demand of water-soluble TPA materials for 
the powerful non-invasive TPM cellular imaging applications. Yet, the problem 
associated with the decreased TPA cross section (δ) in water for cationic water-soluble 
materials as compared to their counterparts in organic solvents is limitedly addressed. 
Besides, the lack of tailored TPA materials for targeted cancer cells imaging and the 
lack of water-soluble red-emissive TPA materials to overcome interference by cell 
auto-fluorescence still need to be addressed. 
In this thesis, a series of star-shaped donor-acceptor conjugated materials is 
reported to address the abovementioned challenges. Our strategy of systematically 
varying the cores (donors), linkers, and peripheries (acceptors) of star-shaped 
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donor-acceptor structures successfully helped us synthesize TPA materials with large 
TPA δ and tunable emission from blue to red in water. Molecular engineering 
strategies using sugar moieties were also developed for enhanced TPA δ and a 
targeting functionality. 
A new synthetic methodology through dithia[3,3]paracyclophane was explored to 
complement the current studies on the TPA properties of [2,2]paracyclophane 
([2,2]PcP) based chromophores. A series of 4,7,12,15-tetrasubstituted [2,2]PcPs with 
push-pull systems (Chapter 2) were attempted to be synthesized. The 
dithia[3,3]paracyclophane route via photo-desulfurization underwent well to yield 
4,7,12,15-tetrabiphenyl[2,2]paracyclophane and 4,7,12,15-tetra-[4-(N,N’-diphenyl 
-amino)-1-phenyl]-[2,2]paracyclophane. However, the final step of 
photo-desulfurization did not occur for the dithia[3,3]paracyclophanes with 
nitrophenyl substitutions. This is due to the decreased reactivity of intermediate 
radicals, which could not undergo intraannular cyclization. The low possibility in 
tuning emission wavelength of [2,2]PcP chromophores into red spectral region via 
weak transannular conjugation triggered us to search for other structures. We next 
synthesized an octupolar glucose functionalized triphenylamine based oligomer via 
Suzuki coupling (TFBS, in Part I, Chapter 3), which possesses enhanced TPA δ 
(~1100 GM, GM is the unit of TPA δ) in water due to its intrinsic self-assembly 
properties. Inspired by this study, we then synthesized a vinylene linked 
glucopyranose conjugated material via Wittig coupling (TVFVBN-S-NH2, in Part II, 
Chapter 3), which shows further enhanced TPA δ in the longer wavelength range 
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compared to TFBS, red-shifted green emission and targeting ability (for 
TVFVBN-S-NH2FA) after being tagged by folic acid, which is a targeting moiety. 
Lastly, a pyrene based donor-acceptor material (Pyrene4BTF-PEG-TAT) was 
synthesized (Part III, Chapter 3) with efficient intramolecular charge transfer (ICT), 
large TPA δ (~500 GM), self-assembly properties and tuned emission wavelength in 
red spectral window in water. All three materials have been successfully demonstrated 
for two-photon fluorescence cellular imaging in a high contrast manner, and 
TVFVBN-S-NH2FA shows targeting ability to folate receptor over expressed human 
breast cancer MCF-7 cells. 
In summary, the synthetic methodologies, the donor-acceptor systems, the 
glycosylation molecular engineering strategies demonstrated as well as the underlying 
mechanisms unveiled in this PhD project provide useful guidelines in future 
advancement of star-shaped donor-acceptor TPA materials with water-solubility, large 
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Chapter 1: Introduction 
Materials comprising π-electrons delocalized sp1- or sp2-hybridization have been 
extensively studied for both theoretical interests and practical applications. 
Conjugated polymers and oligomers have been applied for the fabrication of organic 
light-emitting diodes (OLEDs), organic field effect transistors (OFET), lasers, solar 
cells and biosensors. As compared to traditional semiconductor inorganic materials, 
they have several distinguished advantages such as versatility in synthesis, ease of 
processing, low cost and flexibility.1-2 
Although conjugated polymers have longer electron-delocalized systems relative 
to their small molecules counterparts, their drawbacks regarding structural uncertainty 
make them inappropriate for fundamental investigation of structure-property 
relationships.3-4 Moreover, metallic catalyst is usually residual in conjugated polymers 
due to the difficulty in purification, which ultimately leads to declined device 
performance. In contrast, conjugated oligomers have well-defined structures, 
monodispersity and high chemical purity, providing perfect models for fundamental 
studies and device applications.5-6 
Conjugated oligomers with various architectures have been designed and 
synthesized, among which the star-shaped architecture has recently received 
increasing attention.7 A star-shaped oligomer is composed of one common core 
surrounded by three or more arms. Its electrical, optical, and morphological properties 
can be facilely adjusted via modification of either the core or arm components. For 
instance, the versatility in introducing conjugated systems with opposing electronic 
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properties could allow flexibility tuning of their properties for nonlinear optics (NLO) 
applications. 
By virtue of the abovementioned advantages, conjugated oligomers have been 
widely used in two-photon absorption (TPA) related studies in the past two decades. 
From the viewpoint of fundamental research, TPA related studies using conjugated 
oligomers as molecular models have enriched our knowledge and understanding on 
photon-matter interaction under coherent light excitation and provided valuable new 
information. From the viewpoint of materials application, conjugated oligomers have 
found various important applications based on the non-linear TPA process, such as (1) 
3D optical data storage and micro-fabrication,8-10 (2) optical power limiting,11 (3) 
two-photon (fluorescence) microscopy (TPM),12-13 (4) photo dynamic therapy,14 and 
frequency upconversion lasing.15 Two features are responsible for the advantages of 
TPA based applications: (1) a longer wavelength coherent laser light can be used and 
(2) there is a quadruple dependence of the two-photon excitation probability on the 
input incident of the applied coherent light field. As a result, development of TPA 
materials is of high importance for both theoretical interest and practical applications. 
In the following sections of this chapter, we will firstly give an introduction to the 
main concepts and theoretical considerations on the TPA process to shed light on this 
interesting and important phenomenon. The strategies for molecular design will be 
discussed considering the important factors such as molecular structure motifs (e.g. 
dipolar, quadrupolar and octupolar structures) and molecular components (e.g. donors 
and acceptors). A review on some important examples of star-shaped TPA molecules 
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will be presented. The state of the art for the development of water-soluble TPA 
material for TPM applications will be introduced. These discussions will help make a 
clear rationalization of objectives for my current PhD study, which is stated in the last 
part of Chapter 1. 
1.1 TPA: Main Concepts and Theoretical Considerations 
TPA was firstly proposed by Maria Goppert-Mayer in her doctoral thesis in 
1931.16 The revolutionary TPA theories further deepened our knowledge on 
“photon-matter” interaction.17-19 Before the prediction of TPA, scientists only 
considered the traditional one-photon process, where a molecule or atom may absorb 
one photon from the incident light and make a transition from a lower energy level to 
a higher energy level; or conversely, it may emit one photon from a higher energy 
level to a lower energy level. Both processes could be easily observed in our daily life 
and under common experimental conditions. 
In contrast, TPA process is a simultaneous absorption of two photons in order to 
excite the molecule or atom from a lower energy state (usually a ground state) to a 
higher energy excited state. The energy of the two photons adds up to the energy of 
the excited molecule or atom: 
Һʋଵ ൅ 	Һʋଶ ൌ ܧ  (1-1) 
where Һ = h/2π, and h is the Plank constant, ʋi is the frequency of the i-th absorbed 
photon, E is the transition energy. Figure 1.1 shows the two typical types of TPA 
situations. According to quantum mechanics, the absorption takes place through a 
so-called virtual state; however, no real intermediate level is populated during 
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absorption since it is simultaneous. In case A, two photons of the same frequency are 
absorbed to make the transition, which is called a degenerate TPA process. Case B 
describes the nondegenerate TPA process of absorbing two photons of different 
frequencies. The former case occurs in a single-beam TPA process, and the latter 
under a two-beam (e.g. excitation beam and probe beam) TPA process. 
 
Figure 1.1. Illustration of degenerate (A) and nondegenerate (B) TPA processes. 
The decay of an incident light flux, F, passing through an optical medium along a 
propagation direction, z, and due solely to TPA can be expressed as: 
– ௗிௗ௭ ൌ ܰߪଶܨଶ  (1-2) 
where N is the number density of molecules, σ2 is the TPA cross section. TPA cross 
section (also named δ) is usually quoted in the unit of GM after M. Goppert-Mayer. 1 
GM = 10-50 cm4 s photon-1 molecule-1, which indicates that the cross section is also a 
function of both space and time. This is because the applied light in two-photon 
excitation is usually a focused and pulsed beam, of which the intensity is a function of 
time and space. 
According to equation 1-2, TPA probability is proportional to the square of the 
light intensity as mentioned earlier; however it is too small to be measured under 











observation was demonstrated in the 1961 by Kaiser and Garrett,20 one year after the 
invention of laser devices and 30 years after its prediction. It is interesting to note that 
being one of the only two female Nobel Laureates in Physics after Marie Curie; 
Goppert-Mayer was awarded not for her two-photon contribution but her excellent 
work in the nuclear physics such as the nuclear shell model. 
1.2 Molecular Strategies for Designing TPA Materials 
The development of mode-pocked ultrafast pulsed lasers in the 1990s provides the 
extremely high peak intensity light source for efficient instantaneous TPA processes, 
which facilitates flurries of advanced applications based on TPA as mentioned earlier. 
In turn, more advanced TPA materials with large δ, combined with other tailored 
functionalities are highly in demand for specific applications. A large number of 
conjugated oligomers with direct and efficient TPA have been designed and 
synthesized. The structure-property relationships on these TPA molecules have been 
reviewed, providing useful information to design and synthesize conjugated materials 
with large δ.21-27 
Strong intramolecular charge transfer (ICT) from the donor to acceptor after two 
photon excitation, prior to emission occurs in molecules with push-pull structures, 
which could have large transition state dipole moments. The emission then stems from 
the strongly polar emissive state. It has been reported that increasing the electron rich 
components (donors) or electron deficient components (acceptors) strength in the 
conjugated system to enhance the ICT in the excited state could yield larger δ values 
(more examples shown in the following sections).28 Thus, considering the ICT, 
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incorporation of electron rich components (donors) and electron deficient components 
(acceptors) into conjugated system is an effective way to obtain large δ.29-31 On the 
other hand, extension of conjugation is also considered as a very important factor, 
which leads to extended charge separation in transition states.21, 31-34 Furthermore, 
increased coplanarity usually obtained through replacement of single bond linkers 
with vinylene or ethynylene linkers has also been proven effective to obtain large δ.35 
 
Figure 1.2. Illustration of dipolar, quadrupolar and octupolar structures, D = donor, A = 
acceptor, black stick = π connector. 
As shown in Figure 1.2, publications on molecular structures for enhanced TPA 
generally focus on four types. Type I molecules consist of one donor on one side and 
an acceptor on the other side, which are asymmetrical dipolar (D-π-A) chromophores. 
Type II molecules are symmetrical with donors or acceptors on both sides, named 
quadrupolar (D-π-A-π-D or A-π-D-π-A) structures. In comparison, type I molecules 
appear to be more effective in yielding large δ.21, 36-38 
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With the recognition of important benefits of multidimensional conjugation, the 
strategy of molecular branching to further increase δ of TPA molecules becomes more 
and more popular. The design concepts include the examples shown in Figure 1.2 as 
type III and type IV. Type III could be considered as the unification of the former type 
I and type II with extended dimensionality. When dipolar molecules are jointed 
together, the intramolecular charge flow could be either from the center to the outside 
or vice versa. These types of TPA chromophores are defined as octupolar if their 
overall molecular geometries belong to the following symmetry classification: 
octahedral (Oh), tetrahedral (Td), trigonal planar (Dnh, n = 3, 4,...), and trigonal 
bipyramid (C3h).39 A key advantage of such design is “cooperative effect”, which 
could significantly increase δ through firstly increasing the number density of TPA 
active units per molecule and secondly the excitonic coupling between each branch 
(TPA active unit).40-41 Moreover, multi-branched star-shaped architectures could 
overcome the intrinsic drawbacks of linear molecules (e.g. molecular aggregation and 
large anisotropy), giving advantages such as enhanced two-photon excited 
fluorescence in concentrated solution and solid state.42-44 
To design and synthesize effective TPA materials, it is very important to design 
molecular components (donors, acceptors and bridges) and to integrate them into the 
above mentioned dipolar, quadrupolar and octupolar chromophores. Classical electron 
withdrawing terminal groups (acceptors) that are often used include: nitro,45-50 
cyano,21 sulfonyl,47-49, 51-57 triflyl (CF3SO2-),52-53 aldehyde49, 58-59 and phosphonate.45 
Electron-deficient heterocyclics are also used as terminal acceptors, including 
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4-pyridyl, 2-benzoxazole, 2-benzothiazole,58-64 1,3,5-triazine,65 triazole66 and 
quinoline.67 To facilitate the electron flow, conjugated bridges such as 
phenylene-vinylene, phenylethynyl and 2,7-fluorenyl (including their analogues) are 
very frequently selected for TPA chromophores’ design. For terminal electron donors, 
the disubstituted amino groups (dialkyl or diphenyl) are common, largely due to their 
readily availability and the balance between their electron donating abilitiy and 
oxidative stability.23 
The construction of multi-branched chromophores requires core structures which 
can afford multi-functionalization. A variety of multi-functionalized core structures 
that are either electron rich or deficient have been used. Electron withdrawing cores 
that are usually used include 1,3,5-tricyanobenzene68-69 and triazine.70-72 As electron 
donating cores, triphenylamine,53-54, 72-73 bridged triphenylamine,74-75 pyrene,76 
truxene,77 triazatruxene78 and hexabenzocoronene79-80 are commonly used. Recently, 
TPA molecules with cross sections over 5000 GM have been obtained in 
triphenylamine based structures.27 TPA cross sections over 10, 000 GM have also been 
obtained in anthracene, hexabenzocoronene, squaraine and porphyrin based 
molecules.27 In the following Part I to III, selected chromophores based on the 
structural relevance to the molecules studied in this thesis are reviewed. 
I [2,2]Paracylophane Based Oligomers: 
TPA chromophores 1-9 using [2,2]paracyclophane ([2,2]PcP) as core have been 
synthesized by Bazan and coworkers, which offer very interesting properties.81-82 The 
star-shaped, two-layer dimers held together by [2,2]PcP core generally show δ 
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approximately twice of that of one-layer monomers. A systematic increase in the 
conjugation length in 1-3, which possess donor terminals, is accompanied by 
increased δ (1410, 3430 and 3890 GM for 1-3, respectively). Organic soluble 4-6 were 
also synthesized with different donors, showing δ of 1290, 1690 and 2080 GM, 
respectively. The largest value for 6 indicates that triphenylamine is the best donor in 
the three to construct TPA chromophores. The water-soluble counterparts 7-9 (δ = 370, 
700 and 690 GM in water, respectively) were also synthesized by introducing 
quaternized ammonium groups. Triphenylamine terminated 9 shows the highest 
quantum yield (η) in H2O among the three, which indicates that triphenylamine as a 




Figure 1.3. Structures of [2,2]paracyclophane based TPA molecules 1-9. 
The synthesis of 4,7,12,15-tetrasubstituted [2.2]PcP with donor and acceptor 
groups were also synthesized and the impact of substitution patterns on through-space 
charge transfer was investigated.83 However, the TPA properties of [2,2]PcPs 
containing both donors and acceptors were not studied. In addition, the synthesis of 
4,7,12,15-tetrasubstituted [2,2]PcPs has always been a big challenge and interests for 
materials chemists. The traditional Heck coupling on 4,7,12,15-tetrabromo[2,2] 
-paracyclophane to synthesize symmetrically substituted 4,7,12,15-tetrasubstituted 




































separate.84 Although the Wittig route developed by Bazan et al. offers a higher 
reaction yield and easier purification as compared to the Heck route, the preparation 
of the precursor for Wittig coupling requires harsh reaction conditions and gives a low 
yield. The bromo/formyl combination method (Scheme 1.1) to synthesize 
asymmetrical 4,7,12,15-tetrasubstituted [2,2]PcPs also faces the same difficulty in 
product purification as in the Heck route.83 Another important route to synthesize 
either substituted or non-substituted [2,2]paracyclophanes is based on the 
desulfurization of their precursor dithia[3,3]paracyclophanes. Photo-desulfurization of 
dithia[3,3]paracyclophanes to synthesize [2,2]PcP is well documented.85 It could 
therefore be explored as a new synthetic route to the synthesis of various 
4,7,12,15-tetrasubstituted [2,2]PcPs. 
 
Scheme 1.1. The preparation of “bormo/formyl precursors” for further combined Wittig and 
Heck coupling route to synthesize asymmetrical 4,7,12,15-tetrasubstituted [2,2]PcPs. 
Reagents and conditions: (i) 2 equiv. n-BuLi, DMF. 
II Octupolar Triphenylamine Based Oligomers: 
Triphenylamine is the most widely used electron donating core to construct 
octupolar TPA chromophores, due to the advantages such as ease in synthesis and 
good balance between oxidative stability and electron donating ability as mentioned 
above. Octupolar chromophores 10 and 11 (Figure 1.4) with triphenylamine or 
nitrogen cores were reported by Prasad et al. to demonstrate the effect of molecular 
branching on further enhancement of TPA cross sections for the first time.40, 86 The 
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reported TPA cross sections for 10 and 11 were both ~23000 GM when measured 
using Z-scan method with a nanosecond (ns) pulsed laser. However, the reported value 
at 790 nm under a femtosecond (fs) pulsed laser was 132 GM. The overestimated ns 
values in comparison with fs values are ascribed to the excited-state absorption.87-89 
However, the large values under the Z-scan condition are still strong evidences that 
the triphenylamine (donor) and benzothiazole (acceptor) pair can bring in effective 
ICT. 
 
Figure 1.4. Structures of triphenylamine based TPA molecules 10 and 11. 
A number of other TPA molecules based on triphenylamine have been synthesized. 
Figure 1.5 shows some examples of triphenylamine centered TPA molecules. TPA 
molecules 12-16 containing a triphenylamine core with strong acceptor peripheral 
groups via phenylene-ethynylene linkers have been synthesized by Blanchard-Desce’s 
group.52 The reported maximum TPA cross sections for 12 to 16 at 740 nm were 30, 




























these derivatives could be significantly enhanced in the near infrared (NIR) region 
with elongated derivatives bearing strong electron withdrawing peripheral groups. 
Their results indicate that by modifying and lengthening the conjugated branches, 
even larger TPA cross-sections could be obtained. 
TPA molecules 17-19, and 20-22 with a triphenylamine core and acceptor 
terminal groups via phenylene-vinylene linkers have been synthesized by 
Blanchard-Desce’s group53 and Cho’s group90 respectively. Molecules 17 to 19 were 
designed by increasing the transition dipole of branches to increase the excitonic 
coupling between branches. The reported maximum TPA cross sections increased 
from 1340 to 1430 and 2070 GM for 17-19, respectively. Strong solvatochromism91 
was observed for the three compounds, which is due to the formation of highly polar 
emissive excited states. Cho’s group also reported phenylene-vinylene linked 
molecules (20-22) with D-A branches. The reported maximum TPA value for 22 was 
1200 GM, which is higher than those for 20 (430 GM) and 21 (220 GM). This is a 
similar trend to Blanchard-Desce’s report that increased TPA cross sections with 




Figure 1.5. Structures of triphenylamine based TPA molecules 12-25. 
TPA molecules 23-25 with a triphenylamine core and fluorene-vinylene linkers 
were reported by Blacnchard-Desce’s group.52, 92 In particular, 23 and 25 possess D-A 
branches, while 24 possesses D-D branches. The maximum TPA cross sections for 
23-25 were 1265, 3660 and 2080 GM, respectively. The fact that the maximum TPA 
cross section for 24 is the largest among the three indicates the effectiveness of 
introducing D-D branches for enhanced TPA cross sections. However, the TPA values 
of 24 show sharp decrease after its maximum value at 740 nm, and even smaller 






















































maximum TPA cross section of 25 is much larger than that of 15, despite that they 
have the same donor-acceptor pair. As a result, the discrepancy is associated to the 
only difference in bridges. 
The above examples provide us some directions for further design of 
triphenylamine based molecules with large TPA cross sections: (1) a suitable donor 
acceptor pair is needed to fulfill a good ICT and therefore large cross sections; (2) 
D-A branches are useful to obtain larger cross sections over the long wavelength range. 
(3) phenylene-vinylene and fluorene-vinylene linkers are superior over 
phenylene-ethynylene linkers. In particular, fluorene with two benzene rings fused by 
a five member ring as a linker possesses both good planarity and rigidity, which is 
most superior among the three. 
III Pyrene Based Oligomers: 
Pyrene as an electron rich planar structure when used as a core for TPA materials 
should also bring in many merits. Cho et al. reported a series of pyrene centered TPA 
oligomers (26-29). 29 substituted with four donor groups shows the largest δ (1150 
GM) in the series.76 However, the reports on pyrene based TPA oligomers are few and 
far between. More studies on pyrene based TPA materials (e.g. with D-A branches) 




Figure 1.6. Structures of pyrene based TPA molecules 26-29. 
1.3 Water-Soluble TPA Materials for Bioimaging Applications with TPM 
TPM was first demonstrated by Webb and his coworkers in 199012 and has 
emerged as a very popular and powerful bioimaging technique. TPM utilizes a pulsed 
laser of the longer visible or NIR wavelength for excitation and produces frequency 
upconverted fluorescence in the visible region. A Ti:sapphire laser with ultra-short 
(100-150 fs) pulses of light around 800 nm (at a repetition rate of ~100 MHz) and a 
very large peak power value is often used for two-photon (excited) fluorescence 
(TPEF) imaging. 
TPM has several advantages as compared to the traditional one-photon confocal 
laser scanning microscopy (CLSM), such as higher brightness, deeper penetration, 
less photo damage, less photo bleaching and higher resolution.93-98 As TPA is a 
third-order nonlinear process, the intensity of TPEF is proportional to the square of the 
intensity of the input light. The highly localized input light eliminates the use of 
aperture in front of the detector and maximizes the signal detected to achieve high 
brightness. The used laser, which is often of long wavelength (800 nm and above) and 
requires minimum power, ensures greater penetration depth, less photo damage and 
photo bleaching to the biological samples. 
The efficient application of TPM for bioimaging is highly dependent on the 
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development of advanced TPA materials. As most biological processes occur in polar 
aqueous media, the water-solubility is a prerequisite for TPA materials when used for 
TPM bioimaging. On the other hand, to obtain a good signal to noise sensitivity, TPA 
materials with large TPA action cross section (defined as ηδ = fluorescence quantum 
yield × TPA cross sections) are necessary.81, 99 
Commercially available one-photon dyes are not tailored for TPM, which show 
small δ of less than 100 GM.93, 100-103 As have been reviewed in the previous section, 
most of the organic TPA chromophores with large δ of more than 2000 GM, however, 
are not water-soluble and not suitable for bioimaging. It should be noted that quantum 
dots (QDs) as two-photon absorbing materials have been shown high photostability 
and high brightness, but the intrinsic toxicity of them in the oxidative environment 
limits their applications in long-term monitoring of cellular events.104-106 On the other 
hand, fluorescent proteins (FPs) used for TPM imaging generally show small δ of less 
than 300 GM.107 In addition, their drawbacks related to maturation and monomeric 
state were reported to show severe cytotoxicity effect.108 In this context, water-soluble 
organic π-conjugated materials which could circumvent the shortcomings of QDs and 
FPs are in a high and urgent demand for TPEF imaging applications. 
The strategy of introducing ionic groups onto the molecular side chains has been 
widely used to prepare water-soluble chromophores. However, cationic TPA 
chromophores have been reported to show sharply decreased δ in H2O as compared to 
their neutral counterparts in organic solvents.81, 109 In addition, their η in water is also 
low due to fierce interaction between polar water molecules and chromophores in 
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their excited states through non-radiative decay.110 Till now, very limited efforts have 
been made to address these problems. Bazan et al. have reported that addition of 
surfactant sodium dodecyl sulfate (SDS) into water-soluble paracyclophane 
chromophores could increase the δ and η values due to micelle formation.99 Similarly, 
Jen et al. reported that encapsulation of TPA fluorophores with an amphiphilic block 
copolymer, poly(methacrylic acid)-block-polystyrene (PMAA-b-PS), led to increased 
δ values of the fluorophore in micelles.111 The micellization-enhanced TPA cross 
sections are associated with the incorporation of optically active units within the 
hydrophobic microenvironment in the interior of micelles. Another strategy that has 
also been used to obtain water-solubility is to introduce poly ethylene glycol (PEG) 
chains. For example, Liu’s group reported a molecular brush strategy of modifying 
conjugated polymers with PEG chains, which resulted in water-soluble conjugated 
polymers.112 
Targeted cancer cell imaging with fluorescent materials is of vital importance in 
cancer prognosis and treatment at early stage.113-116 A wide range of targeting moieties, 
such as folate,117-118 epidermal growth factor,119 transferrin,120 or antibodies,121 which 
specifically bind to the antigen or receptor over expressed in cancer cells have been 
functionalized onto fluorescent materials for targeted fluorescence imaging. However, 
there are limited reports on the conjugation of organic TPA materials for targeted TPM 
imaging. Belfield’s group reported the conjugation of linear TPA oligomers with the 
cyclic Arg-Gly-Asp (RGD) peptide or goat antirat IgG antibody for targeted 
imaging.122-124 However, the reported TPA values for their probes are relatively small 
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ranging from ~30 GM to 300 GM at ~800 nm. The development of TPA materials 
possessing large TPA cross sections for targeted cell imaging is highly in demand. 
As compared to commonly used blue and green emitters, red emissive TPA 
materials are highly desirable due to the low autofluorescence of biosubstrate in the 
red spectral window.125 Although red emissive FPs have been discovered, they 
generally show small δ and disadvantages such as severe cytotoxicity effect as 
aforementioned.106-107 Also, QDs with red emission have the drawbacks of toxicity in 
the oxidative environment.104-105 As a result, organic red-emissive TPA materials 
which could circumvent the shortcomings of FPs and QDs become attractive. So far 
the reported organic red TPA emitters include those based on dipyrromethene boron 
difloride (BODIPY, δ = 4-112 GM),126-127 2,1,3-benzothiadiazole (BT, δ < 800 
GM)128-132 and cyano-styrylbenzene (δ < 360 GM)133-134. These molecules generally 
have small TPA δ with limited or no water-solubility. Therefore, red emissive organic 
water-soluble TPA materials are highly desirable for TPEF imaging applications. 
1.4 Aim of Study and Thesis Outline 
In summary, the increasing interest in conjugated materials is due to their 
importance in both structure-properties relationships studies and potential for various 
optoelectronic applications. In particular, star-shaped oligomers, which allow 
flexibility tuning of their structural components to interpret inter-chromophores 
interactions, are particularly interesting to us. As a consideration of the application 
scope, TPM is a powerful technique for biological imaging, of which the advancement 
is dependent on the development of efficient TPA materials. However, water-soluble 
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TPA materials with large TPA cross sections in water, targeting ability and red 
emission are still highly in demand. 
In this PhD project, we focused on star-shaped conjugated materials with 
systematically varied conjugated backbone structures and secondary functionalities to 
gain knowledge of inter-chromophore interactions within a conjugated oligomeric 
system and guide further design of TPA materials for TPM applications. This PhD 
study integrates molecular design, synthesis and characterization, with demonstration 
in applications. 
Chapter 2 focuses on understanding of the effect of interesting transannular 
interactions on the TPA properties of [2,2]PcP connected oligomers containing both 
donors and acceptors, the design and synthesis of a series of donor and acceptor 
substituted [2,2]PcPs using the dithia[3,3]paracyclophane route was attempted. The 
results show that, however, the photodesulfurization of diathiaparacyclophanes with 
acceptors could not go smoothly to afford paracyclophanes. As a continuing work to 
synthesize TPA materials with further red-shifted emission wavelength, I expand the 
PhD project by studying more other star-shaped architectures, of which the emission 
wavelength is likely to be tuned to the red spectral region. 
In Chapter 3, the synthesis and TPEF cell imaging applications of a series of 
triphenylamine or pyrene based conjugated materials with blue to red emission are 
presented. Firstly using triphenylamine as a core, an octupolar oligomer with blue 
emission is designed and synthesized in Part I. Glycosylation strategy was used to 
bring in water-solublity and self-assembly ability. A compared study to the neutral 
 21 
 
counterpart and quaternized counterpart (with quaternized ammonium side chains) is 
presented. To further tune the emission to longer wavelength and increase TPA cross 
sections, the single bond linkers of the oligomer in Part I are replaced by double bond 
linkers to yield oligomers in Part II. The backbone of these oligomers has increased 
coplanarity and elongated conjugation as compared to that in Part I. At the same time, 
further design of the sugar moiety into glycopyranose which could allow further 
conjugation to targeted moieties is introduced to endow chromophores with targeting 
ability. In Part III, we report the synthesis of a water-soluble TPA chromophore using 
rigid, planar and electron rich pyrene as a core, of which the emission wavelength has 
been successfully tuned into the red spectral region. 





Chapter 2: Paracyclophane Based TPA Materials 
Introduction 
The [2,2]PcP with two face to face benzene rings bridged by ethylene is an 
interesting building block for organic chromophores, which provides interesting 
models to study the through-space conjugation phenomena. Bazan et al. reported that 
4,7,12,15-tetrasubstituted [2,2]PcPs possess the best balance between through-bond 
and through-space conjugation compared to other substitution patterns, and offer very 
interesting optical properties potentially useful as optoelectronics.135 TPA materials 
constructed on [2,2]PcP building blocks have also been preliminarily studied by 
Bazan’s group, which indicate the high promise of 4,7,12,15-tetrasubstituted [2,2]PcP 
derivatives as TPA materials for applications.81-82 
While symmetrical 4,7,12,15-tetrasubstituted [2,2]PcPs are relatively easier to 
synthesize through the Horner-Emmons route via the (4,7,12,15)-tetra 
-(diethylphosphonatemethyl)[2.2]paracyclophane precursor, asymmetrical 4,7,12,15 
-tetrasubstituted [2,2]PcPs are difficult to obtain because of the low reaction yield and 
complex purification procedures in this route.136 For example, a formyl/bromo 
precursor (as shown in Scheme 1.1 in Chapter 1) with two carbonyl groups on single 
benzene could not be obtained due to the difficulty in forming of two anions on a 
single ring and HPLC is usually needed for product separation. Although 
4,7,12,15-tetrasubstituted [2,2]PcPs containing both donors and acceptors are of 
particular interest due to their promise in yielding large TPA cross sections, there are 
few publications on the TPA properties of these chromophores. The development of 
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new synthetic method is therefore significant, which will be useful in the synthesis of 
TPA materials based on 4,7,12,15-tetrasubstituted [2,2]PcPs. 
Dithia[3,3]paracyclophanes have long been known as precursors for 
[2,2]PcPs;137-141 however, it’s adoption in material chemistry to synthesize 
paracyclophane based materials is uncommon. With a working history of cyclophane 
chemistry, our group has recently developed a series of 4,7,12,15-tetrasubstituted 
[2,2]PcPs with fluorenes, carbazoles, thiophenes as arms for OLEDs applications, 
which will be published soon. Further extension of this route to the synthesis of 
4,7,12,15-tetrasubstituted [2,2]PcPs with donors and acceptors is important for the 
development of TPA materials. 
In this chapter, we report the synthesis of a series of donors and acceptors 
substituted dithia[3,3]paracyclophanes and the attempt of their conversion into 
4,7,12,15-tetrasubstituted [2,2]PcPs through the photodesulfurization route. To fulfill 
a good ICT, triphenylamine was chosen as the donor and nitrobenzene was chosen as 
the acceptor. Figure 2.1 shows the chemical structures of 4,7,12,15-tetrasubstituted 
[2,2]PcPs with different combinations of donors and acceptors (PcP1-PcP5). PcP1 was 
synthesized as a model compound. The tetra-nitrobenzene (acceptors) substituted 
derivative is not included due to its extreme insolubility. PcP1 and PcP2 were 
successfully obtained; however, our attempt to convert the dithia[3,3]paracyclophanes 
into [2,2]PcPs by photodesulfurization did not go smoothly for those which are 




Figure 2.1. Chemical strutures of donor-acceptor substituted [2,2]PcPs, PcP1-PcP5. 
Results and Discussion 
Synthesis and Characterization 
The synthetic route towards [2,2]paracyclophanes PcP1-PcP5 is depicted in 
Scheme 2.1 and Scheme 2.2. 1,4-dibromo-p-xylene was brominated using 
N-bromosuccinimide (NBS) in benzene to afford 1,4-dibromo-2,5-bis(bromomethyl) 
-benzene 30 in 65% yield. The bromomethyl groups of 30 was then protected by 
methoxyl groups using sodium methoxide to give 
1,4-dibromo-2,5-bis(methoxylmethyl)benzne 31 in 62% yield, which is a key 
precursor for the synthesis of “single-layer” chromophores. 4-Bromobiphenyl was 
converted into 4-biphenylboronic acid 32 in 48% yield. Ullmann coupling between 
diphenylamine and 1-bromo-4-iodobenzene afforded 1-N,N’-diphenylamino-4 










4-(N,N’-diphenylamino)-1-phenylboronic acid 34 in 28% yield. 1-iodo-4-nitrobenzene 
was converted into 4,4,5,5-tetramethyl-2-(4-nitrophenyl)-1,3,2-dioxaborolane 35 upon 




Scheme 2.1. Reagents and conditions: (i) NBS, benzene, reflux under light; (ii) CH3OH, 
CH3ONa; (iii) n-BuLi, trimethylborate, -78 °C to RT, HCl (1 M); (iv) xylene/toluene, 
1,10-phenanthroline, KOH, CuI; (v) n-BuLi, trimethylborate, -78 °C to RT, HCl (1 M); (vi) 
bis(pinacolato)diborane, [Pd(dppf)Cl2], KOAc, DMSO (anhydrous), 85 οC, overnight; (vii) 32, 


























































































33, K2CO3 (2 M, aq), Pd(PPh3)4, TBAB, toluene, overnight; (ix) 34, K2CO3 (2 M, aq), 
Pd(PPh3)4, TBAB, toluene, overnight; (x) step 1: 33, K2CO3 (2 M, aq), Pd(PPh3)4, TBAB, 
toluene, 6h; step 2: 34, K2CO3 (2 M, aq), Pd(PPh3)4, TBAB, toluene, overnight; (xi) HBr gas, 
CHCl3, 24 h; (xii) thiourea, ethanol, reflux, overnight. 
The “single-layer” chromophores were synthesized via Suzuki coupling between 
the boronic acid/ester and 31. Coupling 2 equiv. of 32, 33, 34 with 31 afforded 
symmetrical layers 1,4-bisbiphenyl-2,5-bis(methoxymethyl)benzene 36, 
1,4-[4-(N,N’-diphenylamino)-1-phenyl]-2,5-bis(methoxymethyl)benzene 39 and 
1,4-bis(4-nitropheyl)-2,5-bis(methoxylmethyl)benzene 42 in 90%, 86% and 70% yield, 
respectively. Two consecutive Suzuki coupling of 31 to 1 equiv. of 33 and 1 equiv. of 
34, respectively afforded asymmetrical layer 1-(4-nitrophenyl)-2 
-(N,N’-diphenylaminophenyl)-2,5-bis(methoxylmethyl)benzene 44 in overall 44% 
yield for two steps. Methoxylmethyl groups of 36, 39, 42 and 44 were deprotected 
into bromomethy groups using HBr gas in CHCl3 to afford 
1,4-bisbiphenyl-2,5-bis(bromomethyl)benzene 37, 1,4-[4-(N,N’-diphenylamino)-1 
-phenyl]-2,5-bis(bromomethyl)benzene 40, 1,4-bis(4-nitropheyl)-2,5-bis(bromom 
-ethyl)benzene 43 and 1-(4-nitrophenyl)-4-(N,N’-diphenylaminophenyl)-2,5 
-bis(bromomethyl)benzene 45 in 78%, 90%, 83% and 82% yield, respectively. Then 
37, 40 and 45 were reacted with thiourea in ethanol to afford mercaptomethyl 
functionalized 1,4-bisbiphenyl-2,5-bis(mercaptomethyl)benzene 38, 1,4-[4-(N,N’-di 
-phenylamino)-1-phenyl]-2,5-bis(mercaptomethyl)benzene 41 and 1-(4-nitrophenyl)-4 





Scheme 2.2. Reagents and conditions: (i) KOH, ethanol (95%), 3 days; (ii) trimethylphosphite, 
UV radiation, 24h. 
The typical route to a [2,2]PcP is depicted in Scheme 2.2. The 
dithia[3,3]paracyclophane is obtained by coupling 1 equiv. of bisbromomethyl 
precursor and 1 equiv. of bismercaptomethyl precursor using KOH as base under high 
dilution condition with 95% ethanol as the solvent. Photodesulfurization of a 
dithia[3,3]paracyclophane in trimethylphosphite solvent under UV radiation at 254 nm 
affords the corresponding [2,2]PcP. In our study, the coupling between 37 and 38; 40 
and 41 afforded symmetrical dithia[3,3]paracyclophanes 47 (19% yield) and 48 (31% 
yield), which underwent photodesulfurization to give [2,2]PcPs, PcP1 and PcP2 in 62% 
and 73% yield, recpevtively. Coupling between 41 and 43 afforded asymmetrical 
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dithia[3,3]paracyclophanes 49 with a donor-donor (DD) layer and an 
acceptor-acceptor (AA) layer in 31% yield. Coupling between 45 and 46 afforded two 
regioisomers (50 and 51), with two donor-acceptor (DA) layers of different charge 
transfer directions. However, the photodesulfurization of 49, 50 and 51 did not yield 
the desired product PcP3, PcP4 and PcP5. 
 
Figure 2.2. Comparison of NMR spectra for 47, PcP1, 48 and PcP2. 
Figure 2.2 shows the 1H NMR spectra for 47, 48, PcP1 and PcP2. The bridge 
 30 
 
–CH2– protons in dithia[3,3]paracyclophanes 47 appear as a geminally coupled AB 
system, which indicates that the two protons on a bridge carbon are chemically 
nonequivalent. On the other hand, the bridge –CH2– protons of PcP1 resonate as 
multiplets, because the protons on the neighbor bridge carbon also couple with them 
after desulfurization. Similar splitting patterns for bridge protons are observed for 48 
and PcP2. The 1H NMR spectrum for 49 is shown in Figure 2.3. The bridge –CH2– 
protons of the nitrophenyl substituted layer in 49 resonate as an AB system at δ 4.30 
(2H, J = 14.5 Hz), 3.64 (2H, J = 14.5 Hz), while the bridge –CH2– protons of the 
triphenylamine substituted layer appear as a singlet at δ 4.08 (4H). This could be due 
to the coincidental chemical shift equivalence. The 1H NMR spectra for 50, 51 are 
also shown in Figure 2.3. One can identify that, 51, which is composed of two D-A 
layers with the ICT direction of 60° difference tends to have a larger overall dipole 
and therefore larger polarity than 50, which have two D-A layers of ICT directions of 
120° difference and decreased overall dipole.142 As such, the aromatic protons on the 
nitrophenyl rings for the more polar 51 have larger chemical shifts than those for 50. 
Furthermore, the fact that 50 was collected as the first spot and 51 as the second spot 
in the separation of these two dithia[3,3]paracyclophanes by column chromatography 
again affirms the larger polarity of 51 than 50. The bridge –CH2– protons for 50 
resonate as two doublets at δ 4.31 (2H, J = 15 Hz), 3.75 (2H, J = 15.5 Hz), and a 
triplet at δ 3.97 (4H, J = 14.5 Hz), which is probably an overlap of two doublets. In 
contrast, the bridge –CH2– protons in 51 resonate as two sets of AB systems at δ 4.33 
(2H, J = 15.5 Hz), 3.75 (2H, J = 15.5 Hz), and δ 4.00 (2H, J = 15 Hz), 3.95 (2H, J = 
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15 Hz), respectively. 
 
Figure 2.3. Comparison of NMR spectra for 49, 50, 51. 
Scheme 2.3 shows the reaction mechanism for photodesulfurization.143 Georghiou 
et al. reported that the presence of electron withdrawing (e.g. bromine) groups on the 
6- or 15-position of a dithia[3,3]metacyclophane could inhibit the sulphur elemination 
or intrannular cyclization.144 Yamato et al. also reported the ineffective transannular 
cyclization of bromine substituted 8-methoxy[2.2]metacyclophanes into the 
corresponding tetrahydropyrenes using benzyltrimethyl ammonium tribromide 
(BTMA-Br3). They suggested that the cyclization is affected by decreased π-electron 
density of the substituted benzene ring, which is deactivated.145 Scaiano et al. reported 
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the substantially decreased reactivity of isobenzofuranyl radicals after nitro group 
substitution.146 We propose herein that the failed photodesulfurization for 49-51 is 
ascribed to the presence of strong electron withdrawing nitro substituents. 
 
Scheme 2.3. Mechanism of a typical photo desulfurization. 
Optical Properties 
The normalized UV-vis absorption and PL spectra for 47 and PcP1 in chloroform 
is shown in Figure 2.4. Dithiaparacyclophane 47 shows a maximum absorption at 294 
nm. In contrast, PcP1 shows a maximum absorption at 324 nm, and a weaker band 
appears at 264 nm. The peaks at 264 nm and 324 nm are assigned to the π-π* 
transitions in the single deck and the phane-state chromophores, respectively. The 
maximum emission of 47 and PcP1 locates at 385 nm and 425 nm, respectively. The 
red-shifted emission spectrum is due to the enhanced interchromophore conjugation in 
paracyclophane PcP1 as compared to in dithiacyclophane 47. Figure 2.5 shows the 
normalized UV-vis absorption and PL spectra of 48 and PcP2 in chloroform. The 
maximum absorption of 48 locates at 312 nm and emission maximum at 438 nm. The 
maximum absorption of PcP2 locates at 360 nm with weaker band at 312 nm, and the 
emission maximum locates at 447 nm. In a similar way, the peaks at 312 nm and 360 
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nm are assigned to the π-π* transitions the single deck and the phane-state 
chromophores, respectively. The red-shifted emission spectrum is due to the enhanced 
interchromophore conjugation in paracyclophane PcP2 as compared to in 
dithiacyclophane 48 similar to that between 47 and PcP1. 
 
Figure 2.4. Normalized UV-vis absorption (dash line) and PL (solid line) spectra of 47 (black) 
and PcP1 (red) in chloroform (excited at λmax). 
 
Figure 2.5. Normalized UV-vis absorption (dash line) and PL (solid line) spectra of 48 (black) 
and PcP2 (red) in chloroform (excited at λmax). 

























































































Figure 2.6. Normalized UV-vis absorption (dash line) and PL (solid line) spectra of 49 (black), 
50 (red) and 51 (blue) in chloroform (excited at λmax). 
Figure 2.6 shows the normalized UV-vis absorption and PL spectra for 49, 50 and 
51 in chloroform. The maximum absorption of 49 locates at 341 nm and a weaker 
peak at 307 nm. The peak at 341 nm is assigned to the the π-π* transitions in 
phane-state chromophores phane state chromophores, while the peak at 307 nm is 
assigned to the single deck with triphenylamine substitutions. The emission maximum 
of 49 locates at 409 nm, with a secondary peak at 435 nm and a shoulder at 384 nm. In 
contrast, the UV-vis absorption spectra for 50 and 51 are similar to each other, with 
the absorption maximum at 307 nm. The PL spectrum for 50 shows emission 
maximums at 409 nm with two secondary peaks at 435 nm and 384 nm, respectively. 
And the PL spectrum for 51 shows emission maximum at 409 nm, a secondary peak at 
435 nm and a shoulder at 384 nm. 
Summary 
As a summary, we have attempted to synthesize a series of 4,7,12,15 
-tetrasubstituted [2,2]paracyclophanes with donors and acceptors using the 


































dithia[3,3]paracyclophane route. The results show that the photodesulfurization 
procedure works well on dithiaparacyclophanes containing only donors. However, for 
those containing acceptors, photodesulfurization was not successful due to the 
decreased reactivity of the intermediate radical species. To solve this problem, 
alternative methods such as vacuum pyrolysis, or Wttig rearrangement/Raney Nickel 
method could be considered. This study however, provides a reference for the 
synthesis of [2,2]paracyclophane based chromophores in the future. 
Experimental Sections 
Materials and Instruments 
Chemicals and reagents were purchased from Aldrich Chemical Co. unless 
otherwise stated. NMR spectra were collected on a Bruker ACF 300 or AMX 500 
spectrometer with chloroform-d as the solvent (unless otherwise stated) and 
tetramethylsilane as the internal standard. 
Synthesis 
1,4-Dibromo-2,5-bis(bromomethyl)benzene (30): 1,4-Dibromo-2,5-dimethyl 
-benzene (2.6 g, 10 mmol), NBS (3.9 g, 22 mmol) and a catalytic amount of benzoyl 
peroxide were mixed in benzene (100 mL). The suspension was refluxed under 
irradiation for 4 h. After the reaction mixture was cooled to RT, dichloromethane (300 
mL) was added and the inorganic salts were removed by filtration. The filtrate was 
washed with water (150 mL, 3 times) and brine (150 mL). The organic layer was dried 
over anhydrous MgSO4. Solvent was removed by rotary evaporation to give white 
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solid. The crude product was recrystallized twice from ethanol to give 30 as white 
crystals (2.7 g, 65% yield). 1H NMR (CDCl3, 300 MHz, δ ppm): 7.64 (s, 2H), 4.49 (s, 
4H). 13C NMR (CDCl3, 75.5 MHz, δ ppm): 138.96, 135.33, 123.26, 31.45. MS (EI, 
m/z): 421.0 (M+). 
1,4-Dibromo-2,5-bis(methoxylmethyl)benzne (31): Small pieces of sodium 
(0.69 g, 30 mmol) were added into methanol (42 mL) in a 100 mL round bottom flask. 
After the reaction became moderated, 1,4-dibromo-2,5-bis(bromomethyl) benzene 
(2.11 g, 5 mmol) was added slowly into the round bottom flask. The round bottom 
flask was equipped with a reflux condenser and refluxed at 60 °C for 6 h. The closed 
system was purged with argon gas. The methanol solvent was removed by rotary 
evaporator and the mixture was then extracted with diethyl ether and washed with 
water. The organic layer was then dried by anhydrous MgSO4 and solvent was 
removed. The product was purified by column chromatography with DCM/hexane 
(1:4, v/v) as eluent to afford 31 as white solid (1.0 g, 62.1% yield). 1H NMR (CDCl3, 
300 MHz, δ ppm): 7.63 (s, 2H), 4.47 (s, 4H), 3.47 (s, 6H). 13C NMR (CDCl3, 125 
MHz, δ ppm): 138.38, 132.21, 121.18, 73.11, 58.76. MS (EI, m/z): 323.9 (M+). 
4-Biphenylboronic acid (32): n-BuLi (1.6 M in hexane, 12.5 mL, 20 mmol) was 
added dropwise into a stirring solution of 4-bromobiphenyl (2.3 g, 10.0 mmol) in 
anhydrous THF (25 mL) under nitrogen at -78 °C. After keeping at -78 °C for 1 h, 
trimethylborate (2.3 mL, 20 mmol) was added dropwise. The reaction mixture was 
stirred at RT overnight. The reaction was first quenched with H2O and then 2 M HCl 
aqueous solution was added dropwise to obtain an acidic solution (pH 1-2). The 
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mixture was then poured into ice water while stirring and extracted with diethyl ether. 
The organic layer was dried by anhydrous MgSO4 and solvent was removed. The 
crude product was purified by column chromatography firstly using toluene then 
diethyl ether to give 32 as white solid (0.94 g, 48% yield). 1H NMR (DMSO-d6, 500 
MHz, δ ppm): 8.05 (s, 2H), 7.88 (d, 2H, J = 7.55 Hz), 7.68 (d, 2H, J = 8.2 Hz), 7.63 (d, 
2H, J = 7.55 Hz), 7.47 (t, 2H, J = 8.2 Hz), 7.37 (t, 1H, J = 8.2 Hz). 13C NMR 
(DMSO-d6, 125 MHz, δ ppm): 142.06, 140.62, 135.25, 129.40, 128.03, 127.18, 
126.12. MS (EI, m/z): 198.1 (M+). 
1-N,N’-Diphenylamino-4-bromobenzene (33): A mixture of diphenylamine (7.5 
g, 44.4 mmol) and 1-bromo-4-iodobenzene (12.55 g, 44.4 mmol), xylene (50 mL) and 
toluene (25 mL) were mixed in a 100 mL round bottom flask. KOH (19.47 g, 347 
mmol) was added into the mixture followed by 1,10-phenanthroline (0.31 g, 1.72 
mmol ) and then CuI (0.42 g, 2.18 mmol). The round bottom flask was equipped with 
a condenser and heated rapidly to reflux at 125 °C for 40 h. After cooling down to RT, 
H2O was added and dichloromethane (DCM) was used for extraction. The organic 
layer was washed with water and dried by anhydrous MgSO4. After solvent removal, 
the crude solid was then purified firstly by recrystalization from methanol and then by 
column chromatography with using hexane as eluent to give 33 as white crystals (12 g, 
83% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 7.33 (d, 1H, J = 8.2 Hz), 7.27 (t, 2H, 
J = 7.55 Hz), 7.09 (d, 2H, J = 8.2 Hz), 7.05 (t, 1H, J = 6.95 Hz), 6.96 (d, 1H, J = 7.6 
Hz). 13C NMR (CDCl3, 125 MHz, δ ppm): 148.07, 147.73, 132.83, 130.06, 125.81, 
125.10, 123.91, 115.46. MS (EI, m/z): 323.0 (M+). 
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4-(N,N’-Diphenylamino)-1-phenylboronic acid (34): n-BuLi (1.6 M in hexane, 
10 mL, 16 mmol) was added dropwise into a stirring solution of 
1-N,N’-diphenylamino-4-bromobenzene (3.57 g, 11 mmol) in dry THF (30 mL) under 
nitrogen at -78 °C. After keeping at -78 °C for 1 h, trimethylborate (2 mL, 16.5 mmol) 
was added dropwise at -78 °C. The reaction mixture was stirred for 2 h at RT. The 
reaction was quenched by H2O and then 6 M HCl aqueous solution was added 
dropwise to obtain an acidic solution (pH 1-2) and stirred for another 15 min. The 
mixture was then poured into ice water and extracted with DCM. The combined 
organic layer was dried by MgSO4 and solvent was removed. The crude product was 
purified by gradient column chromatography using DCM:ethyl acetate (EtOAc) as 
eluent to give 34 as white solid (0.84 g, 28% yield). 1H NMR (DMSO-d6, 500 MHz, δ 
ppm): 7.84 (s, 2H), 7.68 (d, 2H, J = 8.9 Hz), 7.33 (m, 4H), 7.08 (m, 6H), 6.69 (d, 2H, 
J = 8.2 Hz). 13C NMR (DMSO-d6, 75.5 MHz, δ ppm): 149.30, 147.37, 135.80, 129.91, 
124.75, 123.69, 121.65. MS (EI, m/z): 271.1 (M+ - OH), 245.1 (M+ - B(OH)2). 
4,4,5,5-Tetramethyl-2-(4-nitrophenyl)-1,3,2-dioxaborolane (35): 1-Iodo-4-nitro 
-benzene (1.5 g, 7 mmol), bis(pinacolato)diborane (2.5 g, 9.7 mmol), KOAc (2 g, 21 
mmol), and dry DMSO (30 mL) were mixed together in a 100 mL flask. After 
degassing, Pd(dppf)Cl2 (154 mg, dppf = 1,1'-bis(diphenylphosphanyl) -ferrocene) was 
added. The reaction mixture was kept at 80 °C overnight, and then cooled to RT. The 
organic solvent was removed, and the residual solid was dissolved in EtOAc and 
washed with water. After drying with MgSO4, the solvent was removed. The crude 
product was purified by chromatography using EtOAc/hexane (1:10, v/v) as eluent to 
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give 35 as white solid (1.2 g, 80%). 1H NMR (CDCl3, 500 MHz, δ ppm): 8.17 (d, 2H, 
J = 8.2Hz), 7.94 (d, 2H, J = 8.2 Hz), 1.35 (s, 12H). 13C NMR (CDCl3, 125 MHz, δ 
ppm): 149.88, 135.67, 122.42, 84.64, 24.88. MS (EI, m/z): 249.2 (M+), 234.1 (M+ - 
CH3). 
1,4-Bisbiphenyl-2,5-bis(methoxymethyl)benzene (36): 4-Biphenylboronic aicd 
(1.2 g, 6 mmol), 1, 4-dibromo-2,5-bis(bromomethyl) benzene (0.65 g, 2 mmol), 
TBAB (catalytic amount), Pd(PPh3)4 (100 mg, 2% mmol), K2CO3 (10 mL, 2 M, aq) 
and 40 mL toluene were mixed in a 100 mL one-neck flask. The flask equipped with a 
condenser was then evacuated and filled with nitrogen three times. The reaction 
mixture was then heated to 100 °C overnight. After cooling to RT, the reaction 
mixture was extracted with DCM and the combined organic layer was washed with 
water and brine and dried over anhydrous MgSO4. After solvent removal, the crude 
product was purified by column chromatography using hexane/DCM (4:1, v/v) as 
eluent to afford 36 as white solid (0.85 g, 90% yield). 1H NMR (CDCl3, 300 MHz, δ 
ppm): 7.69 (m, 4H), 7.55 (m, 5H), 7.39 (m, 1H). 13C NMR (CDCl3, 75.5 MHz, δ ppm): 
141.48, 141.32, 140.75, 140.12, 135.56, 131.71, 130.46, 129.52, 128.06, 127.77, 
127.54, 73.05, 58.94. MS (EI, m/z): 470.3 (M+). 
1,4-Bisbiphenyl-2,5-bis(bromomethyl)benzene (37): HBr gas was bubbled 
vigorously through a solution of 36 (470 mg, 1 mmol) in CHCl3 (150 mL) for 15 min. 
The reaction mixture was stirred for additional 24 h. White precipitate come out of the 
reaction which was filtered and collected to give 37 as a white solid (445 mg, 78% 
yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 7.72 (d, 2H, J = 8.2 Hz), 7.67 (d, 2H, J = 
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6.95 Hz), 7.59 (d, 2H, J = 8.2 Hz), 7.51 (m, 3H), 7.39 (t, 1H, J = 7.55 Hz). MS (EI, 
m/z): 568.1 (M+). 
1,4-Bisbiphenyl-2,5-bis(mercaptomethyl)benzene (38): A solution of 37 (200 
mg, 0.35 mmol) and thiourea (54 mg, 0.71 mmol) in ethanol (25 mL) was heated at 
reflux for overnight. After the solvent, the dithiouronium salt was suspended in 
aqueous KOH solution (400 mg, 7 mmol, 50 mL) and heated at reflux for overnight. 
The mixture was then acidified to pH 2-3 and extracted with chloroform. The organic 
layer was washed sequentially with water and brine and then dried over anhydrous 
MgSO4. The solvent was then removed to give 38 as a white solid (140 mg, 86% 
yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 7.71 (m, 4H), 7.54 (d, 2H, J = 1.9 Hz), 
7.48 (t, 2H, J = 7.55 Hz), 7.40 (m, 2H), 3.78 (d, 2H, J = 7.55 Hz), 1.78 (t, 1H, J = 7.55 
Hz). MS (EI, m/z): 474.2 (M+). 
1,4-[4-(N,N’-Diphenylamino)-1-phenyl]-2,5-bis(methoxymethyl)benzene (39): 
4-(N,N’-Diphenylamino)-1-phenylboroic acid (690 mg, 2.4 mmol), 
4-dibromo-2,5-bis(bromomethyl)benzene (258 mg, 0.8 mmol), TBAB (cat. amount), 
toluene (30 mL), K2CO3 (5 mL, 2 M, aq) and Pd(PPh3)4 (70 mg, 2% mmol) were 
mixed in a one neck flask. The flask equipped with a condenser was then evacuated 
and filled with nitrogen three times. The reaction mixture was then heated at 100 °C 
overnight. After cooling to RT, the reaction mixture was extracted with DCM and the 
combined organic layer was washed with water and brine. After dried over anhydrous 
MgSO4, the solvent was removed. The crude product was purified by column 
chromatography using hexane/DCM (2:1, v/v) as eluent to afford 39 as white solid 
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(450 mg, 86% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 7.48 (s, 1H), 7.32 (m, 6H), 
7.17 (m, 6H), 7.05 (t, 2H, J = 6.9 Hz), 4.44 (s, 2H), 3.38 (s, 3H). 13C NMR (CDCl3, 
125 MHz, δ ppm): 147.76, 146.96, 140.34, 134.69, 134.40, 130.99, 130.12, 129.29, 
124.52, 123.04, 122.96. MS (EI, m/z): 652.4 (M+). 
1,4-[4-(N,N’-Diphenylamino)-1-phenyl]-2,5-bis(bromomethyl)benzene (40): 
HBr gas was bubbled vigorously through a solution of 
1,4-[4-(N,N’-diphenylamino)-1-phenyl]-2,5-bis(methoxymethyl)benzene (450 mg, 
0.69 mmol) in CHCl3 (150 mL) for 15 min. The reaction mixture was stirred for 
additional 24 h. The organic solution was washed with brine and water to neutral 
followed by solvent removal to give 40 as greenish white solid (466 mg, 90% yield). 
1H NMR (CDCl3, 500 MHz, δ ppm): 7.45 (s, 1H), 7.36 (d, 2H, J = 8.2 Hz), 7.30 (t, 4H, 
J = 8.2 Hz), 7.18 (m, 6H), 7.06 (t, 2H, J = 7.6 Hz), 4.54 (s, 2H). 13C NMR (CDCl3, 
125 MHz, δ ppm): 147.58, 147.51, 135.51, 133.17, 129.79, 129.38, 124.77, 123.24, 
122.87, 31.91. MS (EI, m/z): 750.2 (M+), 590.2 (M+ - 2Br). 
1,4-[4-(N,N’-Diphenylamino)-1-phenyl]-2,5-bis(mercaptomethyl)benzene (41): 
A solution of 1,4-[4-(N,N’-diphenylamino)-1-phenyl]-2,5-bis(bromomethyl)benzene 
(200 mg, 0.27 mmol) and thiourea (41 mg, 0.54 mmol) in ethanol (40 mL) was heated 
at reflux overnight. After solvent removal, the dithiouronium salt was suspended in 
aqueous KOH solution (290 mg, 5.4 mmol, 50 mL) and heated at reflux overnight. 
The mixture was cooled down in ice water and then acidified to pH 2-3. The mixture 
was extracted with DCM and washed sequentially with water and brine. The 
combined organic layer was dried over anhydrous MgSO4 followed by solvent 
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removal to give 41 as a white solid (171 mg, 98% yield). 1H NMR (CDCl3, 500 MHz, 
δ ppm): 7.33 (s, 1H), 7.30 (m, 6H), 7.17 (m, 6H), 7.05 (t, 2H, J = 7.6 Hz), 3.77 (d, 2H, 
J = 6.9 Hz), 1.76 (t, 1H, J = 7.6 Hz). 13C NMR (CDCl3, 125 MHz, δ ppm): 147.66, 
147.19, 140.27, 137.43, 134.02, 131.47, 129.93, 129.35, 124.65, 123.11, 123.07. MS 
(EI, m/z): 656.3 (M+), 624.3 (M+ - SH). 
1,4-Bis(4-nitrophenyl)-2,5-bis(methoxylmethyl)benzene (42): 4,4,5,5-Tetra 
-methyl-2-(4-nitrophenyl)-1,3,2-dioxaborolane (370 mg, 1.5 mmol), 
1,4-dibromo-2,5-bis(bromomethyl)benzene (161 mg, 0.5 mmol), K2CO3 (3 mL, 2 M 
aq), TBAB (cat. amount), Pd(PPh3)4 (30 mg, 3% mmol) and toluene (20 mL). The 
flask equipped with a condenser was then evacuated and filled with nitrogen three 
times. The reaction mixture was then heated to 100 °C overnight. After cooling down 
to RT, the reaction mixture was extracted with DCM. The combined organic layer was 
washed with water and brine and dried over anhydrous MgSO4. After solvent removal, 
the crude product was purified by column chromatography using hexane/DCM (1:1, 
v/v) as eluent to offer 42 as white solid (139 mg, 70% yield). 1H NMR (CDCl3, 500 
MHz, δ ppm): 8.31 (d, 2H, J = 8.5 Hz), 7.62 (d, 2H, J = 8.5 Hz), 7.49 (s, 1H), 4.32 (s, 
2H), 3.36 (s, 3H). 13C NMR (CDCl3, 125 MHz, δ ppm): 147.38, 146.73, 139.93, 
135.25, 131.17, 130.14, 123.49, 72.02, 58.46. MS (EI, m/z): 408.1 (M+). 
1,4-Bis(4-nitrophenyl)-2,5-bis(bromomethyl)benzene (43): HBr gas was 
bubbled vigorously through a solution of 42 (150 mg, 0.36 mmol) in CHCl3 (150 mL) 
for 15 min. The reaction mixture was stirred for additional 24 h. After reaction, 
nitrogen was bubbled into the reaction solution to remove excess HBr gas, then water 
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was added and organic layer was separated and washed to neutral. The organic layer 
was then dried over MgSO4 followed by solvent removal to afford 43 as yellow solid 
(143 mg, 83% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 8.37 (d, 2H, J = 8.5 Hz), 
7.69 (d, 2H, J = 8.5 Hz), 7.45 (s, 1H), 4.39 (s, 2H). 13C NMR (CDCl3, 125 MHz, δ 
ppm): 147.75, 145.46, 140.54, 135.97, 132.84, 129.97, 123.84, 29.99. MS (EI, m/z): 
505.9 (M+), 424.9 (M+ - Br). 
1-(4-Nitrophenyl)-4-(N,N’-diphenylaminophenyl)-2,5-bis(methoxylmethyl)be
nzene (44): (a) 4-(N,N’-Diphenylamino)-1-phenylboronic acid (636 mg, 2.2 mmol) 
and 1,4-dibromo-2,5-bis(methoxylmethyl)benzene (644 mg, 2 mmol), Pd(PPh3)4 (60 
mg, 3% mmol), TBAB (cat. amount), toluene (40 mL) and Na2CO3 (5 mL, 2 M, aq) 
were mixed together in 100 mL round bottle flask, the set up was then degased. The 
reaction was kept at 100 °C for 6 h and then cooled to RT. DCM was added for 
extraction; organic layer was washed successively with brine and water, and then 
dried with MgSO4. After solvent removal, the crude product was purified by gradient 
column chromatography using EtOAc/hexane (1:150, v/v) to afford 
1-bromo-4-(N,N’-diphenylaminophenyl)-2,5-bis(methoxylmethyl)benzene as white 
solid (450 mg, 50% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 7.76 (s, 1H), 7.45 (s, 
1H), 7.31 (t, 4H, J = 8.2 Hz), 7.25 (d, 2H, J = 8.2 Hz), 7.18 (d, 4H, J = 8.2 Hz), 7.14 
(d, 2H, J = 8.2 Hz), 7.07 (t, 2H, J = 7.6 Hz), 4,58 (s, 2H), 4.40 (s, 2H), 3.50 (s, 3H), 
3.40 (s, 3H). 13C NMR (CDCl3, 125 MHz, δ ppm): 147.68, 147.32, 140.64, 136.76, 
136.49, 133.48, 132.82, 130.40, 129.95, 129.39, 124.67, 123.17, 122.95, 121.32, 




(259 mg, 0.53 mmol), 4,4,5,5-tetramethyl-2-(4-nitrophenyl)-1,3,2-dioxaborolane (200 
mg, 0.8 mmol), Pd(PPh3)4 (30 mg, 3% mmol), TBAB (cat. amount), toluene (40 mL) 
and Na2CO3 (5 mL, 2 M, aq) were mixed together in 100 mL round bottle flask, the 
set up was then degased. The reaction was kept at 100 °C overnight and then cooled to 
RT. DCM was added for extraction; organic layer was washed successively with brine 
and water, and then dried with MgSO4. After solvent removal, the crude product was 
purified by gradient column chromatography using EtOAc/hexane (1:4, v/v) to afford 
44 as yellow solid (246 mg, 88% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 8.30 (d, 
2H, J = 9 Hz), 7.65 (d, 2H, J = 8.5 Hz), 7.50 (d, 2H, J = 10.5 Hz), 7.32 (m, 6H), 7.18 
(m, 6H), 7.06 (t, 2H, J = 7 Hz), 4.46 (s, 2H), 4.33 (s, 2H), 3.40 (s, 3H), 3.37 (s, 3H). 
13C NMR (CDCl3, 125 MHz, δ ppm): 147.66, 147.46, 147.35, 147.15, 141.76, 138.57, 
135.55, 134.46, 133.59, 131.80, 130.52, 130.25, 130.01, 129.37, 124.69, 123.38, 
123.18, 122.88, 72.34, 72.19, 58.41, 58.28. MS (EI, m/z): 530.2 (M+). 
1-(4-Nitrophenyl)-4-(N,N’-diphenylaminophenyl)-2,5-bis(bromomethyl)benze
ne (45): HBr gas was bubbled vigorously through a solution of 
1-(4-nitrophenyl)-4-(N,N’-diphenylaminophenyl)-2,5-bis(methoxylmethyl)benzene 
(156 mg, 0.29 mmol) in CHCl3 (150 mL) for 15 min. The reaction mixture was stirred 
for additional 24 h. The organic solution was washed with brine and water to neutral, 
dried followed by solvent removal to give 45 as yellow solid (150 mg, 82% yield). 1H 
NMR (CDCl3, 500 MHz, δ ppm): 8.35 (d, 2H, J = 8.5 Hz), 7.69 (d, 2H, J = 8.5 Hz), 
7.48 (s, 1H), 7.42 (s, 1H), 7.35 (d, 2H, J = 8.5 Hz), 7.31 (t, 4H, J = 7.5 Hz), 7.18 (m, 
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6H), 7.08 (t, 2H, J = 7.5 Hz), 4.54 (s, 2H), 4.39 (s, 2H). 13C NMR (CDCl3, 125 MHz, 
δ ppm): 147.86, 147.48, 146.10, 142.60, 139.00, 136.10, 135.33, 133.33, 132.73, 
132.15, 130.04, 129.70, 129.43, 128.34, 124.90, 124.40, 123.73, 123.42, 122.69, 
31.29, 30.63. MS (EI, m/z): 628.0 (M+). 
1-(4-Nitrophenyl)-4-(N,N’-diphenylaminophenyl)-2,5-bis(mercaptomethyl)be
nzene (46): A solution of 2-(4-nitrophenyl)-5-(N,N’-diphenylaminophenyl) 
-1,4-bromomethylbenzene (166 mg, 0.27 mmol) and thiourea (41 mg, 0.54 mmol) in 
ethanol (25 mL) was heated at reflux overnight. After solvent removal, the 
dithiouronium salt was suspended in aqueous KOH solution (290 mg, 5.4 mmol, 50 
mL) and heated at reflux overnight. The mixture was cooled down in ice water and 
then acidified to pH 2-3 and extracted with DCM. The organic layer was washed 
sequentially with water and brine and dried over anhydrous MgSO4 followed by 
solvent removal to give 46 as a white solid (110 mg, 78% yield). 1H NMR (CDCl3, 
500 MHz, δ ppm): 8.33 (d, 2H, J = 8.5 Hz), 7.64 (d, 2H, J = 8.5 Hz), 7.37 (s, 1H), 
7.31 (m, 7H), 7.16 (t, 6H, J = 8 Hz), 7.09 (t, 2H, J = 5.5 Hz). MS (EI, m/z): 534.1 
(M+). 
5,8,14,17-Tetra(biphenyl)dithia[3,3]paracyclophane (47): A solution of 
1,4-bisbiphenyl-2,5-bis(mercaptomethyl)benzene (70 mg, 0.147 mmol) in degassed 
THF (80 mL) and a solution of 1,4-bisbiphenyl-2,5-bis(bromomethyl) benzene (84 mg, 
0.147 mmol) in degassed THF (150 mL) were mixed together. The combined solution 
was then added slowly into 300 mL degassed 95% ethanol containing KOH (158 mg, 
2.94 mmol) under argon atmosphere. After the completed addition, the reaction 
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mixture was stirred at RT for 72 h under argon. After removal of the bulk of solvent, 
DCM was then used to extract the mixture. The resulting organic layer was washed 
with brine and water sequentially and then dried with anhydrous MgSO4. After solvent 
removal, the crude solid was then purified with column chromatography using 
hexane/DCM (4:1, v/v) as eluent to give 47 as white solid (24 mg, 19% yield). 1H 
NMR (CDCl3, 500 MHz, δ ppm): 7.68 (d, 4H, J = 7.8 Hz), 7.64 (d, 4H, J = 8.2 Hz), 
7.56 (d, 4H, J = 8.2 Hz), 7.48 (t, 4H, J = 7.6 Hz), 7.38 (t, 2H, J = 7.4 Hz), 7.33 (s, 2H), 
4.11 (dd, 4H, J = 15.1 Hz, J = 170.3 Hz). 13C NMR (CDCl3, 125 MHz, δ ppm): 
140.66, 139.86, 139.52, 139.19, 133.56, 132.35, 130.10, 128.86, 127.40, 127.09, 
126.93, 35.54. MS (ESI, m/z): calcd for C64H48S2: 880.3, found 880.6 (M+), 904.8 (M+ 
+ Na). 
4,7,12,15-Tetra(biphenyl)[2,2]paracyclophane (PcP1): 5,8,14,17-Tetra(biphenyl) 
-dithia[3,3]paracyclophane (46 mg, 0.05 mmol) was suspended into 50 mL 
trimethylphosphite in a 100 mL conical flask. The flask was put into a UV reactor and 
was irradiated for 24 h. After removal of trimethylphosphite, the resulting solid was 
redissolved in 50 mL DCM and was washed with brine and water and then dried over 
anhydrous MgSO4. The crude solid was purified with column chromatography with 
hexane/DCM (4:1, v/v) as eluent to give PcP1 as white solid (26 mg, 62% yield). 1H 
NMR (CDCl3, 300 MHz, δ ppm): 7.72 (m, 8H), 7.55 (m, 8H), 7.40 (m, 2H), 6.98 (s, 
2H), 3.70 (m, 2H), 2.97 (m, 2H). 13C NMR (CDCl3, 125 MHz, δ ppm): 140.62, 139.68, 
139.64, 139.45, 137.21, 132.46, 129.49, 128.87, 127.38, 127.18, 127.03, 33.60. MS 




-e (48): A solution of  1,4-[4-(N,N’-diphenylamino)-1-phenyl]-2,5-bis(mercapto 
-methyl)benzene (167 mg, 0.26 mmol) in 150 mL degassed toluene and a solution of 
1,4-[4-(N,N’-diphenylamino)-1-phenyl]-2,5-bis(bromomethyl)benzene (190 mg, 0.26 
mmol) in 300 mL degassed toluene were mixed together. The combined solution was 
then added slowly into a 400 mL degassed 95% ethanol containing KOH (286 mg, 5.1 
mmol) under argon. After the completed addition, the reaction mixture was stirred 
under RT for 72 h under argon. After removal of the bulk of solvent, DCM was then 
used to extract the mixture. The resulting organic layer was washed with brine and 
water sequentially and then dried with anhydrous MgSO4. After solvent removal, the 
crude solid was then purified with column chromatography using hexane/DCM (4:1, 
v/v) as eluent to give 48 as white solid (98 mg, 31% yield). 1H NMR (CDCl3, 500 
MHz, δ ppm): 7.31 (d, 4H, J = 8.7 Hz), 7.24 (m, 10H), 7.11 (d, 8H, J = 7.6 Hz), 7.07 
(d, 4H, J = 8.9 Hz), 7.02 (t, 4H, J = 7.0 Hz), 4.04 (dd, 4H, J = 15.1 Hz, J = 195.4 Hz). 
13C NMR (CDCl3, 125MHz, δ ppm): 147.68, 146.72, 138.89, 134.67, 133.14, 132.15, 
130.41, 129.31, 124.43, 123.27, 122.93. MS (ESI, m/z): calcd for C88H68N4S2: 1245.6, 
found 1291.6 (M+ + 2Na). 
4,7,12,15-Tetra-[4-(N,N’-diphenylamino)-1-phenyl]-[2,2]paracyclophane 
(PcP2): 5,8,14,17-Tetra-[4-(N,N’-diphenylamino)-1-phenyl]-dithia[3,3]paracyclopha 
-ne (98 mg, 0.05 mmol) was suspended into 50 mL trimethylphosphite in a 100 mL 
conical flask. The flask was put into a UV reactor and was irradiated for 24 h. After 
removal of trimethylphosphite, the resulting solid was redissolved in 50 mL DCM and 
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was washed with brine and water and then dried with anhydrous MgSO4. After solvent 
removal, the crude solid was purified with column chromatography with hexane/DCM 
(4:1, v/v) as eluent to give PcP2 as yellowish white solid (67 mg, 73% yield). 1H 
NMR (CDCl3, 500 MHz, δ ppm): 7.27 (m, 4H), 7.21 (t, 8H, J = 7.6 Hz), 7.12 (m, 
12H), 7.01 (t, 4H, J = 7.6Hz), 6.81 (s, 2H), 3.55 (m, 2H), 2.88 (m, 2H). 13C NMR 
(CDCl3, 125MHz, δ ppm): 147.77, 146.55, 139.31, 136.76, 135.21, 132.37, 129.88, 
129.28, 124.20, 124.07, 122.80. MS (FAB, m/z): calcd for C88H68N4: 1181.5, found 
1181.5 (M+). 
5,8-Di(4-nitrophenyl)-14,17-di(4-(N,N’-diphenylamino)-1-phenyl)dithia[3,3]p
-aracyclophane (49): A solution of 1,4-[4-(N,N’-diphenylamino)-1-phenyl]-2,5-bis 
-(mercaptomethyl)benzene (81 mg, 0.12 mmol) in 150 mL degassed toluene and a 
solution of 1,4-bis(4-nitrophenyl)-2,5-bis(bromomethyl)benzene (62 mg, 0.12 mmol) 
in 150 mL degassed toluene were mixed together. The combined solution was then 
added slowly into a 300 mL degassed 95% ethanol containing KOH (139 mg, 2.4 
mmol) under argon atmosphere. After the completed addition, the reaction mixture 
was stirred under RT for 72 h under argon. After removal of the bulk of solvent, DCM 
was then used to extract the mixture. The resulting organic layer was washed with 
brine and water sequentially and then dried with anhydrous MgSO4. After solvent 
removal, the crude solid was then purified with column chromatography using 
hexane/DCM (1:1, v/v) as eluent to give 49 as yellow solid (40 mg, 31 %). 1H NMR 
(CDCl3, 500 MHz, δ ppm): 8.16 (d, 4H, J = 9 Hz), 7.57 (d, 4H, J = 8.5 Hz), 7.39 (m, 
14H), 7.28 (m, 11H), 7.12 (m, 7H), 3.97 (dd, 4H, J = 14.5 Hz, J = 173 Hz) 13C NMR 
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(CDCl3, 125 MHz, δ ppm): 147.49, 147.29, 146.92, 138.89, 138.53, 133.83, 133.71, 
133.64, 132.62, 132.13, 130.80, 129.72, 129.54, 124.63, 123.59, 123.50, 123.43, 
35.47, 34.77. MS (MALTI-TOF, m/z): calcd for C64H48N4O4S2: 1101.3, found 1101.76 
(M+). 
5,14-Di(4-nitrophenyl)-8,17-di(4-(N,N’-diphenylamino)-1-phenyl)dithia[3,3]p
-aracyclophane (50)  & 5,17-Di(4-nitrophenyl)-8,14-di(4-(N,N’-diphenylamino) 
-1-phenyl)dithia[3,3]paracyclophane (51): A solution of 1-(4-nitrophenyl)-4 
-(N,N’-diphenylaminophenyl)-2,5-bis(bromomethyl)benzene (64 mg, 0.1 mmol) in 
100 mL degassed toluene and a solution of 1-(4-nitrophenyl)-4-(N,N’-diphenyl 
-aminophenyl)-2,5-bis(mercaptomethyl)benzene (54 mg, 0.1 mmol) in 100 mL 
degassed toluene were mixed together. The combined solution was then added slowly 
into a 300 mL degassed 95% ethanol containing KOH (112 mg, 2 mmol) under argon 
atmosphere. After the completed addition, the reaction mixture was stirred at RT for 
72 h under argon. After removal of the bulk of solvent, DCM was then used to extract 
the mixture. The resulting organic layer was washed with brine and water sequentially 
and then dried with anhydrous MgSO4. After solvent removal, the crude solid was 
then purified with column chromatography using hexane/DCM (1:1, v/v) as eluent to 
give the first portion of 50 as yellow solid (19 mg, 19% yield). 1H NMR (CDCl3, 500 
MHz, δ ppm): 8.19 (d, 4H, J = 8.7 Hz), 7.50 (d, 4H, J = 8.7 Hz), 7.45 (d, 4H, J = 8.6 
Hz), 7.35 (m, 7H), 7.20 (m, 14H), 7.11 (dd, 7H, J = 7.9 Hz, J = 15.5 Hz), 4.31 (d, 2H, 
J = 15.0 Hz), 3.97 (t, 4H, J = 14.5 Hz), 3.75 (d, 2H, J = 15.5 Hz). MS (MALDI-TOF, 
m/z): calcd for C64H48N4O4S2: 1101.3, found 1101.21 (M+). 
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The second portion was 51 as yellow solid (19 mg, 19% yield). 1H NMR (CDCl3, 500 
MHz, δ ppm): 8.25 (d, 4H, J = 8.8 Hz), 7.74 (d, 4H, J = 8.8 Hz), 7.37 (s, 2H), 7.24 (m, 
8H), 7.08 (m, 24H), 4.34 (d, 2H, J = 15.5 Hz), 3.97 (q, 4H, J = 15.0Hz), 3.75 (d, 2H, J 





Chapter 3. Triphenylamine and Pyrene Based TPA Materials 
with Tunable Emission 
I 
Blue Emissive Triphenylamine Based Oligomer for Generic 
Two-Photon Fluorescence Cellular Imaging 
Introduction 
The development of water-soluble π-conjugated materials with large TPA cross 
sections (δ) in the NIR regions (700-1000 nm) has attracted intensive attention in the 
past two decades for their applications in TPM, which is a powerful technique for 
non-invasive living cell imaging owning several advantages as compared to that for 
one-photon microscopy (OPM).93-98 Molecular strategies for designing π-conjugated 
materials as discussed in Chapter 1 indicate the promise of star-shaped architecture to 
develop robust TPA materials. [2,2]PcP based star-shaped chromophores feature a 
relatively weak transannular conjugation, which is less likely to red-shift their 
emission wavelength into the red spectral window. This triggered us to expand our 
study to other core structures to organize a star-shaped chromophore. Triphenylamine 
as the most widely used core for octupolar TPA molecules is a good choice. 
As mentioned in Chapter 1, the problem associated with the significantly 
decreased δ in water for cationic π-conjugated TPA molecules relative to that for their 
neutral counterparts in organic solvents is limitedly addressed.99, 111 Glycolipids and 
carbohydrate compounds are very well known to us and they have been reported to 
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self-assemble into regular layers or spherical micelles in aqueous media.147 It occurs 
to us that attachment of glucose groups could be an effective strategy to develop 
amphiphilic multi-branched conjugated molecules with intrinsic self-assembly 
properties. Unlike the micelle-assisted systems, this molecular design could integrate 
the hydrophilic terminals and the backbone to yield robust water-soluble TPA 
materials for two-photon fluorescence imaging. Although several examples of metal 
complexes have been developed as probes for two-photon fluorescence imaging of 
living cells,148-150 these probes are generally highly toxic to cells and possess small δ 
values (< 100 GM). To the best of our knowledge, there are only a limited number of 
organic fluorophores designed for two-photon imaging of living cells,151-154 of which 
the δ values are also very small (< 20 GM). 
In Part I of this chapter, we report a star-shaped glycosylated conjugated oligomer 
(TFBS) with high TPA cross sections in aqueous solution for two-photon fluorescence 
imaging of living cells. The designed octupolar structure uses triphenylamine as the 
donor, fluorene as the bridge and phenylbenzo[d]thiazole as the terminal acceptor, 
which fulfills a good charge transfer feature from center to terminals.155A cationic 
conjugated oligomer (TFBC) as the counterpart of TFBS has also been synthesized to 
investigate how the terminal group of conjugated oligomers affects their self-assembly 
behavior in aqueous media and in turn determines their linear and non-linear 




Figure 3.1.1. The chemical structures of TFBN, TFBC, TFBS-OAc and TFBS. 
Results and Discussion 
Synthesis and Characterization 
The synthetic route towards conjugated oligomers TFBN, TFBC and TFBS is 
depicted in Scheme 3.1.1. 2,7-Dibromo-9,9'-bis(6-bromohexyl)fluorene was 
synthesized according to our previous reports.5, 156-159 Coupling 1-amino-2-thiophenol 
with 4-bromobenzaldehyde in N-methyl-2-pyrrolidone (NMP) at 110 ºC for 3 days 
afforded 2-(4-bromophenyl)benzo[d]thiazole (52) in 80% yield.47 52 was then 
converted to boronic ester 1-benzothiazole-4-phenylpinacolatoborane (53) in 86% 
yield upon heating with bis(pinacolato)diborane and KOAc in anhydrous dioxane at 
90 ºC.160 Coupling between 1 equiv. of 53 and 2,7-dibromo-9,9'-bis 
-(6-bromohexyl)fluorene under the Suzuki coupling reaction condition afforded 
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2-(4-(2-bromo-9,9'-bis(6-bromohexyl)-fluoren-7-yl)phenyl)benzo[d]thiazole (55) in 
50% yield. Further Suzuki coupling reaction between 55 and 
4,4',4''-tris(pinacolatoborane)phenylamine (56) at a molar ratio of 3.6:1 afforded the 
desired neutral oligomer (TFBN) in 18% yield. The correct chemical structure of 
TFBN was affirmed by NMR spectroscopy (Figure 3.1.2) and MALDI-TOF mass 
spectroscopy. The cationic derivative TFBC was obtained in 86% yield by 
quaternization of TFBN using trimethylamine in THF/H2O.161 The 1H NMR spectrum 
of TFBC shows a single broad peak at 3.02 ppm which is assigned to the methyl 
protons in -CH2CH2N(CH3)3. Integration of the methyl peak area to that of the other 
alkyl peaks is 9:12, indicating 100% quaternization for TFBN (Figure 3.1.3). 
 
Scheme 3.1.1. The synthetic route to oligomers TFBN, TFBC and TFBS. Reagents and 
conditions: i) NMP, 110 ºC, 3 days; ii) bis(pinacolato)diborane, KOAc, Pd(dppf)Cl2, dioxane, 
80 ºC, overnight; iii) & iv) Na2CO3, Pd(PPh3)4, toluene/H2O, 100 ºC, overnight; v) THF/H2O, 
NMe3, 24h; vi) 1-thio-β-D-glucose tetraacetate, THF, K2CO3, RT, 2 days; vii) NaOMe, 










































A post-functionalization approach was adopted to synthesize the 
glucose-substituted oligomer TFBS.162-163 Coupling TFBN with 1-thio-β-D-glucose 
tetraacetate at a molar ratio of 1:9 in THF at RT afforded acetylated precursor 
TFBS-OAc in 67% yield. The characteristic singlet resonance peaks of acetyl 
protons164 were observed at 2.01-1.96 ppm in the 1H NMR spectrum of TFBS-OAc 
(Figure 3.1.4), indicating the successful attachment of acetylated glucose onto TFBN. 
Moreover, when one compares the NMR spectra between TFBN and TFBS-OAc, the 
characteristic triplet for protons in -CH2Br was not observed in the spectrum of 
TFBS-OAc, indicating 100% replacement of Br by acetylated glucose. After 
deacetylation of TFBS-OAc in MeOH/DCM at RT using NaOCH3, the 
glucose-substituted oligomer TFBS was obtained in 93% yield after dialysis against 
Mill-Q water using a 3 KDa molecular weight cut off membrane. The disappearance 
of characteristic peaks of acetyl protons in 1H NMR spectrum of TFBS (Figure 3.1.5) 
affirmed complete deacetylation. In addition, the correct molecular mass of TFBS was 





Figure 3.1.2. 1H-NMR of TFBN (* indicates CDCl3). 
 
Figure 3.1.3. 1H-NMR of TFBC (* indicates MeOD and H2O). 
 















Figure 3.1.5. 1H-NMR of TFBS (* indicates DMSO and H2O). 
 
Figure 3.1.6. MALDI-TOF mass spectrum of TFBS. 
Self-Assembly in Water 
Dynamic light scattering (DLS) was performed to probe the self-assembly 
behaviours of TFBC and TFBS in water. Figure 3.1.7a shows the DLS spectrum of 2.5 
μM TFBS in water. The mean hydrodynamic diameter was measured to be 61 nm, 
with a polydispersity of 0.29. Similar to the previously reported micellization 
behaviours of sugar substituted molecules,165 the formation of nanoparticles for TFBS 
is due to the glucose substituents. In contrast, no DLS signal was observed for 2.5 μM 










































level in solution.166 Similarly, there was no DLS signal observed for 2.5 μM TFBS and 
TFBC in DMSO. 
The atomic force microscopy (AFM) height image and the corresponding cross 
section analysis of TFBS nanoparticles on silicon wafer are shown in Figure 3.1.7b 
and Figure 3.1.7c, respectively. Monolayer spherical nanoparticles are observed with 
relatively uniform diameter and narrow height distribution. This indicates ordered 
self-assembly of TFBS in pure water rather than random aggregation. For all the 
nanoparticles, an average diameter of 80 nm was determined by statistical analysis 
and an average central height of 10 nm was obtained by cross-sectional analysis. The 
smaller size in vertical height is caused by collapse upon transforming the 
nanoparticles from solution state into dry state, which rationalizes the larger size of 
nanoparticles measured by AFM compared to that by DLS.112 It is expected that the 
self-assembly of TFBS in aqueous solution would enhance the hydrophobicity of local 
environment for the star-shaped backbone. 
 
Figure 3.1.7. a) Hydrodynamic diameter of TFBS in water at [TFBS] = 2.5 μM; b) AFM 
height image and c) cross section analysis of TFBS nanoparticles. 
























Linear Optical Properties 
The solvent effect on the optical properties of the neutral oligomer TFBN was 
investigated. Figure 3.1.8 shows the UV-vis absorption and photoluminescence (PL) 
spectra of 2 μM TFBN in toluene, DCM and dimethylformamide (DMF). With 
increasing solvent polarity, the maximum emission wavelength progressively 
red-shifts from 440 nm in toluene to 540 nm in DCM and 640 nm in DMF. The 
solvent-dependent emission maximum originates from the charge transfer character of 
the excited state of TFBN, which is clearly understood by molecular orbital simulation 
conducted on a single arm of TFBN. As shown in Figure 3.1.9, the highest occupied 
molecular orbital (HOMO) energy level of the arm is mainly delocalized over the 
triphenylamine and fluorene units, while the lowest unoccupied molecular orbital 
(LUMO) is nearly localized on the phenylbenzo[d]thiazole unit. The orbital patterns 
implicate that the HOMO-LUMO transition for TFBN is accompanied by charge 
transfer from the electron donating triphenylamine to the electron deficient 
phenylbenzo[d]thiazole unit in the excited state. The quantum yield of TFBN 
decreases from 0.86 in toluene to 0.69 in DCM and 0.10 in DMF, measured using 
quinine sulphate in 0.1 M H2SO4 as standard. The quenched fluorescence of TFBN 
with increasing solvent polarity further proves its charge-transfer excited state. As a 
result of the solvent dependent emission, the solution fluorescent color of TFBN is 
blue in toluene, green in DCM and orange in DMF (the inset in Figure 3.1.8). On the 
other hand, TFBN has the same absorption spectrum in all solvents, which indicates 
that the ground state of TFBN is less sensitive to solvent polarity, as both states are 
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exposed to the same local environment.112 
 
Figure 3.1.8. UV-Vis absorption (dashed) and PL spectra (solid) of TFBN in toluene (blue), 
DCM (red) and DMF (black) at a concentration of 2 μM (excited at λmax). The inset shows the 
fluorescence from solutions of TFBN in toluene, DCM and DMF under a hand-held UV-Lamp 
with λmax = 365 nm. 
 
Figure 3.1.9. Representation of HOMO and LUMO energy levels and the frontier molecular 
orbitals of a single arm of TFBN obtained from density functional theory (DFT) calculation at 
the B3LYP/6-31G* level. The 6-bromohexyl side chains are replaced with methyl groups in 
the calculations. 
The UV-vis absorption and PL spectra of TFBC and TFBS in DMSO and pure 
water are shown in Figure 3.1.10. In DMSO, both the absorption and PL spectra of 
TFBC and TFBS are nearly the same. The absorption and emission maxima are at 388 

































and 660 nm, respectively. Moreover, they have a similar quantum yield of 0.09. In 
water, the absorption maxima for TFBC and TFBS are at 384 nm and 388 nm, while 
the emission maxima for TFBC and TFBS are at 575 nm and 533 nm, respectively. 
The quantum yields of TFBC and TFBS in water are 0.03 and 0.10, respectively. As 
TFBC and TFBS share the same conjugated framework, both should show decreased 
fluorescence with increased solvent polarity due to the charge transfer character of 
their excited states. The higher quantum yield of TFBS in water agrees with the DLS 
and AFM results, which show that TFBS self-assembles into nanoparticles in water. 
The nanoparticles should increase the hydrophobicity in the local environment of 
TFBS, which leads to the higher quantum yield relative to that of TFBC.167 As such, 
the aqueous solution of TFBS shows much brighter fluorescence (the inset in Figure 




Figure 3.1.10. a) UV-Vis absorption spectra and b) PL spectra of TFBC (square) and TFBS 
(circle) in DMSO (black) and water (red) at a concentration of 2 μM (excited at λmax), the inset 
shows the fluorescence from solutions of TFBC and TFBS in water under a hand-held 
UV-lamp with λmax = 365 nm. 
TPA Properties 
The TPA spectra of TFBN, TFBC and TFBS were collected using a standard 
TPEF technique with a femtosecond pulsed laser source.102, 168 To avoid the 
interference on TPEF by laser excitation, TPA spectra were measured starting at the 
wavelength where each individual oligomer has nearly no emission. In addition, 
limited by the laser availability in our experiments, TFBN in toluene was investigated 
in the range from 640 nm to 810 nm; TFBC and TFBS in water were studied from 740 
nm to 900 nm, and TFBS and TFBC in DMSO were measured in the range from 800 












































nm to 970 nm. 
The TPA spectrum of TFBN in toluene shows a maximum TPA cross section (δmax) 
of 2494 GM at 680 nm (Figure 3.1.11a). This value is higher than that for the linear 
benzothiazole containing counterparts (< 1600 GM).169-171 On the other hand, as 
compared to AF-350 reported by Tan et al.,40, 72 TFBS has a larger TPA cross section 
than AF-350 at ~790 nm, when both are measured using a femtosecond pulsed laser 
(~500 GM vs 132 GM). The large δ value of TFBN in toluene is mainly ascribed to 
efficient ICT from centre to peripheries in the octupolar structure. In water, TFBS 
shows a δmax of 1195 GM at 740 nm (Figure 3.1.11b), while the TPEF spectra for 
TFBC are barely detectable under the same experimental conditions. In DMSO, the 
δmax values of TFBC and TFBS are observed at 800 nm (Figure 3.1.12), which are 435 
and 444 GM, respectively. It should be noted that the δ value of TFBS in water at 800 




Figure 3.1.11. (a) TPA cross sections of TFBN in toluene. (b) TPA cross sections of TFBS in 
water. 
As TFBN, TFBC and TFBS have the same conjugated framework; their TPA 
values in different solvents should be associated with the solvent effect and molecular 
assembly. Wang et al.172 suggested that the enhancement of δ from a solvent of low 
polarity to that of intermediate polarity is associated with the charge separation 
assisted by the solvent and the resulting change in the electronic structure provides a 
main perturbation on δ. On the other hand, Woo et al. reported that water could 
influence the electronic structure of D-π-A-π-D chromophores via hydrogen bonding, 
which led to decreased ICT.109 As a consequence, a substantial drop in δ was observed 
in water as compared to that in organic solvents. A similar trend is observed for TFBC, 













































which is well dissolved at molecular level in both DMSO and water. However, as 
TFBS forms self-assembled nanoparticles in water, the star-shaped backbone is 
isolated within a relatively hydrophobic environment. As such, TFBS shows a 
significantly higher δmax in water as compared to that for TFBC. This argument is 
further supported by the comparable δmax values in DMSO for TFBC and TFBS 
(Figure 3.1.12), as both are well dissolved at molecular level. However, the δmax of 
TFBS in water is still lower than that for TFBN in toluene, indicating the inevitable 
loss of TPA when converting TPA molecules from low-polar organic solvents into 
high-polar aqueous media. 
A deviation of the TPA maximum from the theoretical value (the double of the 
one-photon absorption maximum) is observed, which is possibly because a higher 
energy excited singlet state could be reached with greater probability by two-photon 
excitation as compared to that by one-photon excitation. As a result, the blue-shifted 
TPA maximum for TFBN relative to that of one-photon absorption maximum is 
observed.  
 
Figure 3.1.12. TPA cross sections of TFBS (black) and TFBC (red) in DMSO. 






















Two-Photon Fluorescence Imaging of Living Cells 
To demonstrate the ability of TFBS as probe for living cell imaging in vitro, 
human cervical cancer cell (Hela cell) line was used as an example. Hela cells were 
incubated with an aqueous solution of TFBS at a concentration of 0.5 μM for 2 hours. 
After the cell uptake, excess of TFBS was washed away and the live cells were 
imaged using TPM. The excitation wavelength was fixed at 800 nm with a laser 
power of ~4 W, which corresponded to 10 mW average power in the focal plane. The 
fluorescent signals were collected from 500 nm to 600 nm. It should be noted that 
TFBS has a δ value of ~570 GM at 800 nm in water, which is sufficient to obtain 
bright TPM images. Moreover, the δ values of TFBS reach up to 1200 GM in the 
range of 730-800 nm, which are larger than that for a number of recently reported 
two-photon fluorescence probes designed for cellular imaging applications.124, 152-155, 
173 As shown in Figure 3.1.13A, the bright green fluorescence indicates successful 
internalization of TFBS by living Hela cells. As a glucose analogue, TFBS is possibly 
internalized by Hela cells through a glucose-specific transport system rather than by 
passive diffusion.173 The TPEF/transmission overlapped image (Figure 3.1.13C) 
suggests that TFBS is mainly located in the cytoplasm area. To identify its 
intracellular localization, we co-stained Hela cells with TFBS and an endosomal 
tracker (LysoTracker Red).174 However, the lack of overlap between LysoTracker Red 
and TFBS indicated that TFBS randomly accumulated throughout cytosol (Figure 
3.1.14). Further work on co-staining cells with TFBS and other vesicular specific 




Figure 3.1.13. A) TPEF B) transmission and C) TPEF/transmission overlapped images of live 
Hela cells upon incubation with TFBS for 2 hours at a concentration of 0.5 μM. Images A-C 
have the same scale bar. 
 
Figure 3.1.14. Colocalization of TFBS (A, λex = 405 nm, 1.25 mW laser power, 510-560 nm 
band pass filter) and LysoTracker Red DND-99 (B, λex = 543 nm, 1 mW laser power, 565-655 
nm band pass filter). Image C is the overlapped image of A and B. Image D is the 
transmission image. Image E is the overlaped image of C and D. Image F shows the 3D 
sectional image. Hela cells were first incubated with 0.5 μM of TFBS for 2 h at 37 °C, and the 
cells were further stained with 50 nM of LysoTracker Red DND-99 in 1× PBS buffer for 5 
min at RT. Images A-E share the same scale bar. 
Cytotoxicity Study 
The cytotoxicity of TFBS was evaluated for mouse embryonic fibroblast normal 
cells (NIH-3T3) using methylthiazolyldiphenyl-tetrazolium (MTT) cell viability assay. 
Figure 3.1.15 shows the in vitro NIH-3T3 cell viabilities after being cultured with 
aqueous TFBS solution at the concentrations of 0.5 and 1 μM for 24, 48 and 72 hours, 
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respectively. The cell viabilities are close to 100% within the tested period of time, 
which indicates low cytotoxicity of TFBS. This low cytotoxicity would benefit TFBS 
for in vitro and in vivo cellular imaging applications. 
 
Figure 3.1.15. Cell viability of NIH-3T3 fibroblast cells after incubation with TFBS at the 
concentrations of 1 and 0.5 μM for 24, 48, and 72 hours, respectively. 
Conclusion 
In conclusion, we have synthesized a glycosylated star-shaped neutral conjugated 
oligomer (TFBS) using a post-functionalization strategy for two-photon fluorescence 
imaging of living cells. Due to the presence of hydrophilic glucose substituents, TFBS 
is able to self-assemble into nanoparticles in aqueous media. The nanoparticles show a 
high TPA cross section of ~1200 GM at 740 nm in water, which is higher than that for 
recently reported water-soluble TPA chromophores for TPM applications. In contrast, 
the TPA spectrum for its cationic counterpart (TFBC) is not measurable using TPEF 
method, due to its extremely low fluorescence in water, which highlights the 
importance of glucose substitution in achieving high TPA action cross-sections in 
water. Moreover, TFBS has low cytotoxicity and efficient permeability to living cells, 
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high-contrast and non-viral manner. This study thus demonstrates an effective 
molecular engineering strategy to develop robust water-soluble TPA materials for 
TPM applications. 
Experimental Section 
Materials and Instruments 
Chemicals and reagents were purchased from Aldrich Chemical Co. unless 
otherwise stated. NMR spectra were collected on a Bruker ACF 300 or AMX 500 
spectrometer with chloroform-d as the solvent (unless otherwise stated) and 
tetramethylsilane as the internal standard. Elemental analysis was carried out by the 
Microanalysis Lab of the National University of Singapore. UV-vis spectra were 
recorded on a Shimadzu UV-1700 spectrometer. Fluorescence measurements were 
carried out on a Perkin Elmer LS-55 instrument equipped with a xenon-lamp 
excitation source and a Hamamatsu (Japan) 928 photomultiplier tube (PMT), using 
90ο angle detection for solution samples. Quantum yields were measured using 
quinine sulfate as the standard, with a quantum yield of 55% in H2SO4 (0.1 M). 
Synthesis 
2-(4-Bromophenyl)benzo[d]thiazole (52): A mixture of 4-bromobenzaldehyde 
(3.7 g, 20 mmol), 2-aminothiophenol (2.5 g, 20 mmol), and N-methyl-2-pyrrolidone 
(NMP) (30 mL) was heated in an oil bath at 110 °C for 72 h. The reaction was allowed 
to open to air, which was then poured into 1:1 ethanol/water. The precipitates were 
collected, recrystallized from ethanol to afford 52 as yellow needle crystals. (2.8 g, 48% 
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yield) 1H NMR (CDCl3, 500 MHz, δ ppm): 8.07 (d, 1H, J = 8.2 Hz), 7.94 (d, 2H, J = 
8.5 Hz), 7.89 (d, 1H, J = 7.9 Hz), 7.61 (d, 2H, J = 8.6 Hz), 7.50 (t, 1H, J = 7.7 Hz), 
7.39 (t, 1H, J = 7.6 Hz). 13C NMR (CDCl3, 125 MHz, δ ppm): 166.68, 154.08, 135.06, 
132.55, 132.23, 128.91, 126.51, 125.46, 125.44, 123.34, 121.67. HRMS (EI, m/z): 
calcd for C13H8N179Br132S1: 288.9561, and C13H8N181Br132S1: 290.9540, found 
288.9566, 290.9548. 
2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]thiazole 
(53): 2-(4-Bromophenyl)benzo[d]thiazole (2.4 g, 8.3 mmol), bis(pinacolato)diborane 
(2.5 g, 10 mmol), KOAc (2.9 g,  29 mmol) and dioxane (60 mL) were mixed 
together in a 100 mL flask. After degassing, [Pd(dppf)Cl2] (250 mg, dppf = 
1,1'-bis(diphenylphosphanyl)ferrocene) was added. The reaction mixture was kept at 
85 °C overnight, which was then cooled to RT. After the organic solvent was removed, 
the residual was dissolved in dichloromethane and washed with water. After drying 
with MgSO4, the solvent was distilled out. The crude product was purified by 
chromatography using ethylacetate/hexanes (1:9, v/v) as eluent to give 53 as a white 
solid (2.4 g, 86% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 8.02 (dd, 4H, J = 8.1 Hz, 
J = 79.7 Hz), 7.99 (dd, 2H, J = 8.0 Hz, J = 95.8 Hz), 7.49 (t, 1H, J = 7.7 Hz), 7.38 (t, 
1H, J = 7.6 Hz), 1.37 (s, 12H). 13C NMR (CDCl3, 125 MHz, δ ppm): 167.97, 154.18, 
135.87, 135.39, 135.16, 126.69, 126.38, 125.33, 123.36, 121.65, 84.11, 25.04.  
HRMS (EI, m/z): calcd for C19H20O2N111B132S1: 337.1308, found 337.1312. 
2-(4-(2-Bromo-9,9'-bis(6-bromohexyl)-fluoren-7-yl)phenyl)benzo[d]thiazole 
(55): 2-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzo[d]thiazole (216 
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mg, 0.64 mmol) and 2,7-dibromo-9,9'-bis(6-bromohexyl)fluorene (1.3 g, 1.9 mmol), 
Pd(PPh3)4 (37 mg, 0.02 mmol), tetrabutylammoniumbromide (cat. amount), toluene (8 
mL), 2M Na2CO3 aqueous solution (1 mL) were mixed together in a 100 mL round 
bottom flask, and the mixture was then degassed. The reaction was kept at 100 οC 
overnight before it was cooled to RT. DCM was added for extraction, and the organic 
layer was washed successively with brine and water, and then dried with MgSO4. 
After solvent removal, the crude product was purified with gradient column 
chromatography using ethyl acetate/ hexane (1:100, v/v) and then (1:9, v/v) to afford 
55 as a white solid (166 mg, 33% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 8.21 (d, 
2H, J = 8.3 Hz), 8.11 (d, 1H, J = 8.1 Hz), 7.93 (d, 1H, J = 7.9 Hz), 7.80 (d, 2H, J = 8.3 
Hz), 7.76 (d, 1H, J = 7.9 Hz), 7.66 (dd, 1H, J = 1.4 Hz, J = 7.9 Hz), 7.60 (m, 2H), 
7.51 (m, 4H), 7.41 (t, 1H, J = 7.6 Hz), 3.28 (t, 4H, J = 6.8 Hz), 2.06-1.96 (m, 4H), 
1.70-1.64 (m, 4H), 1.25-1.07 (m, 8H), 0.70-0.64 (m, 4H). 13C NMR (CDCl3, 125 MHz, 
δ ppm): 167.35, 154.08, 152.78, 150.71, 143.52, 139.83, 139.43, 139.18, 134.90, 
132.34, 130.10, 127.88, 127.45, 126.23, 126.00, 125.07, 123.06, 121.49, 121.27, 
121.20, 121.04, 120.20, 55.30, 39.93, 33.76, 32.46, 28.82,  27.59, 23.43. HRMS (EI, 
m/z): calcd for C38H38N179Br332S1: 777.0275, C38H38N179Br181Br232S1: 781.0234, 
C38H38N179Br281Br132S1: 779.0255, found 777.0255, 781.0214, 779.0223. 
4,4',4"-Tris(pinacolatoborane)phenylamine (56): Tris(4-bromophenyl)amine 
(1.93 g, 4 mmol), bis(pinacolato)diborane (3.75 g, 15 mmol), KOAc (7.0 g, 70 mmol), 
and dioxane (60 mL) were mixed together in a 100 mL flask. After degassing, 
[Pd(dppf)Cl2] (0.5 g, dppf = 1,1'-bis(diphenylphosphanyl)ferrocene) was added. The 
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reaction mixture was kept at 85 °C overnight before it was cooled to RT. The organic 
solvent was removed, and the residual was dissolved in dichloromethane and washed 
with water. After drying the organic layer with MgSO4, the solvent was removed. The 
crude product was purified by flash chromatography using hexane and 
dichloromethane (2:1, v/v) as eluent to give 56 as a white solid (4.2 g, 59% yield). 1H 
NMR (CDCl3, 500 MHz, δ ppm): 7.68 (d, 6H, J = 8.3 Hz), 7.07 (d, 6H, J = 8.4 Hz), 
1.34 (s, 36H). 13C NMR (CDCl3, 125 MHz, δ ppm): 149.80, 135.94, 123.50, 83.70, 
24.90. 
4,4',4"-Tris(4-(2-(4-(benzo[d]thiazol-2-yl)phenyl)-9,9'-bis(6-bromohexyl)fluor
en-7-yl)phenylamine (TFBN): 2-(4-(2-Bromo-9,9'-bis(6-bromohexyl)-fluoren-7-yl) 
-phenyl)benzo[d]thiazole (395 mg, 0.5 mmol) and 4,4',4''-tris(pinacolatoborane) 
-phenylamine (88 mg, 0.14 mmol), Pd(PPh3)4 (37 mg, 3% mmol), 
tetrabutylammonium bromide (cat. amount), toluene (5 mL), 2M Na2CO3 aqueous 
solution (1 mL) were mixed together in a 50mL Schlenk flask, and the mixture was 
degassed. The reaction was kept at 100 οC for 48 h before it was cooled to RT. 
Dichloromethane was added for extraction; organic layer was washed successively 
with brine and water, and then dried with MgSO4. After the solvent was removed 
under reduced pressure, the crude product was purified by gradient column 
chromatography using toluene/hexanes (5:1, v/v), followed by toluene to afford TFBN 
as a yellowish green solid (60 mg, 18% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 
8.21 (d, 6H, J = 8.0 Hz), 8.11 (d, 3H, J = 8.0 Hz), 7.93 (d, 3H, J = 7.5 Hz), 7.83 (m, 
12H), 7.65 (m, 18H), 7.52 (t, 3H, J = 7.5 Hz), 7.41 (d, 3H, J = 7.5 Hz), 7.34 (d, 6H, J 
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= 8.0 Hz), 3.28 (t, 12H, J = 6.8 Hz), 2.11-2.08 (m,12H), 1.69-1.65 (m,12H), 1.24-1.10 
(m, 24H), 0.89-0.77 (m, 12H). 13C NMR (CDCl3, 125 MHz, δ ppm): 151.51, 146.84, 
144.07, 140.92, 139.80, 139.64, 138.92, 135.99, 135.10, 132.42, 129.07, 128.26, 
128.09, 128.03, 127.67, 126.43, 126.32, 125.87, 125.34, 125.26, 124.56, 123.24, 
121.67, 121.29, 120.92, 120.38, 120.28, 55.30, 40.35, 34.00, 32.67, 29.10, 27.80, 
23.69. MS (MALDI-TOF, m/z): calcd for C132H126Br6N4S3: 2344.4 found 2344.3. 
4,4',4"-Tris(4-(2-(4-(benzo[d]thiazol-2-yl)phenyl)-9,9'-bis(6-N,N,N-trimethyla
mmonium)hexyl)fluoren-7-yl)phenylamine (TFBC): Trimethylamine (2 mL) was 
added dropwise to a solution of TFBN (30 mg) in THF (5 mL) at 78 °C. The mixture 
was stirred for 12 h, and then allowed to warm to RT. The precipitate was redissolved 
by addition of methanol (5 mL). After the mixture was cooled to 78 °C, additional 
trimethylamine (2 mL) was added, and the mixture was stirred at RT for 24 h. After 
solvent removal, acetone was added to precipitate the quaternized salt TFBC as 
yellow powders (27 mg, 82% yield). 1H NMR (CD3OD, 500 MHz, δ ppm): 8.11-7.25 
(m, 18H), 3.19 (m, 4H), 3.02 (s, 18H), 2.20 (m, 4H), 1.53 (m, 4H), 1.15 (m, 8H), 0.76 
(m, 4H). 13C NMR (CD3OD, 125 MHz, δ ppm): 167.86, 153.84, 146.83, 141.05, 
139.56, 134.72, 132.04, 127.87, 127.75, 127.25, 126.49, 125.98, 125.40, 124.48, 
122.52, 121.66, 121.02, 120.51, 66.27, 55.37, 52.14, 39.47, 28.83,25.37, 23.53, 22.29. 
MS (MALDI-TOF, m/z): calcd for C150H180Br4N10S3: 2538.0, found 2537.8 (M+- 2Br). 
4,4',4"-Tris(4-(2-(4-(benzo[d]thiazol-2-yl)phenyl)-9,9'-bis(6-thiol-β-D-glucose 
tetraacetate)hexyl)fluoren-7-yl)phenylamine (TFBS-OAc): TFBN (30 mg, 0.013 
mmol), 1-thiol-β-D-glucose tetraacetate (45 mg, 0.123 mmol), and potassium 
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carbonate (130 mg, 1.23 mmol) were placed in a 25 mL round-bottom flask under 
nitrogen atmosphere. Degassed THF (7 mL) was added to the reaction flask, and the 
mixture was stirred at RT for 2 days. After solvent removal, the residue was dissolved 
in dichloromethane (15 mL), washed with water, and dried over anhydrous MgSO4. 
After solvent removal, the crude product was purified by column chromatography on 
silica gel firstly with hexane/EtOAc (1:1, v/v) to remove excess glucose tetraacetate, 
which was followed by hexane/EtOAc (1:2, v/v) to give the target compound as 
yellow solid after precipitation in 20 mL of methanol (35 mg, 67% yield). 1H NMR 
(CDCl3, 500 MHz, δ ppm): 8.22 (d, 6H, J = 8 Hz), 8.11 (d, 3H, J = 8 Hz), 7.94 (d, 3H, 
J = 8 Hz), 7.84 (m, 12H), 7.67 (m, 18H), 7.52 (t, 3H, J = 8 Hz), 7.41 (t, 3H, J = 7.5 
Hz), 7.33 (d, 6H, J = 8.5 Hz), 5.17 (m, 6H), 5.03 (t, 6H, J = 10 Hz), 4.97 (t, 6H, J = 
9.5 Hz), 4.39 (m, 6H), 4.20 (m, 6H), 4.07 (m, 6H), 3.64 (m, 6H), 2.57 (m, 12H), 2.09 
(m, 84H), 1.70 (m, 12H), 1.18 (m, 24H), 0.73 (m, 12H). 13C NMR (CDCl3, 125 MHz, 
δ ppm): 170.16, 169.38, 169.32, 167.71, 154.22, 151.51, 146.79, 144.07, 140.91, 
139.77, 138.86, 135.07, 132.39, 128.09, 127.99, 127.66, 126.42, 125.25, 124.50, 
123.21, 120.24, 83.57, 83.54, 75.80, 73.89, 69.88, 68.33, 62.12, 55.32, 40.52, 32.63, 
29.88, 29.57, 29.46, 28.47, 23.78, 20.71, 20.68, 20.61, 20.58. 
4,4',4"-Tris(4-(2-(4-(benzo[d]thiazol-2-yl)phenyl)-9,9'-bis(6-thiol-β-D-glucose
)-hexyl)fluoren-7-yl)phenylamine (TFBS): TFBS-OAc (30 mg, 0.007 mmol) was 
dissolved in 2 mL of dry dichloromethane and 4 mL of anhydrous methanol under 
nitrogen, 0.3 mL of 0.5 M NaOMe in methanol was subsequently added into the 
solution. The resulting mixture was allowed to react overnight under vigorous stirring 
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at RT. After removing the solvent under reduced pressure, water was added to the 
residue, and the solution was dialyzed against Mill-Q water for 12 hours before it was 
lyophilized to give TFBS as yellow solid (21 mg, 93% yield). 1H NMR (DMSO, 500 
MHz, δ ppm): 8.22-7.27 (m, 18H), 4.98 (m, 4H), 4.39 (m, 2H), 4.16 (m, 2H), 3.61 (m, 
2H), 3.36 (m, 2H), 3.05 (m, 4H), 2.17 (m, 4H), 1.34 (m, 16H), 0.64 (m, 4H). 13C 
NMR (DMSO, 125 MHz, δ ppm): 167.47, 154.17, 151.92, 146.75, 143.69, 141.03, 
138.26, 134.97, 132.13, 128.32, 128.10, 127.19, 126.01, 124.73, 123.36, 122.84, 
121.01, 85.51, 81.37, 78.65, 73.53, 70.48, 61.65, 56.51, 39.85, 39.69, 39.52, 29.70, 
28.58, 19.03. MS (MALDI-TOF, m/z): calcd for C168H12N4O30S9: 3034.1, found 
3034.1(M+). 
TPA Measurement 
TPA spectra were measured using TPEF spectroscopy. The measurements were 
conducted with the excitation of 1 kHz pulse train having a typical pulse duration of 
120 fs and energy of 0.6 μJ/pulse from an optical parametric amplifier, which was 
driven by a Ti:sapphire regenerative amplifier. TPEF was collected in a conventional 
back-scattering geometry, dispersed in a 50 cm monochromator and detected with a 
photomultiplier using standard lock-in amplification. 
The concentrations of solutions were about 10 μM in toluene (TFBN), DMSO 
(TFBC and TFBS) and water (TFBC and TFBS) respectively. 
4,4’-Bis(diphenylamino)stilbene (BDPAS) in toluene was used as reference for TFBN 
in toluene and rhodamine 6G in methanol was used as references for the other 4 




Where δ1 and δ2 are the TPA cross sections, F1 and F2 are the TPEF intensities, η1 
and η2 are the fluorescence quantum yields, c1 and c2 are the concentrations, n1 and n2 
are the refractive indexes of solvents (1 corresponds to reference, 2 is sample). 
Cell Culture and Incubation 
Hela cells and NIH-3T3 fibroblast cells were cultured in Dulbecco’s Modified 
Eagle Medium (DMEM) medium containing 10% fetal bovine serum and 1% 
penicillin–streptomycin at 37 οC in a humidified environment containing 5% CO2. 
Before experiments, the cells were precultured until confluence was reached. 
Cell Viability 
MTT assays were performed to assess the metabolic activity of NIH-3T3 
fibroblast cells. NIH-3T3 cells were seeded in 96-well plates (Costar, IL, USA) at an 
intensity of 2 × 104 cells/mL. After 48 h incubation, the medium was replaced by 
TFBS solutions at the concentrations of 0.5 and 1 μM, and the cells were then 
incubated for 24, 48 and 72 h, respectively. After the designated time intervals, the 
wells were washed twice with 1×PBS buffer and freshly prepared MTT (100 μL, 0.5 
mg/mL) solution in culture medium was added into each well. The MTT medium 
solution was carefully removed after 3 h incubation in the incubator. 
Isopropanol (100 μL) was then added into each well and the plate was gently 
shaken for 10 minutes at RT to dissolve all the precipitate formed. The absorbance of 
MTT at 570 nm was monitored by the microplate reader (Genios Tecan). Cell viability 
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was expressed by the ratio of the absorbance of the cells incubated with TFBS 
solutions to that of the cells incubated with culture medium only. 
Two-photon Fluorescence Imaging 
Hela cells were cultured in chamber (LAB-TEK, Chambered Coverglass System) 
at 37 °C for qualitative study. After 80% confluence, the medium was removed and 
the adherent cells were washed twice with 1 × PBS buffer. TFBS solution (0.8 mL, 0.5 
μM) was then added to the chamber. After incubation for 2 h, cells were washed three 
times with 1 × PBS buffer. The cells were then imaged with multiphoton microscopes 
(Leica TCS SP5 X) with a Leica HCX PL APO 63x/1.20 W CORR CS objective lens. 
The probe was excited with a mode-locked Ti-Sapphire laser source (Chameleon Ultra 
ІІ) at the wavelength of 800 nm with an output power of ~4 W, which corresponded to 
10 mW average power in the focal plane. Internal PMTs were used to collect the 





Green Emissive Triphenylamine Based Oligomer for Targeted 
Two-photon Fluorescence Cellular Imaging 
Introduction 
Water-soluble derivatives of organic TPA materials generally show a significantly 
decreased δ value as compared to their neutral counterparts in organic solvents.99, 
109-110 In Part I of this chapter, we have addressed this problem by integration of 
glucose moieties with the star-shaped π-conjugated oligomer to yield a robust 
water-soluble TPA material (TFBS). TFBS shows high TPA δ = ~1200 GM at 740 nm 
and is used for two-photon fluorescence imaging of Hela cells.175 An effective strategy 
of increasing coplanarity is well known to increase the TPA cross sections of 
π-conjugated oligomers. By replacing the single bond linkers with vinylene linkers, 
not only the coplanarity but also the conjugation length is increased, which could 
increase the TPA cross sections on one hand and red-shift the emission wavelength on 
the other hand.  
Despite the vital importance of targeted cancer cell imaging, there are limited 
reports on the conjugation of organic TPA materials with targeting moieties (e.g. folate, 
antibody, transferrin, epidermal growth factor) for targeted TPEF imaging. Motivated 
by the fact that chitosan, a linear polysaccharide with D-glucosamine unit, allows 
diverse functionalization through the active amine groups,176-178 it occurs to us that we 
could design a glycosylated material for further conjugation to targeting moieties to 
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yield a robust two-photon absorbing material for targeted cancer cell imaging. 
 
Figure 3.2.1. The chemical structures of TVFVBN, TVFVBN-S-NHAc and 
TVFVBN-S-NH2. 
In Part II, we report a star-shaped glucopyranose functionalized oligomer 
(TVFVBN-S-NH2) with a large TPA δ value for targeted two-photon fluorescence 
imaging of cancer cells. The chemical structures of TVFVBN, TVFVBN-S-NHAc and 
TVFVBN-S-NH2 are shown in Figure 3.2.1. We adopted the same pair of donor and 
acceptor, however fluorene vinylene is selected as the bridge due to its good 
molecular coplanarity, which is favourable to high δ values and red-shifted absorption 
and emission maxima as compared to those for TFBS. The influence of glucopyranose 
functionalization on the linear and TPA properties of TVFVBN-S-NH2 is studied. The 
application of folic acid conjugated TVFVBN-S-NH2FA for targeted two-photon 
 80 
 
fluorescence imaging of human breast adenocarcinoma (MCF-7) cells is 
demonstrated. 
Results and Discussion 
Syntheis and Characterization 
The synthetic route towards TVFVBN-S-NH2 is depicted in Scheme 3.2.1. 
2-p-Tolylbenzo[d]thiazole 57 was obtained in 84% yield by heating 
4-methylbenzaldehyde with 2-aminothiophenol in N-methyl-2-pyrrolidone (NMP) at 
110 οC for 72 h. Monobromination of 57 with NBS in CCl4 under light irradiation 
afforded 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 58 in 64% yield. 58 was then 
converted to its phosphonate salt diethyl (4-(benzo[d]thiazol-2-yl)phenyl) 
-methylphosphonate 59 in 84% yield upon heating with triethyl phosphite at 180 οC 
for 3 h.179 Tris(4-formylphenyl)amine 60 was synthesized from triphenylamine and 
DMF using a modified procedure from literature report.180-181 60 was then treated with 
NaBH4 to yield tris(4- hydroxymethylphenyl)amine 61. Further bromination of 61 
with HBr gas afforded tris(4-bromomethylphenyl)amine 62, which upon heating with 
triethyl phosphite at 120 οC yielded tris(4-diethyl phosphonatemethylphenyl)amine 63 
in an overall yield of 67% for three steps. 
9,9-Bis(6-bromohexyl)-9H-fluorene-2,7-dicarbaldehyde 64 was synthesized in 39% 
yield from 2,7-dibromo-9,9-bis(6-bromohexyl)-9H-fluorene using n-BuLi and 
anhydrous DMF at -78 οC. Coupling one equiv. of 59 with 64 under Horner-Emmons 
condition afforded monoaldehyde 65 in 35% yield. Horner-Emmons coupling between 
three equiv. of 63 and 65 gave TVFVBN in 65% yield. The correct structure of 
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TVFVBN was affirmed by NMR and MALDI-TOF mass spectroscopy (Figure 3.2.2 
and 3.2.3). 
 
Scheme 3.2.1. The synthetic route towards TVFVBN-S-NH2 and TVFVBN-S-NH2FA. 
Reagents and conditions: (i) NMP, 110 οC, 72 h; (ii) NBS, CCl4, reflux, 1 h; (iii) triethyl 
phosphite, 180 οC, 3 h; (iv) POCl3, DMF (anhydrous), 0 οC, 1 h, followed by 100 οC overnight; 
(v) NaBH4, MeOH, reflux, 5 h; (vi) HBr(g), CHCl3, RT, overnight; (vii) triethyl phosphite, 
120 οC, overnight; (viii) n-BuLi, DMF (anhydrous), THF (anhydrous), -78 οC to RT, overnight; 
(ix) 3, potassium tert-butoxide, THF (anhydrous), -10 οC, 4 h; (x) 63, potassium tert-butoxide, 
THF (anhydrous), 0 οC, 6 h; (xi) 2-acetamido-2-deoxy-1-thio-β-D-glucopyranose 
3,4,6-triacetate, K2CO3, THF (anhydrous), RT, 72 h; (xii) hydrazine monohydrate, reflux, 48 h; 
(xiii) folic acid, DCC/NHS, pyridine, RT, overnight. 
Further reaction between TVFVBN and 2-acetamido-2-deoxy-1-thio-β-D 




















61 R = CH2OH
62 R = CH2Br


























in 80% yield. The disappearance of the triplet at 3.29 ppm (CH2Br) in the 1H NMR 
spectrum (Figure 3.2.4) of TVFVBN-S-NHAc indicates 100% attachment of 
glucopyranose onto TVFVBN. The correct molecular mass was confirmed by the 
MALDI-TOF spectroscopy (Figure 3.2.5). Cleavage of the amides in 
TVFVBN-S-NHAc in the presence of hydrazine under reflux condition182-184 afforded 
TVFVBN-S-NH2 in 94% yield after dialysis and freeze drying. The 1H NMR 
spectrum for TVFVBN-S-NH2 is shown in Figure 3.2.6. The singlet for acetyl groups 
from the 1H-NMR spectrum of TVFVBN-S-NHAc is almost unobservable, which 
indicates the successful deacetylation of NHAc and OAc groups to NH2 and OH, 
respectively. The folic acid conjugation was conducted using 
N,N'-dicyclohexylcarbodiimide/N-hydroxysuccinimide (DCC/NHS) at a molar ratio of 
1:10 for folic acid and TVFVBN-S-NH2 to give folic acid functionalized 
TVFVBN-S-NH2FA. After purification by dialysis using a 3.5 KDa molecular weight 
cut-off membrane against Mill-Q water for two days, TVFVBN-S-NH2FA was 
obtained in quantitative yield as orange powders after freeze drying. The 1H-NMR 





Figure 3.2.2. 1H-NMR spectrum of TVFVBN in CDCl3. 
 
Figure 3.2.3. MALDI-TOF mass spectrum of TVFVBN. 
 
Figure 3.2.4. 1H-NMR spectrum of TVFVBN-S-NHAc in CDCl3. 





















































































































































NAME             wg0318
EXPNO                 3
PROCNO                1
F2 - Acquisition Parameters
Date_          20110318
Time              17.38
INSTRUM           av500
PROBHD   5 mm BBO BB-1H
PULPROG            zg30
TD                32768
SOLVENT           CDCl3
NS                    8
DS                    0
SWH           10330.578 Hz
FIDRES         0.315264 Hz
AQ            1.5860696 sec
RG                203.2
DW               48.400 usec
DE                 6.00 usec
TE                300.4 K
D1           1.00000000 sec
TD0                   1
======== CHANNEL f1 ========
NUC1                 1H
P1                11.30 usec
PL1               -2.00 dB
SFO1        500.1330885 MHz
F2 - Processing parameters
SI                16384
SF          500.1300136 MHz
WDW                  EM
SSB                   0
LB                 0.30 Hz
GB                    0

































































































































































































































































































































































































*** Acquisition  Parameters ***
LOCNUC : 2H
NS :              8
NUCLEUS : off
O1 :        3088.51 Hz
PULPROG : zg30
SFO1 :    500.1330885 MHz
SOLVENT : CDCl3
SW :        20.6557 ppm
TD :          32768
TE :          300.0 K
*** Processing Parameters ***
LB :           0.30 Hz
SF :    500.1300140 MHz











Figure 3.2.5. MALDI-TOF mass spectrum of TVFVBN-S-NHAc. 
 
Figure 3.2.6. 1H-NMR spectrum of TVFVBN-S-NH2 in DMSO. 
 




































































































































































































































































































































































































































































































































The self-assembly behaviours of TVFVBN-S-NH2 and TVFVBN-S-NH2FA were 
studied using DLS. As shown in Figure 3.2.8, the mean diameter for TVFVBN-S-NH2 
in water is ~49 nm with a polydispersity (PDI) of 0.23 (Figure 3.2.8a), while that for 
TVFVBN-S-NH2FA is ~50 nm with a PDI of 0.27 (Figure 3.2.8b). The polydispersities 
for both (0.23 and 0.27) are less than 0.3, which indicate that they form nanoparticles 
that are medium-dispersed in water.185-187 
 
Figure 3.2.8. DLS spectra of 2 μM TVFVBN-S-NH2 (a) and TVFVBN-S-NH2FA (b) in water, 
and TEM images of TVFVBN-S-NH2 (c) and TVFVBN-S-NH2FA (d) nanoparticles. 
Transmission electron microscopy (TEM) was performed to study the morphology 

















































TVFVBN-S-NH2 and TVFVBN-S-NH2FA solutions (2 μM in water) onto copper grid. 
As shown in Figures 3.2.8c and 3.2.8d, both TVFVBN-S-NH2 and TVFVBN-S-NH2FA 
form spherical nanoparticles with mean diameters of ~20 nm. The smaller size in TEM 
as compared to those in DLS is due to the shrinking of samples when transformed into 
dry state from solutions.112, 188 The fact that both TVFVBN-S-NH2 and 
TVFVBN-S-NH2FA have nearly the same nanoparticles size indicates that folic acid 
conjugation does not obviously change the self-assembly behaviour of 
TVFVBN-S-NH2 in water. However, it is noteworthy that both TVFVBN-S-NH2 and 
TVFVBN-S-NH2FA are dissolved into molecular level in DMSO with no DLS signals. 
Linear Optical Properties 
The UV-vis absorption and PL spectra of TVFVBN in different solvents at a 
concentration of 2 μM are shown in Figure 3.2.9. The absorption spectra of TVFVBN 
in toluene, DCM and DMF have the same shape and maxima, which indicate that the 
ground state of TVFVBN is not sensitive to solvent polarity.167, 189 On the other hand; 
the emission maximum of TVFVBN in toluene is at 486 nm, which is red-shifted to 
564 nm in dichloromethane. The quantum yields of TVFVBN in toluene and 
dichloromethane are 0.99 and 0.68, respectively, measured using Rhodamine 6G in 
methanol as the reference. However, under the same experimental conditions, no 
fluorescence is observed for TVFVBN in DMF. Our previous molecular orbital 
simulation indicates that charge transfer from electron rich triphenylamine to electron 
deficient benzothiazole units exists in excited state.175 Similarly, the red-shifted 
emission maxima and decreased fluorescence quantum yields with increased solvent 
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polarity for TVFVBN are due to the charge transfer characteristics of its excited state. 
As a result, bright greenish blue and orange fluorescent colours are observed for the 
toluene and dichloromethane solutions of TVFVBN, while its DMF solution is not 
emissive (the inset of Figure 3.2.9). 
 
Figure 3.2.9. UV-vis absorption (dashed) and PL (solid) spectra of TVFVBN in toluene 
(black), DCM (blue) and DMF (green). The inset shows the fluorescence from the solutions of 
TVFVBN in toluene, DCM and DMF under a hand-held UV lamp with λmax = 365 nm. 
 
Figure 3.2.10. UV-vis absorption (dashed) and PL (solid) spectra of TVFVBN-S-NH2 in 
DMSO (black) and H2O (red) , and TVFVBN-S-NH2FA in H2O (blue) . The inset shows the 
fluorescence of TVFVBN-S-NH2 in H2O and DMSO under a hand-held UV lamp with λmax = 
365 nm. 
The absorption and emission spectra of TVFVBN-S-NH2 in DMSO and pure 
toluene DCM DMF























































water are presented in Figure 3.2.10. The absorption spectra of TVFVBN-S-NH2 in 
DMSO and water are similar, with the maximum at 393 nm. The emission maxima of 
TVFVBN-S-NH2 in DMSO and water locate at 494 nm and 542 nm, respectively. The 
quantum yield of TVFVBN-S-NH2 in water is 0.21, which is substantially higher than 
that in DMSO (0.07). The higher quantum yield of TVFVBN-S-NH2 in water as 
compared to that in DMSO is ascribed to the formation of nanoparticles, as supported 
by the DLS and TEM measurements. In DMSO, TVFVBN-S-NH2 is dissolved into 
molecular level as aforementioned, and the charge transfer between TVFVBN-S-NH2 
and DMSO quenches the fluorescence. However, the nanoparticles formed in water 
provide hydrophobic microenvironment for TVFVBN-S-NH2, which reduces its 
interaction with water for fluorescence quenching.112 After conjugation with folic acid, 
the optical properties of TVFVBN-S-NH2FA are nearly the same as those for 
TVFVBN-S-NH2, which indicate that folic acid conjugation does not change the 
linear optical properties of TVFVBN-S-NH2 in water. As shown in the inset of Figure 
3.2.10, the aqueous solution of TVFVBN-S-NH2 shows bright yellow fluorescence, 
indicating a high potential for optical applications. 
TPA Properties 
The TPA spectra of TVFVBN in toluene, TVFVBN-S-NH2 and 
TVFVBN-S-NH2FA in water were collected using a standard TPEF technique with a 
femtosecond pulsed laser source.102, 168 To avoid the interference on TPEF by laser 
excitation, TPA spectra were measured starting at the wavelength where each 
individual oligomer has nearly no emission. In addition, limited by the laser 
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availability in our experiments, TVFVBN in toluene was investigated in the range 
from 740 nm to 900 nm, while TVFVBN-S-NH2 in water was studied from 750 nm to 
900 nm. 
 
Figure 3.2.11. TPA cross sections of TVFVBN in toluene. 
 
Figure 3.2.12. TPA cross sections of TVFVBN-S-NH2 in water. 














































Figure 3.2.13. TPA cross sections of TVFVBN-S-NH2FA in water. 
The TPA spectrum of TVFVBN in toluene (Figure 3.2.11) shows a maximum δ 
value of 3031 GM at 820 nm. This value is ~500 GM larger than TFBN (2494 
GM),175 which is ascribed to the increased coplanarity with ethylene linker for 
TVFVBN. This δ value is also larger than those for octupolar tribranched molecules 
using triphenylamine as the core, with fluorenyl-ethylene linker and SO2CF3 (2080 
GM)53 or CHO (1265 GM)92 as the peripheries, respectively. This agrees with that an 
elongated conjugated backbone and a proper degree of ICT favour larger TPA δ 
values.190 
The TPA spectrum of TVFVBN-S-NH2 in water is shown in Figure 3.2.12. The 
maximum TPA δ value is 1098 GM at 780 nm, giving an action cross section value 
(ηδ) of 230 GM. As TVFVBN and TVFVBN-S-NH2 share the same backbone, the 
decrease of TPA δ value compared to that in toluene is due to the solvent effect, 
because water can influence the electronic structure of Donor-Acceptor chromophores 
via hydrogen bonding, which leads to decreased ICT.109 Further study of 
TVFVBN-S-NH2FA under the same conditions yielded a similar 　δ value (Figure 























3.2.13). As a consequence, the large TPA ηδ of TVFVBN-S-NH2 in water would 
ensure a high brightness in two-photon biological imaging applications. Moreover, the 
λmax(TPA) of 780 nm makes TVFVBN-S-NH2 more appealing for biological 
applications as compared to TFBS, since excitation at longer wavelength can lead to 
less photo-damage and photo-bleaching. 
Targeted Two-photon Fluorescence Cancer Cell Imaging 
To demonstrate the potential of glycosylated materials in targeted cellular 
imaging, CLSM and TPEF cellular imaging of MCF-7 cancer cells were investigated 
with TVFVBN-S-NH2FA and TVFVBN-S-NH2. MCF-7 cancer cells are known to 
overexpress folate receptors, and therefore TVFVBN-S-NH2FA with folate targeting 
ligands is expected to offer a higher uptake by MCF-7 cells compared to 
TVFVBN-S-NH2. MCF-7 cells were incubated with TVFVBN-S-NH2 and 
TVFVBN-S-NH2FA at the molar concentration of 1 μM before fixation and image. As 
shown in Figure 3.2.14, both CLSM images of MCF-7 cells incubated with 
TVFVBN-S-NH2 (Figure 3.2.14A) and TVFVBN-S-NH2FA (Figure 3.2.14B) show 
green fluorescence. In addition, the fluorescence from Figure 3.2.14B is about 3 times 
(estimated using ImageJ, quantification data shown in Figure 3.2.15) more intense as 
compared to that from Figure 3.2.14A, which indicates the increased cellular uptake 
of TVFVBN-S-NH2FA by MCF-7 cells. Figures 3.2.14D and 3.2.14E are the overlay 
images with nuclei stained, which clearly indicate that both TVFVBN-S-NH2 and 




Figure 3.2.14. CLSM images of MCF-7 breast cancer cells after incubation with 
TVFVBN-S-NH2 (A) and TVFVBN-S-NH2FA (B); Image A or B together with propidium 
iodide nucleus stain is shown in (D) or (E). CLSM images of MCF cells incubated firstly with 
free folic acid for 30 min and then with TVFVBN-S-NH2FA for 2 h (C). Image (C) together 
with propidium iodide nucleus stain is shown in (F). All images share the same scale bar. 
 
Figure 3.2.15. Integrated intensity of individual MCF-7 cancer cell after incubation with 
TVTVBN-S-NH2FA (A) and TVTVBN-S-NH2 (B) using CLSM; with TVTVBN-S-NH2FA (C) 
and TVTVBN-S-NH2 (D) using TPM. Images were processed by ImageJ and 30 cells with 
similar size were analyzed individually for each sample. 
To confirm the folate receptor-mediated targeting effect of TVFVBN-S-NH2FA, 
we studied the competitive effect of folic acid on the endocytosis of 
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fluorescence image of free folic acid pretreated MCF-7 cells shows lower intensity as 
compared to that in Figure 3.2.14B. This indicates that the uptake of 
TVFVBN-S-NH2FA is greatly inhibited by the free folic acid treatment, which 
effectively blocks the interaction between TVFVBN-S-NH2FA and the folate receptor 
on the cell surface.118 In addition, NIH-3T3 fibroblast normal cells, which lack folate 
receptor on the cell membrane, were also used as a negative control. The CLSM 
images of NIH-3T3 cells treated with TVFVBN-S-NH2FA and TVFVBN-S-NH2 are 
shown in Figure 3.2.16. The fluorescence intensities in Figure 3.2.16A (stained with 
TVFVBN-S-NH2) and Figure 3.2.16C (stained with TVFVBN-S-NH2FA) are 
comparable to each other, which are weaker than that in Figure 3.2.14B (estimated 
using ImageJ, quantification data shown in Figure 3.2.17). These data indicate the 
specific binding between TVFVBN-S-NH2FA and folate receptor on cell surface, 
which shows the ability of TVFVBN-S-NH2FA to discriminate folate-positive cancer 
cells from others. 
 
Figure 3.2.16. CLSM images of NIH-3T3 cells incubated with TVFVBN-S-NH2 (A) and 
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TVFVBN-S-NH2FA (C) for 2 h. Image A or C together with propidium iodide nucleus stain is 
shown in (B) or (D). Images A-D share the same scale bar. 
 
Figure 3.2.17. Integrated intensity of individual MCF-7 cancer cells incubated firstly with 
free folic acid then with TVFVBN-S-NH2FA (A) and NIH-3T3 cells after incubation with 
TVFVBN-S-NH2 (B) and TVFVBN-S-NH2FA (C) using CLSM; Images were processed by 
ImageJ and 30 cells with similar size were analyzed individually for each sample. 
 
Figure 3.2.18. A) TPEF images of MCF-7 breast cancer cells after incubation with 
TVFVBN-S-NH2 (A) and TVFVBN-S-NH2FA (B). A and B share the same scale bar. 
The TPEF images MCF-7 cells incubated with TVFVBN-S-NH2 and 
TVFVBN-S-NH2FA are shown in Figures 3.2.18A and 3.2.18B, respectively. Green 
fluorescence was obtained in both images upon excitation at 800 nm with an average 
laser power of 10 mW on the focal plane. The fluorescence from Figure 3.2.18B is 
substantially brighter than that from Figure 3.2.18A (quantification data shown in 
Figure 3.2.15), which is ascribed to the increased cellular uptake of 






















fluorescence from Figure 3.2.18B should benefit from the large TPA cross section of 
TVFVBN-S-NH2 in the 750-830 nm region (up to 1098 GM), which is substantially 
larger than a number of fluorescent probes designed for TPEF imaging applications.124, 
152-154, 173 These data clearly illustrate the potential of using TVFVBN-S-NH2FA as 
two-photon fluorescent probe for targeted TPEF cellular imaging. 
Cytotoxicity and Photo-Stability Study 
The cytotoxicity of TVFVBN-S-NH2 and TVFVBN-S-NH2FA was evaluated for 
MCF-7 cells using MTT cell viability assay. Figure 3.2.19 shows the in vitro MCF-7 
cell viabilities after being cultured with TVFVBN-S-NH2 and TVFVBN-S-NH2FA 
solution at the concentrations of 1, 10 and 100 μM for 24, 48 and 72 hours, 
respectively. Within the test period of time, the cell viabilities are close to 100% at 10 
μM each (10 times the concentration used for imaging studies in this work), indicating 
low cytotoxicity of both TVFVBN-S-NH2 and TVFVBN-S-NH2FA. When the 
concentration is increased to 100 μM, both oligomers exhibit slight cytotoxicity (the 
cell viabilities drop to ~80%). These studies indicate that both oligomers are suitable 
for in vitro and in vivo cellular imaging studies. The changes in the CLSM and TPM 
images of MCF-7 cells treated with TVFVBN-S-NH2FA before and after continuous 
laser scanning for 10 min were also monitored. As shown in Figure 3.2.20, the 
intensity decreases in both the CLSM and TPM fluorescence image are less than 20% 
of its original intensity (estimated using Image J), which indicate good photostability 




Figure 3.2.19. Cell viability of MCF-7 breast cancer cells after incubated with 
TVFVBN-S-NH2 and TVFVBN-S-NH2FA at the concentrations of 1, 5 and 10 μM for 24, 48, 
and 72 hours, respectively. 
 
Figure 3.2.20. CLSM images of MCF-7 cells incubated with TVFVBN-S-NH2FA under 
continuous laser scanning for 0 min (A), 5 min (B) and 10 min (C) upon excitation at 405 nm. 
TPEF images under continuous laser scanning for 0 min (D), 5 min (E) and 10 min (F) upon 
excitation at 800 nm. All images share the same scale bar. The figure on the right shows the 
quantification data of the fluorescence intensities decrease in CLSM and TPM images 
processed using ImageJ. 
Conclusion 
In summary, we have synthesized glucopyranose functionalized star-shaped 





































































The precursor oligomer TVFVBN-S-NH2 has been found to self-assemble into 
nanoparticles with a quantum yield of 0.21 in water. These nanoparticles have a large 
TPA cross section of ~1100 GM at 780 nm in aqueous solution when calculated based 
on molecules. More importantly, this glycosylated material is born with a reactive 
amine group on each glucopyranose substituent, which allows further modification 
with versatile biocompatible elements or bio-recognition moieties. As a demonstration, 
folic acid was conjugated to TVFVBN-S-NH2 to yield TVFVBN-S-NH2FA, which 
shows similar self-assembly behaviours and optical properties as those to 
TVFVBN-S-NH2. Cellular study reveals that both nanoparticles show low cytotoxicity, 
and TVFVBN-S-NH2FA is more favourable to MCF-7 cells, due to specific folic 
acid-folate receptor interaction on cell membrane. As a result, this study highlights the 
glycosylation strategy as an effective molecular engineering approach to develop 
robust materials with good water-dispersibility, self-assembly ability and large TPA 
cross sections for targeted cancer cell imaging. 
Experimental Sections 
Materials and Instruments 
Chemicals and reagents were purchased from Sigma-Aldrich Chemical Co. 
(Singapore) unless otherwise stated. NMR spectra were collected on a Bruker AMX 
500 spectrometer with chloroform-d as the solvent (unless otherwise stated) and 
tetramethylsilane as the internal standard. Elemental analyses were carried out by the 
Microanalysis Laboratory of the National University of Singapore. UV-vis spectra 
were recorded on a Shimadzu UV-1700 spectrometer. Fluorescence measurements 
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were carried out on a Perkin Elmer LS-55 instrument equipped with a xenon-lamp 
excitation source and a Hamamatsu (Japan) 928 photomultiplier tube (PMT), using 
90ο angle detection for solution samples. Quantum yields were measured using 
Rhodamine 6G in methanol as reference. 
Synthesis 
2-p-Tolylbenzo[d]thiazole (57): A mixture of 4-methylbenzaldehyde (7 mL, 58 
mmol), 2-aminothiophenol (7 mL, 65 mmol), and NMP (50 mL) was heated in an oil 
bath at a temperature of 110 °C for 72 h. The reaction was allowed to open to air, 
which was then poured into 1:1 ethanol/water. The precipitates were collected, 
recrystallized from ethanol to afford 57 as yellow needle crystals (11 g, 84% yield). 
1H NMR (CDCl3, 500 MHz, δ ppm): 8.06 (d, 1H, J = 8 Hz), 7.99 (d, 2H, J = 8.5 Hz), 
7.89 (d, 1H, J = 8 Hz), 7.49 (t, 1H, J = 7 Hz), 7.37(t, 1H, J = 8 Hz), 7.29 (d, 2H, J = 8 
Hz), 2.43 (s, 3H). 13C NMR (CDCl3, 125 MHz, δ ppm): 168.25, 154.19, 141.44, 
134.98, 131.00, 129.74, 127.52, 126.26, 125.02, 123.08, 121.58, 21.54. MS (EI, m/z): 
225.1 (M+). 
2-(4-(Bromomethyl)phenyl)benzo[d]thiazole (58): 2-p-Tolylbenzo[d]thiazole 
57 (1.5 g, 6.7 mmol) and NBS (1.2 g, 6.7 mmol) were mixed in CCl4 (40 mL). The 
suspension was irradiated to reflux under a 120 W lamp for 1 h. Completion of 
reaction was confirmed by TLC. After cooling down to RT, the succinimide salt was 
filtered off and solvent was removed under reduced pressure. The residue was 
dissolved in dichloromethane and washed with water for three times. The organic 
layer was dried with MgSO4 and solvent was subsequently removed under reduced 
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pressure. The crude product was recrystallized from ethanol to yield 58 as white 
crystals. (1.4 g, 64% yield) 1H NMR (CDCl3, 500 MHz, δ ppm): 8.09-8.06 (m, 3H), 
7.90 (d, 1H, J = 8 Hz), 7.51-7.48 (m, 3H), 7.40 (t, 1H, J = 8 Hz), 4.53 (s, 2H). 13C 
NMR (CDCl3, 125 MHz, δ ppm): 167.13, 154.16, 140.58, 135.13, 133.66, 129.68, 
126.43, 125.37, 123.37, 121.65, 32.55. MS (EI, m/z): 303.0 (M+), 305.0 (M+), 224.1 
(M+-Br). 
Diethyl(4-(benzo[d]thiazol-2-yl)phenyl)methylphosphonate (59): 2-(4-(Bromo 
-methyl)phenyl)benzo[d]thiazole 58 (1.2 g, 4 mmol) and triethyl phosphite (1.0 g, 6 
mmol) were mixed and heated at 180 °C for 3 h under argon atmosphere. After 
cooling down to 50 °C, excess of triethyl phosphite was distilled off under vacuum. 
The crude yellow solid product was dissolved in diethyl ether and precipitate in 
hexane to afford 59 as white needle crystals (1.2 g, 84% yield). 1H NMR (CDCl3, 500 
MHz, δ ppm): 8.11-8.07 (m, 3H), 7.93 (d, 1H, J = 8 Hz), 7.51 (t, 1H, J = 7.5 Hz), 
7.47-7.45 (m, 2H), 7.42 (t, 1H, J = 7 Hz). 13C NMR (CDCl3, 125 MHz, δ ppm): 
167.68, 154.16, 135.09, 135.05, 135.02, 132.37, 132.34, 130.46, 130.41, 127.72, 
127.69, 126.33, 125.19, 123.21, 121.60, 62.30, 62.25, 34.47, 33.38, 16.41, 16.36. MS 
(EI, m/z): 361.1 (M+), 224.0 (M+-C4H10O3P). 
Tris(4-formylphenyl)amine (60): Phosphorus oxychloride (9.5 mL, 101.9 mmol) 
was added dropwise to dry DMF (7.3 mL, 94.3 mmol) at 0 °C under argon 
atmosphere. The mixture was stirred at 0 °C for 1 h and additionally stirred at RT for 1 
h. After the addition of triphenylamine (5.0 g, 20.4 mmol) in chloroform (5 mL), the 
mixture was stirred at 100 °C overnight. After cooling, the solution was poured into 
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400 mL of ice water and the resulting mixture was neutralized to pH 7 with 5% NaOH 
aqueous solution. After extraction with dichloromethane, the organic layer was 
washed with brine and water for three times. The organic layer was dried with MgSO4 
and solvent was removed under reduced pressure. The residue was filtered through a 
short column with hexane/dichloromethane (1:2, v/v) to produce yellowish solids. 
After drying, the solid was added into an ice-cooled mixture of phosphorus 
oxychloride (9.5 mL, 101.9 mmol) and dry DMF (7.3 mL, 94.3 mmol) under argon 
atmosphere. The resulting mixture was heated at 100 °C overnight. After cooling, the 
solution was poured into 400 mL of ice water and the resulting mixture was 
neutralized to pH 7 with 5% NaOH aqueous solution, which was then extracted with 
dichloromethane. The organic layer was washed with brine and water, and dried over 
MgSO4. After the solvent was removed under reduced pressure, the residue was 
columned using hexane/dichloromethane (1:4, v/v) to yield 60 as yellow crystals (2.7 
g, 40% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 9.96 (s, 3H), 7.85 (d, 6H, J = 8.5 
Hz), 7.27 (d, 6H, J = 7 Hz). 13C NMR (CDCl3, 125 MHz, δ ppm): 190.51, 151.21, 
132.59, 131.52, 124.55. MS (EI, m/z): 329.0 (M+). 
Tris(4-hydroxyphenyl)amine (61): Tris(4-formylphenyl)amine 60 (1.0 g, 3.0 
mmol) and NaBH4 (1.6 g, 42.6 mmol) were suspended into 50 mL of methanol, which 
was then refluxed for 5 h. After cooling down to RT, the reaction solution was 
quenched with water. The mixture was further diluted with 200 mL of water and 
neutralized to pH = 7 using diluted acetic acid. White solid precipitated after 
neutralization, which was collected via centrifugation and dried under vacuum to give 
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61 as white solid (1 g, 98% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 7.25 (d, 6H, J 
= 8.5 Hz), 7.06 (d, 6H, J = 8.5), 4.65 (s, 6H). 13C NMR (CDCl3, 125 MHz, δ ppm): 
147.27, 135.31, 128.30, 124.17, 65.08. MS (EI, m/z): 335.2 (M+). 
Tris(4-bromomethylphenyl)amine (62): HBr gas was bubbled into a suspension 
of tri(4-hydroxyphenyl)amine 61 (500 mg, 1.5 mmol) in 200 mL of CHCl3 for 20 min. 
The resulted solution was allowed to stir at RT for 2 days in a sealed round bottom 
flask. Nitrogen gas was then bubbled into the solution to remove excess of HBr gas. 
The resulted solution was washed with 150 mL of saturated NaHCO3 and then washed 
with brine before drying with MgSO4. Solvent removal under reduced pressure gave 
62 as white solid (708 mg, 90% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 7.27 (d, 
6H, J = 8.5 Hz), 7.03 (d, 6H, J = 8 Hz), 4.49 (s, 6H). MS (EI, m/z): 524.9 (M+), 444.0 
(M+-Br). 
Tris(4-diethylphosphonatemethylphenyl)amine (63): Tri(4-bromomethyl 
-phenyl)amine 62 (500 mg, 0.95 mmol) and triethyl phosphite (712 mg, 4.3 mmol) 
were mixed under argon atmosphere. The resulted mixture was heated at 120 °C 
overnight. After cooling down to 50 °C, the excess of triethyl phosphite was removed 
using vacuum distillation. The residue was dissolved in diethyl ether and poured into 
30 mL hexane to give 63 as colorless oil (500 mg, 76% yield). 1H NMR (CDCl3, 500 
MHz, δ ppm): 7.16-7.14 (m, 6H), 6.97 (d, 6H, 8.5 Hz), 4.04 (quintet, 12H), 3.09 (d, 
6H, J = 21.5 Hz), 1.25 (t, 18H, J = 7.5 Hz). 13C NMR (CDCl3, 125 MHz, δ ppm): 
146.45, 146.43, 130.66, 130.60, 125.78, 125.70, 124.08, 124.06, 62.13, 62.08, 33.64, 
32.54, 16.36, 16.32. MS (EI, m/z): 695.4 (M+). 
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9,9-Bis(6-bromohexyl)-9H-fluorene-2,7-dicarbaldehyde (64): 2,7-Dibormo 
-9,9-di(6-bromohexy)fluorene (3.9 g, 6.0 mmol) in 60 mL of freshly distilled THF 
was cooled to -78 °C with a dry ice/acetone bath under argon atmosphere. At -78 °C, 
n-BuLi in hexane (9 mL, 12.4 mmol) was added dropwise into the solution, which 
was stirred for 30 min. Anhydrous DMF (1.2 mL, 15 mmol) was subsequently added, 
and the solution was stirred for another 2 h at -78 °C before kept at RT overnight. The 
resulting mixture was quenched with water, and the solvent was removed by 
evaporation. After extraction with dichloromethane, the organic phase was separated 
and dried over MgSO4. After solvent removal under reduced pressure, the residue was 
purified with silica gel column using hexane/DCM (3:2, v/v) to afford 64 as colorless 
oil (1.3 g, 39% yield) which solidified after standing in fridge overnight. 1H NMR 
(CDCl3, 500 MHz, δ ppm): 10.07 (s, 2H), 7.92-7.88 (m, 6H), 3.20 (t, 4H, J = 7 Hz), 
2.07-2.04 (m, 4H), 1.69-1.56 (m, 4H), 1.11-1.02 (m, 8H), 0.88-0.53 (m, 4H). 13C 
NMR (CDCl3, 125 MHz, δ ppm): 191.93, 152.51, 145.56, 136.58, 130.37, 123.33, 
121.43, 55.45, 39.83, 33.69, 32.52, 28.87, 27.70, 23.59. MS (EI, m/z): 548.2 (M+). 
7-((E)-2-(4-(Benzo[d]thiazol-2-yl)phenyl)vinyl)-9,9-bis(6-bromohexyl)-9H-flu
orene-2-carbaldehyde (65): Diethyl (4-(benzo[d]thiazol-2-yl)phenyl) 
-methylphosphonate 59 (200 mg, 0.55 mmol) and 9,9-Bis(6-bromohexyl)-9H-fluorene 
-2,7-dicarbaldehyde 64 (274 mg, 0.50 mmol) were dissolved in 10 mL freshly distilled 
THF under argon atmosphere. The solution was cooled to -10 °C, and a suspension of 
potassium tert-butoxide (140 mg, 1.24 mmol) in 5 mL dry THF was added dropwise. 
The reaction was kept at -10 °C for 4 h, and then quenched with water. The solvent of 
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the mixture was removed by evaporation. After extraction with dichloromethane, the 
organic layer was washed with brine and water, dried with MgSO4 and solvent was 
removed under reduced pressure. The residue was columned with DCM/hexane (1:1, 
v/v) to give 65 as yellow solid (132 mg, 35% yield). 1H NMR (CDCl3, 500 MHz, δ 
ppm): 10.07 (s, 1H), 8.13-8.08 (m, 3H), 7.92 (d, 1H, J = 8 Hz), 7.88-7.83 (m, 3H), 
7.78 (d, 1H, J = 7.5 Hz), 7.69 (d, 2H, J = 8.5 Hz), 7.60 (d, 1H, J = 8 Hz), 7.54-7.49 (m, 
2H), 7.40 (t, 1H, J = 8 Hz), 7.34 (d, 1H, J = 16.5 Hz), 7.26 (d, 1H, J = 16.5 Hz), 3.27 
(t, 4H, J = 7 Hz), 2.08-2.06 (m, 4H), 2.05-1.68 (m, 4H), 1.63-1.08 (m, 8H), 0.65-0.59 
(m, 4H). 13C NMR (CDCl3, 125 MHz, δ ppm): 192.19, 167.64, 154.21, 152.48, 151.47, 
147.09, 139.91, 139.69, 137.80, 135.43, 135.03, 132.79, 130.87, 130.49, 128.23, 
128.00, 127.10, 126.42, 126.31, 125.25, 123.20, 122.84, 121.64, 121.42, 121.08, 
120.14, 55.19, 40.14, 33.82, 32.58, 28.99, 27.76, 23.57. MS (EI, m/z): 755.3 (M+). 
N-Tris(4,4',4"-((1E)-2-(2-((E)-2-(4-(benzo[d]thiazol-2-yl)phenyl)vinyl)-9,9-bis
(6-bromohexyl)-9H-fluoren-7-yl)vinyl)phenyl)phenylnamine (TVFVBN): 7-((E) 
-2-(4-(benzo[d]thiazol-2-yl)phenyl)vinyl)-9,9-bis(6-bromohexyl)-9H-fluorene-2-carba
ldehyde 65 (100 mg, 0.13 mmol) and tris(4-diethylphosphonatemethylphenyl)amine 
63 (26 mg, 0.037 mmol) was mixed in 10 mL of dry THF under argon atmosphere, 
and the solution was cooled down to 0 °C. A suspension of potassium tert-butoxide 
(19 mg, 0.17 mmol) in 5 mL of dry THF was added dropwise into the solution. The 
reaction was kept at 0 °C for 6 h before it was quenched with water. The solvent was 
removed under reduced pressure and dichloromethane was used for extraction. The 
organic layer was washed with brine and water and then dried with MgSO4. After 
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solvent removal, the residue was columned using DCM/hexane (1:1, v/v) to give 
TVFVBN as yellow solid (60 mg, 65% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 
8.12-8.07 (m, 9H), 7.91 (d, 3H, J = 8.5 Hz), 7.69-7.67 (m, 12H), 7.56-7.47 (m, 21H), 
7.40 (t, 3H, J = 6 Hz), 7.33 (d, 3H, J = 15.5 Hz), 7.24-7.17 (m, 15H), 3.28 (t, 12H, J = 
7.5 Hz), 2.07-2.04 (m, 12H), 1.69-1.64 (m, 12H), 1.24-1.13 (m, 24H), 0.88-0.86 (m, 
12H). 13C NMR (CDCl3, 125 MHz, δ ppm): 167.71, 154.28, 151.32, 151.28, 141.21, 
140.34, 140.25, 138.92, 136.85, 135.96, 135.06, 132.52, 130.98, 129.06, 127.98, 
127.05, 126.97, 126.39, 126.16, 125.71, 125.19, 124.35, 123.19, 121.64, 120.93, 
120.60, 120.18, 120.10, 114.11, 54.96, 40.38, 34.02, 32.65, 29.09, 27.77, 23.59. MS 
(MALDI-TOF, m/z): calcd. for C144H138Br6N4S3: 2500.5; found 2500.5 (M+). 
N-Tris(4,4',4"-((1E)-2-(2-((E)-2-(4-(benzo[d]thiazol-2-yl)phenyl)vinyl)-9,9-bis
(6-2-acetamido-2-deoxy-1-thio-β-D-glucopyranose-3,4,6-triacetate-hexyl)-9H-fluo
ren-7-yl)vinyl)phenyl)phenylnamine (TVFVBN-S-NHAc): N-tris(4,4',4"-((1E)-2 
-(2-((E)-2-(4-(benzo[d]thiazol-2-yl)phenyl)vinyl)-9,9-bis(6-bromohexyl)-9H-fluoren-
7-yl)vinyl)phenyl)phenylnamine TVFVBN (30 mg, 0.012 mmol), 2-acetamido 
-2-deoxy-1-thio-β-D-glucopyranose 3,4,6-triacetate (52 mg, 0.14 mmol) and K2CO3 
(200 mg, 1.4 mmol) were mixed in 5 mL of THF. The mixture was stirred at RT for 3 
days. The solvent was removed and the residue was dissolved with dichloromethane. 
After washing with brine and water, and drying with MgSO4, the solvent was removed 
under reduced pressure. Gradient column chromatography firstly using ethyl acetate to 
remove excess of 2-acetamido-2-deoxy-1-thio-β-D-glucopyranose 3,4,6-triacetate, 
then EtOAc/MeOH (10:1, v/v) to give TVFVBN-S-NHAc as yellow solid after 
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precipitation from methanol (40 mg, 80% yield). 1H NMR (CDCl3, 500 MHz, δ ppm): 
8.11 (d, 2H, J = 8 Hz), 8.08 (d, 1H, J = 8.5 Hz), 7.91 (d, 1H, J = 8 Hz), 7.69 (m, 4H), 
7.56-7.46 (m, 7H), 7.40-7.36 (m, 2H), 7.25-7.17 (M, 5H), 5.57-5.51 (m, 2H), 
5.14-5.01 (m, 4H), 4.47-4.43 (m, 2H), 4.18-3.99 (m, 6H), 3.58-3.54 (m, 2H), 
2.58-2.52 (m, 4H), 2.00-1.98 (m, 22H), 1.87 (m, 6H), 1.43-1.40 (m, 4H), 1.17-1.11 (m, 
8H), 0.69-0.66 (m, 4H). 13C NMR (CDCl3, 125 MHz, δ ppm): 171.04, 170.63, 170.01, 
169.29, 167.69, 154.16, 151.42, 140.24, 134.99, 128.00, 127.01, 126.42, 125.22, 
123.14, 121.63, 120.93, 84.41, 75.80, 73.87, 68.49, 62.31, 54.97, 53.27, 40.47, 33.39, 
29.80, 29.37, 29.28, 28.38, 28.27, 23.46, 23.20, 20.69, 20.62. MS (MALDI-TOF, m/z): 
calcd. for C228H258N10O48S9: 4193.56; found: 4193.34 (M+). 
N-Tris(4,4',4"-((1E)-2-(2-((E)-2-(4-(benzo[d]thiazol-2-yl)phenyl)vinyl)-9,9-bis
(6-2-amido-2-deoxy-1-thio-β-D-glucopyranose-hexyl)-9H-fluoren-7-yl)vinyl)phen
yl)-phenylnamine (TVFVBN-S-NH2): N-tris(4,4',4"-((1E)-2-(2-((E)-2-(4-(benzo 
-[d]thiazol-2-yl)phenyl)vinyl)-9,9-bis(6-2-acetamido-2-deoxy-1-thio-β-D-glucopyrano
se-3,4,6-triacetate-hexyl)-9H-fluoren-7-yl)vinyl)phenyl)-phenylnamine TVFVBN-S 
-NHAc (20 mg, 0.0047 mmol) and hydrazine monohydrate (1 mL) was heated at 
120 °C in a sealed tube for 2 days. After cooling down to RT, the reaction mixture was 
purified by dialysis against Mill-Q water using a 3.5kDa molecular weight cut-off 
dialysis membrane for 3 days. It was then lyophilized to give TVFVBN-S-NH2 as a 
yellow solid (14 mg, 94% yield). 1H NMR (DMSO-d6, 500 MHz, δ ppm): 8.10 (d, 1H, 
J = 7.5 Hz), 8.01 (d, 1H, J = 7.5 Hz), 7.49 (d, 2H, J = 7 Hz), 7.65-7.60 (m, 4H), 7.52 
(t, 1H, J = 7.5 Hz), 7.45 (t, 1H, J = 8 Hz), 7.35 (d, 2H, J = 6.5 Hz), 7.15 (m, 8H), 6.81 
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(m, 2H), 4.98-4.94 (m, 2H), 4.45-4.10 (m, 4H), 3.62-3.60 (m, 2H), 3.06-2.83 (m, 14H), 
2.41-2.40 (m, 4H), 1.82-1.80 (m, 4H), 1.23 (br, 4H), 0.99-0.91 (m, 8H), 0.40 (br, 4H). 
TVFVBN-S-NH2FA: The conjugation of TVFVBN-S-NH2 with folic acid was 
carried out through DCC/NHS coupling reaction. In brief, folic acid (1 mmol) in 20 
mL of DMSO was activated using DCC (1.2 mmol) and NHS (2 mmol) at 50 °C for 6 
hours. After reaction, the insoluble salt was filtered off. 2 μL of the resulted 
folate-NHS solution (containing 1 x 10-4 mmol of folate-NHS) was added into 
TVFVBN-S-NH2 (3 mg, 1 x 10-3 mmol) in 1 mL of DMSO, together with a catalytic 
amount of pyridine. The reaction mixture was stirred overnight at RT. The resulted 
solution was dialyzed using a 3.5 kDa molecular weight cutoff dialysis membrane for 
2 days to eliminate the unreacted folate-NHS. TVFVBN-S-NH2FA was finally 
collected after lyophilisation in a quantitive yield. 
Cell Culture and Incubation 
MCF-7 breast cancer cells were cultured in DMEM medium containing 10% fetal 
bovine serum and 1% penicillin–streptomycin at 37 οC in a humidified environment 
containing 5% CO2. Before experiments, the cells were precultured until confluence 
was reached. 
Cell Viability 
MTT assays were performed to assess the metabolic activity of MCF-7 breast 
cancer cells. MCF-7 cells were seeded in 96-well plates (Costar, IL, USA) at an 
intensity of 2 × 104 cells/mL. After 48 h incubation, the medium was replaced by 
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TVFNBN-S-NH2 and TVFNBN-S-NH2FA solutions at the concentrations of 1 and 3 
μM, and the cells were then incubated for 24, 48 and 72 h, respectively. After the 
designated time intervals, the wells were washed twice with 1×PBS buffer and freshly 
prepared MTT (100 μL, 0.5 mg/mL) solution in culture medium was added into each 
well. The MTT medium solution was carefully removed after 3 h incubation in the 
incubator. 
Isopropanol (100 μL) was then added into each well and the plate was gently 
shaken for 10 minutes at RT to dissolve all the precipitate formed. The absorbance of 
MTT at 570 nm was monitored by the microplate reader (Genios Tecan). Cell viability 
was expressed by the ratio of the absorbance of the cells incubated with 
TVFNBN-S-NH2 and TVFNBN-S-NH2FA solutions to that of the cells incubated with 
culture medium only. 
One- and Two-Photon Fluorescence Imaging 
MCF-7 cells and NIH-3T3 cells were cultured in chamber (LAB-TEK, 
Chambered Coverglass System) at 37 °C for qualitative study. After 80% confluence, 
the medium was removed and the adherent cells were washed twice with 1 × PBS 
buffer. TVFNBN-S-NH2 and TVFNBN-S-NH2FA solutions (0.8 mL, 1 μM) were then 
added to the chambers. After incubation for 2 h, cells were washed three times with 1 
× PBS buffer and then fixed by 75% ethanol for 20 min, which was further washed 
with 1 × PBS buffer twice. The nuclei were stained with propidium iodide (PI) for 40 
min. The cells were then imaged by CLSM (Zeiss LSM 410, Jena, Germany) with 
imaging software (Fluoview FV1000). TVFNBN-S-NH2 and TVFNBN-S-NH2FA 
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were excited at 405 nm (3% laser power), and the fluorescence was collected from 
505-560 nm. PI was excited at 543 nm and the fluorescence was collected at 575-635 
nm. To study the competitive effect of free folic acid on the endocytosis of 
TVFVBN-S-NH2FA, 50 μg/mL free folic acid in medium was first added into the 
chamber. After 30 min, the medium was replaced by 1 μM TVFVBN-S-NH2FA and 
incubated for 2 h before imaging. 
To obtain two-photon images, the cells (without nuclei stained) were imaged with 
multiphoton microscopes (Leica TCS SP5 X) with a Leica HCX PL APO 63x/1.20 W 
CORR CS objective lens. The probes were excited with a mode-locked Ti-Sapphire 
laser source (Chameleon Ultra ІІ) with 10 mW average power in the focal plane. 
Internal PMTs were used to collect the signals at 505-560 nm in an 8 bit unsigned 





Red Emissive Pyrene Based Oligomer for Generic Two-photon 
Fluorescence Cellular Imaging 
Introduction 
In the first two parts of this chapter, we have successfully tuned the emission 
wavelengths of the octupolar triphenylamine based TPA molecules from the blue to 
the green spectral region via replacement of single bond linkers with vinylene linkers. 
As a continuing work to develop highly desirable TPA materials with further 
red-shifted emission wavelengths, we move on to search for other donor-acceptor 
pairs. 
Pyrene is a very attractive π-centre for construction of fluorescent molecules in 
various applications.191 In particular, 1,3,6,8-tetrasubstituted pyrene based materials 
have shown delocalized π electrons, high photoluminescence efficiency and discotic 
shapes, which represent a very interesting class of materials for optoelectronic 
applications.192-194 It is reported that tetra-substituted 4-(N,N’-dimethyl 
-amino)phenylethynyl pyrene derivatives exhibit large TPA δ of up to 1150 GM.76 
However, these reported pyrene-based TPA materials are limited to organic soluble 
blue and green emitters. Previous studies have shown that extension of conjugation 
length or the introduction of donor and acceptor structures in a π-conjugated system 
can easily lead to red emissive fluorophores.195-197 As pyrene is an electron rich moiety, 
it occurs to us that fine tune the peripheries of pyrene with electron withdrawing 
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groups would likely to yield TPA materials with red emission. 
In Part III of this chapter, we report the design and synthesis of a water-soluble 
pyrene-based orange emitter (Pyrene4BTF-PEG-TAT) with large Stokes shift and 
good TPA δ for one- and two-photon fluorescence imaging. Electron deficient 
benzothiadiazole (BT) groups were selected to form the acceptor-donor pair with 
pyrene. The peripheral fluorenyl units serve to elongate the conjugation and provide 
active sites for click reactions. PEG chains are harnessed onto the fluorenyl units to 
bring in water-solubility. In addition, a cell penetrating peptide (HIV-1 tat peptide) is 
attached to the terminals of PEG to enhance the cellular uptake. The results reveal that 
Pyrene4BTF-PEG-TAT self-assembles into nanoparticles with orange-red emission 
and low cytotoxicity, which are successfully internalized by Hela cells to yield one- 
and two-photon fluorescence images in a high contrast manner. 
Results and Discussion 
Synthesis and Characterization 
The synthetic route towards Pyene4BTF-PEG-TAT is depicted in Scheme 3.3.1. 
Coupling between 2-(9,9-bis(6-bromohexyl)-9H-fluoren-7-yl)-4,4,5,5-tetramethyl 
-1,3,2-dioxaborolane and 4,7-dibromobenzo[c][1,2,5]thiadiazole afforded 
4-(9,9-bis(6-bromohexyl)-9H-fluoren-2-yl)-7-bromobenzo[c][1,2,5]thiadiazole (66) in 
40% yield. 66 was then reacted with bis(pinacolato)diborane in anhydrous dioxane to 
give 4-(9,9-bis(6-bromohexyl)-9H-fluoren-2-yl)-7-(4,4,5,5-tetramethyl-1,3,2-di 
-oxaborolan-2-yl)benzo[c][1,2,5]thiadiazole (67) in 47% yield. Four equiv. of 67 was 
subsequently reacted with 1,3,6,8-tetrabromopyrene in anhydrous dioxane to afford 
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Pyrene4BTF in 60% yield. The correct structure of Pyrene4BTF is affirmed by NMR 
spectroscopy (Figure 3.3.1) and by MALDI-TOF mass spectroscopy (Figure 3.3.2). 
 
Scheme 3.3.1. The synthetic route towards Pyrene4BTF-PEG-TAT. i) Pd(PPh3)4, K2CO3 (2 
M), toluene, 85 οC, overnight; ii) bis(pinacolato)diborane, [Pd(dppf)Cl2], KOAc, dioxane 
(anhydrous), 85 οC, overnight; iii) Pd(PPh3)4, K2CO3, dioxane (anhydrous), 85 οC, overnight; 
iv) DMF/THF, NaN3, RT, 24 h; v) sodium ascorbate, CuSO4, DMF, RT, 24 h; vi) HIV-1 tat 
peptide, sulfo-NHS, EDAC, DMSO/water, RT, overnight. 
Pyrene4BTF was converted to Pyrene4BTF-N3 upon reaction with NaN3 in a 
mixture of DMF/THF for 24 h. The complete replacement of the triplet at 3.28 ppm 
(C5H10CH2Br) by the triplet at 3.12 ppm (C5H10CH2N3) in the 1H NMR spectrum of 
























































between Pyrene4BTF-N3 and propyne-PEG(1k)-COOH afforded 
Pyrene4BTF-PEGCOOH quantitatively. The newly appeared broad peaks at 3.4-3.7 
ppm (PEG) confirm the successful attachment of PEG onto Pyrene4BTF core (Figure 
3.3.4). Furthermore, the integrated areas for the peaks at 4.2 ppm 
(PEGOCH2CH2-triazole) and 2.0 ppm (Fluorenyl-9-CH2C5H10) are the same, which 
indicate the complete attachment of eight PEG chains. This is further confirmed by the 
MALDI-TOF mass, which shows the correct molecular weight of 10570 (Figure 
3.3.5). It is worthy to note that the broadening of the NMR signals is due to the factors 
such as molecular aggregation, hydrogen bonding. Pyrene4BTF-PEGCOOH was 
subsequently conjugated with HIV-1 tat peptide using 
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDAC) and 
N-hydroxysulfosuccinimide (sulfo-NHS) in DMSO/H2O to afford 
Pyrene4BTF-PEG-TAT, which was purified by dialysis against MillQ water for 5 days 
using a 12 KDa molecular weight cut-off membrane. As compared to Figure 3.3.4 (1H 
NMR for Pyrene-4BTF-PEGCOOH), the newly appeared peaks from ~1.0 ppm to 
~2.0 ppm in the 1H NMR spectrum of Pyrene4BTF-PEG-TAT (Figure 3.3.6) are 
assigned to the protons from the tat peptide. As we failed to obtain the molecular mass 
of Pyrene4BTF-PEG-TAT by MALDI-TOF mass spectroscopy, its molecular weight 
was measured using gel permeation chromatography (GPC) with polystyrene in DMF 
solvent as the reference. The molecular weight (Mn) is 16900, which indicates that on 




Figure 3.3.1. 1H NMR spectrum of Pyrene4BTF in CDCl3. 
 
Figure 3.3.2. MALDI-TOF mass spectrum of Pyrene4BTF. 
 































































































































































































































































































































































































































Figure 3.3.4.1H NMR spectrum of Pyrene4BTF-PEGCOOH in MeOD. 
 
Figure 3.3.5. MALDI-TOF mass spectrum of Pyrene4BTF-PEGCOOH. 
 












































































































































































Linear Optical Properties 
The solvent effect on the optical properties for Pyrene4BTF was firstly 
investigated. Figure 3.3.7 shows the UV-vis absorption and PL spectra of Pyrene4BTF 
in toluene, DCM and DMF, respectively. The absorption spectra for Pyrene4BTF in all 
three solvents are similar, indicating that the ground state of Pyrene4BTF is not 
sensitive to solvent polarity.112 The absorption peak at 300 nm is characteristic of the 
unsubstituted parent pyrene. The peaks at 375 nm and 400 nm are ascribed to the π-π* 
transitions of the fluorene segments and the benzothiadiazole segments, respectively. 
In contrast, the emission maxima for Pyrene4BTF progressively red shifted from 558 
nm in toluene to 585 nm in DCM and 614 nm in DMF. The η for Pyrene4BTF are 
0.35 in toluene, 0.18 in DCM and 0.14 in DMF, respectively. The red-shifted emission 
maxima and decreased η for Pyrene4BTF with increasing solvent polarity are ascribed 
to the charge transfer characteristics in the excited states of Pyrene4BTF, which is 
affirmed by molecular simulation. As shown in Figure 3.3.8, the HOMO energy level 
of Pyrene4BTF is mainly delocalized over the pyrene unit, while the LUMO is nearly 
localized on the BT unit. Such orbital patterns implicate that the HOMO-LUMO 
transition for Pyrene4BTF is accompanied by charge transfer from the electron 
donating pyrene to the electron accepting BT unit in the excited state. In polar 
solvents, the stabilization of the excited state of Pyrene4BTF with large dipole 
moments is larger. This leads to the redistribution of the π electrons in the molecules, 
which competes with the excitation of the π electrons in the molecules. The decrease 
of fluorescence quantum yields is affected by non-radiative decay. The fluorescent 
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colours of the solutions (the inset of Figure 3.3.7) change from greenish yellow in 
toluene to orange in DCM and orange red in DMF as a result of the solvent dependent 
emission. 
 
Figure 3.3.7. UV-vis absorption (dashed line) and PL (solid line) spectra of Pyrene4BTF in 
toluene (black), DCM (red) and DMF (blue). Each solution has a concentration of 2 μM. The 
inset shows the emission colour of Pyrene4BTF in toluene, DCM and DMF under a hand-held 
UV lamp upon excitation at 365 nm. 
 
Figure 3.3.8. The HOMO and LUMO energy levels and the frontier molecular orbitals of 
Pyrene4BTF obtained from DFT calculation at the B3LYP/6-31G* level. The 6-bromohexyl 
side chains are replaced with methyl groups in the calculations. 
The UV-vis absorption and PL spectra of Pyrene4BTF-PEG-TAT in DMSO and 
H2O are shown in Figure 3.3.9. The absorption spectra for Pyrene4BTF-PEG-TAT in 

























HOMO: 5.08 eV LUMO: 2.47 eV
 117 
 
DMSO and H2O are similar and the emission maxima in DMSO and H2O locate at 
614 nm and 586 nm, respectively. Usually, chromophores with charge transfer 
characteristics suffer sharp decrease in fluorescence η from organic solvents into 
aqueous media.110, 175 In contrast, the η for Pyrene4BTF-PEG-TAT in water (0.11) is 
comparable to that in DMSO (0.12). To understand this interesting phenomenon, DLS 
was performed for 2 μM Pyrene4BTF-PEG-TAT in water and in DMSO. The DLS 
result (Figure 3.3.9b) shows that Pyrene4BTF-PEG-TAT self-assembles into 
nanoparticles of ~ 190 nm size, while no signal is observed in DMSO. The 
morphology of Pyrene4BTF-PEG-TAT nanoparticles was studied using TEM. The 
TEM image (Figure 3.3.10) indicates the spherical shape of Pyrene4BTF-PEG-TAT 
nanoparticles with average diameter of ~90 nm. The smaller size as compared to the 
DLS result is due to shrinking of nanoparticles transforming into dry state from 
aqueous solution. It is reported that the self-assembled nanoparticles could shield the 
invasion from water to provide a less polar microenvironment than H2O and DMSO 
for the molecular backbone.99. 198-199 This is well supported by the blue-shifted 
emission maximum for Pyrene4BTF-PEG-TAT nanoparticles in H2O as compared to 
that in DMSO as molecular species. The DLS result of Pyrene4BTF-PEGCOOH 




Figure 3.3.9. (a) UV-vis absorption (dashed line) and PL (solid line) spectra of 
Pyrene4BTF-PEG-TAT in DMSO (black) and in H2O (red). Each solution has a concentration 
of 2 μM. The inset shows the emission colours of Pyrene4BTF-PEG-TAT in DMSO and H2O 
under a hand-held UV lamp upon excitation at 365 nm; (b) DLS spectrum of 
Pyrene4BTF-PEG-TAT in water. 
 
Figure 3.3.10. TEM image for Pyrene4BTF-PEG-TAT nanoparticles. 











































Figure 3.3.11. DLS spectrum of Pyrene-4BTF-PEGCOOH in water. 
TPA Properties 
The TPA spectra of Pyrene4BTF in toluene and Pyrene4BTF-PEG-TAT in water 
were collected using a standard TPEF technique with a femtosecond pulsed laser 
source.102, 168 To avoid the interference on TPEF by laser excitation, TPA spectra were 
measured starting at the wavelength where Pyrene4BTF and Pyrene4BTF-PEG-TAT 
have nearly no emission. In addition, limited by the laser available in our experiments, 
TPA cross sections were measured in the range from 800 nm to 950 nm. 
 
Figure 3.3.12. TPA cross sections for Pyrene4BTF in toluene (black) and 
Pyrene4BTF-PEG-TAT in water (red). 
Figure 3.3.12 shows the TPA spectra of Pyrene4BTF in toluene and 










































Pyrene4BTF-PEG-TAT in water. The maximum TPA δ values are 964 GM for 
Pyrene4BTF and 512 GM for Pyrene4BTF-PEG-TAT at 820 nm, respectively. The 
TPA δ for Pyrene4BTF in toluene is comparable to the reported value (1150 GM at 
820 nm) for pyrene-centred 1,3,6,8-tetrakis[4-(N,N-dimethylamino)phenylethynyl] 
-pyrene, consisting of four donor substituents;76 and is higher than that for the 
triphenylamine centred chromophores containing BT acceptors (δ = 800 GM at 780 
nm).73 It is well-known that the third-order nonlinear TPA process is strongly 
dependent on ICT.21-24 For Pyrene-4BTF, the large δ value is ascribed to the efficient 
ICT from pyrene centre to four strong BT acceptors, as shown in Figure 3.3.8. In 
addition, the star-shaped architecture of Pyrene4BTF could bring in cooperative 
enhancement in its TPA δ.53 Although similar TPA λmax and band structure are 
observed for Pyrene4BTF-PEG-TAT in water as compared to Pyrene4BTF in toluene, 
the TPA δ value for the former is lower. This could be ascribed to the difference in 
solvent polarity, as solvents have been reported to yield changes in the electronic 
structures of chromophores and to provide perturbation on δ.109 
One- and Two-Photon Fluorescence Imaging 
To demonstrate the potential of Pyrene4BTF-PEG-TAT in both CLSM and TPEF 
cellular imaging application, Hela cell line was used as an example. Hela cells were 
incubated with 1 µM Pyrene4BTF-PEG-TAT at 37 οC for 2 h. Excess of 
Pyrene4BTF-PEG-TAT was washed away and Hela cells were then fixed and imaged. 
In CLSM, the excitation wavelength was fixed at 405 nm and the fluorescence 
was collected after 610 nm. As shown in Figure 3.3.13, bright red fluorescence from 
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the cells indicates that Pyrene4BTF-PEG-TAT could be effectively internalized by 
Hela Cells. Figure 3.3.13C shows an overlay image of Figure 3.3.13A (CLSM image) 
and Figure 3.3.13B (transmission image), which indicates that Pyrene4BTF-PEG-TAT 
locates primarily in the cytoplasm, which is further affirmed by a 3D cross section 
image (Figure 3.3.13D). 
  
Figure 3.3.13. (A) CLSM, (B) transmission, (C) transmission/CLSM overlay and (D) 3D 
cross sectional images of Hela Cells after incubated with 1 µM Pyrene4BTF-PEG-TAT for 2 h. 
Images A-C share the same scale bar. 
As a negative control, we investigated the CLSM cellular imaging of Hela cells 
incubated with Pyrene4BTF-PEGCOOH, which lacks tat peptide conjugation. As 
shown in Figure 3.3.14A and 3.3.14B, the image of Hela cells stained with 
Pyrene4BTF-PEGCOOH for 2 h only shows weak fluorescence with a few fluorescent 
dots. This indicates that Pyrene4BTF-PEGCOOH has limited cellular uptake by Hela 
cells. This is probably associated with cell repellent effect200 between the proteins on 
cell surface and thick PEG layer of particles, which is clearly visualized by scanning 
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electron microscopy (SEM). The rough morphology for the Pyrene4BTF-PEGCOOH 
nanoparticles (Figure 3.3.15) suggests that PEG grafting chains form outer layer 
during the self-assembly.201 Similar insufficient internalization of materials with PEG 
segments has also been reported.130, 202 In addition, the zeta potential for 
Pyrene4BTF-PEGCOOH nanoparticles was measured to be -5.10 ± 0.36 mV, which is 
due to the presence of carboxylic acid groups at the PEG terminals. After conjugation 
of positively charged tat peptide, the zeta potential for Pyrene4BTF-PEG-TAT 
nanoparticles increases to 14.9 ± 0.60 mV. It is reported that positively charged 
chitosan nanoparticles show increased cellular uptake than negatively charge ones, as 
the cell surface is negatively charged.203 Similarly, the insufficient cellular uptake of 
Pyrene4BTF-PEGCOOH nanoparticles by Hela cells in this study could also be 
attributed to their negative zeta potential. Furthermore, the cellular uptake of 
Pyrene4BTF-PEGCOOH in the presence of free tat peptide was also studied. As 
shown in Figure 3.3.14C and 3.3.14D, the uptake of Pyrene4BTF-PEGCOOH in the 
absence and presence of free tat peptide is similar, which indicates that free tat peptide 
does not have positive effects on the cellular uptake. These results indicate that tat 




Figure 3.3.14. (A) CLSM, (B) CLSM/transmission overlap images of Hela cells incubated 
with Pyrene4BTF-PEGCOOH for 2 h. (C) CLSM, (D) CLSM/transmission overlap images of 
Hela cells incubated with Pyrene4BTF-PEGCOOH in the presence of free tat peptide for 2 h. 
 
Figure 3.3.15. SEM image for Pyrene4BTF-PEGCOOH nanoparticles. 
In TPM, the excitation wavelength was fixed at 800 nm with an average laser 
power of ~25 mW on the focal plane, and the fluorescence was also collected after 
610 nm. It should be noted that the TPA cross section of Pyrene4BTF-PEG-TAT at 
800 nm is ~365 GM, which is sufficient for TPM imaging. As shown in Figure 
3.3.16A, the TPEF image of Hela cells shows bright red fluorescence upon excitation. 





Figure 3.3.16. (A) TPEF, (B) transmission and (C) transmision/TPEF overlay images of of 
Hela Cells after incubated with 1 µM Pyrene4BTF-PEG-TAT for 2 h. Images A-C share the 
same scale bar. 
Cell Viability 
The cytotoxicity of Pyrene4BTF-PEG-TAT was evaluated for Hela Cells using 
MTT cell viability assay. Figure 3.3.17 shows the in vitro Hela cell viabilities after 
being cultured with aqueous Pyrene4BTF-PEG-TAT solutions at concentrations of 1, 
5 and 10 μM for 24, 48 and 72 hours, respectively. Within the period of test, the cell 
viabilities are close to 100% even at the high concentration of 10 μM, which is 10 
times the concentration used for imaging in this study. The low cytotoxicity of 
Pyrene4BTF-PEG-TAT indicates its suitability for cellular imaging applications. 
 





























We have demonstrated that pyrene could be used as an electron donating 
π-centre to construct robust orange-red emissive water-soluble two-photon absorbing 
materials for both one- and two-photon fluorescence imaging applications. Molecular 
simulation reveals efficient intramolecular charge transfer from pyrene (donor) to 
benzothiadiazole (acceptor) within the star-shaped architecture, which consequently 
brings in large TPA δmax of 964 GM for Pyrene4BTF in toluene and 512 GM for 
Pyrene4BTF-PEG-TAT in water at 820 nm, respectively. It was found that 
Pyrene-4BTF-PEG-TAT self-assembled into nanoparticles of ~190 nm in water, which 
could be effectively internalized by Hela cells. The optical properties of 
Pyrene-4BTF-PEG-TAT including large Stokes shift (181 nm in water), orange-red 
emission and large TPA δ highlight its potential as a new imaging material. To the best 
of our knowledge, this is the first example of water-soluble TPA materials based on 
pyrene as the π-donor centre. Future work on selecting other acceptors to pair with 
pyrene is believed to yield more TPA materials with further fine-tuned emission and 
increased δ for bioimaging applications. 
Experimental Sections 
Materials and Methods 
Propyne-PEG(1k)-COOH was purchased from Biomatrik Inc (Zhejiang, China). 
HIV-1 tat peptide with a sequence of NH2-RKKRRQRRRC was synthesized by 
GenicBio Limited. Fetal bovine serum (FBS) was purchased from Gibco (Lige 
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Technologies, Ag, Switzerland). Dulbecco’s modified essential medium (DMEM) was 
a commercial product of National University Medical Institutes (Singapore). CDCl3 
and CD3OD were purchased from Cambridge Isotope Laboratories. 
3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT), 
penicillinstreptomycin solution and all other chemicals and reagents were purchased 
from Sigma-Aldrich (Singapore). Dialysis tubes were purchased from Fisher 
Scientific Pte Ltd (Singapore). NMR spectra were collected on a Bruker ACF 300 or 
AMX 500 spectrometer with CDCl3 or CD3OD as the solvent and tetramethylsilane as 
the internal standard. MALDI-TOF mass were recorded on a Bruker Auto Flex III 
TOF machine at Mass Spectrometry Laboratory of National University of Singapore. 
GPC analysis was conducted on a Waters GPC systems equipped with a Waters 2414 
Refractive Index Detector, a Waters 1515 Isocractic HPLC Pump and a Waters 
717Plus Autosampler. DMF was used as the eluent at a flow rate of 3 mL/min at 35 οC. 
Polystyrene was used as standard. UV-vis spectra were recorded on a Shimadzu 
UV-1700 spectrometer. Fluorescence measurements were carried out on a Perkin 
Elmer LS-55 instrument equipped with a xenon-lamp excitation source and a 
Hamamatsu (Japan) 928 photomultiplier tube (PMT), using 90ο angle detection for 







-lane (123 mg, 2.0 mmol), 4,7-dibromobenzo[c][1,2,5]thiadiazole (590 mg, 2.0 mmol), 
Pd(PPh3)4 (20 mg) and potassium carbonate (2.00 g, 20 mmol) were placed in a 50 
mL round-bottom flask. A mixture of water (10 mL) and toluene (20 mL) was added 
to the flask and the reaction vessel was degassed. The mixture was vigorously stirred 
at 85 οC overnight. After cooling down to RT, the reaction was extracted with DCM. 
The organic layer was washed with brine and water, and then dried with MgSO4 
before solvent removal under reduced pressure. The residue was purified by silica gel 
chromatography using DCM/hexane (1:5, v/v) as the eluent to give 66 as greenish 
yellow crystals (560 mg, 40% yield). 1H NMR (500 MHz, CDCl3, δ ppm): 8.01-7.87 
(m, 3 H), 7.85 (d, 1H, J = 8 Hz), 7.76 (d, 1H, J = 7 Hz), 7.66 (d, 1H, J = 7.5 Hz), 
7.45-7.31 (m, 3H), 3.27 (t, 4H, J = 7 Hz), 2.13-1.96 (m, 4 H), 1.75-1.63 (m, 4 H), 
1.33-1.18 (m, 4 H), 1.18-1.04 (m, 4 H), 0.86-0.66 (m, 4 H). 13C NMR (125 MHz, 
CDCl3, δ ppm): 154.01, 153.36, 152.84, 150.91, 141.77, 140.51, 135.38, 134.50, 
132.32, 128.25, 128.06, 127.59, 127.09, 123.80, 122.92, 120.14, 119.90, 112.82, 55.17, 
40.13, 33.93, 32.61, 29.05, 27.74, 23.62. MS (EI, m/z): 706.5 (M+). 
4-(9,9-Bis(6-bromohexyl)-9H-fluoren-2-yl)-7-(4,4,5,5-tetramethyl-1,3,2-dioxa
borolan-2-yl)benzo[c][1,2,5]thiadiazole (67): 4-(9,9-Bis(6-bromohexyl)-9H-fluoren 
-2-yl)-7-bromobenzo[c][1,2,5]thiadiazole (500 mg, 0.71 mmol), bis-(pina 
-colato)diborane (230 mg, 0.92 mmol), KOAc (2.70 g, 2.9 mmol), and anhydrous 
dioxane (10 mL) were mixed together. After degassing, 19 mg of Pd(dppf)Cl2 was 
added. The reaction mixture was stirred at 85 οC overnight, and then cooled to RT. 
The organic solvent was removed, and the residual solid was extracted with 
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dichloromethane and washed with water. After drying with MgSO4, the solvent was 
removed. The crude product was purified by silica gel chromatography using 
hexane/DCM (1:1, v/v) as the eluent to give 67 as a yellow solid (306 mg, 47% yield). 
1H NMR (500 MHz, CDCl3, δ ppm): 8.27 (d, 1H, J = 7 Hz), 7.97-7.95 (m, 2H), 7.84 
(d, 1H, J = 8 Hz), 7.77-7.76 (m, 2H), 7.38-7.34 (m, 3H), 3.26 (t, 4H, J = 6.5 Hz), 
2.07-2.00 (m, 4H), 1.69-1.63 (m, 4H), 1.47 (s, 12H), 1.28-1.07 (m, 8H) 0.79-0.70 (m, 
4H). 13C NMR (125 MHz, CDCl3, δ ppm): 158.31, 153.46, 150.99, 150.67, 141.68, 
140.61, 139.13, 137.68, 136.12, 128.46, 127.48, 127.03, 126.87, 124.08, 122.90, 





-1,3,2-dioxaborolan-2-yl)benzo[c][1,2,5]thiadiazole (200 mg, 0.28 mmol), 
1,3,6,8-tetrabromopyrene (24 mg, 0.05 mmol), Pd(PPh3)4 (5 mg) and potassium 
carbonate (60 mg, 0.6 mmol) were placed in a 50 mL round-bottom flask. Anhydrous 
dioxane (10 mL) was added after degassing. The reaction mixture was stirred at 85 οC 
overnight, and then cooled to RT. The organic solvent was removed, and the residue 
was extracted with dichloromethane and washed with brine and water. After drying 
with MgSO4, the organic solvent was removed. The crude product was purified by 
silica gel chromatography using hexane/DCM (1:2, v/v) as the eluent to give 
Pyrene4BTF as an orange-red solid (80 mg, 60% yield). 1H NMR (500 MHz, CDCl3, 
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δ ppm): 8.52 (s, 2H), 8.10-8.01 (m, 20H), 7.91 (d, 4H, J = 8 Hz), 7.79 (d, 4H, J = 6.5 
Hz)), 7.40-7.36 (m, 12H), 3.28 (t, 16H, J = 6 Hz), 2.11-2.05 (m, 16H), 1.70-1.65 (m, 
16H), 1.27-1.10 (m, 32H), 0.89-0.77 (m, 16H). 13C NMR (125 MHz, CDCl3, δ ppm): 
155.62, 153.92, 150.95, 150.82, 141.56, 140.67, 136.17, 134.39, 133.08, 131.68, 
129.80, 128.41, 127.62, 127.49, 127.07, 126.01, 123.94, 122.91, 120.11, 119.91, 55.19, 
40.19, 33.99, 32.63, 29.08, 27.76, 23.66. MS (MALDO-TOF, m/z): Calcd. for 







5]thiadiazole (Pyrene4BTF) (30 mg, 0.01 mmol) and NaN3 (80 mg, 1.23 mmol) were 
dissolved in THF/DMF (10 mL/30 mL). The resulted mixture was stirred at RT for 24 
hours, which was then transferred into a 1 KDa molecular cut-off dialysis membrane 
and dialyzed against MillQ water for 5 days to remove DMF and THF. The resulted 
aqueous suspension was extracted with dichloromethane. After drying and solvent 
removal under reduced pressure, Pyrene4BTF-N3 was obtained as an orange solid (24 
mg, 85% yield). 1H NMR (500 MHz, CDCl3, δ ppm): 8.51 (s, 2H), 8.10-8.05 (m, 
20H), 7.91 (d, 4H, J = 8 Hz), 7.79 (d, 4H, J = 7 Hz), 7.41-7.35 (m, 12H), 3.12 (t, 16H, 
J = 7 Hz), 2.11-2.04 (m, 16H), 1.44-1.38 (m, 16H), 1.19-1.11 (m, 32H), 0.81-0.74 (m, 
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16H). 13C NMR (125 MHz, CDCl3, δ ppm): 155.62, 153.91, 150.94, 150.82, 141.57, 
140.67, 136.15, 134.38, 129.79, 128.42, 127.50, 127.08, 126.00, 123.89, 122.90, 
120.12, 119.92, 55.19, 51.37, 40.22, 29.47, 28.68, 26.31, 23.70. 
Pyrene4BTF-PEGCOOH: Pyrene-4BTF-N3 (20 mg, 0.008 mmol) and 
Propyne-PEG1k-COOH (130 mg, 0.13 mmol) were dissolved in THF (5 mL). CuSO4 
(3 mg, 0.018 mmol) and sodium ascorbate (3 mg, 0.015 mmol) in water (3 mL) were 
subsequently added. The mixture was stirred at RT for 24 hours under argon. The 
resulted mixture was filtered through 0.45 μm membrane filter before dialysis against 
MillQ water using a 6 KDa molecular cut-off dialysis membrane to remove excess of 
PEG. Pyrene4BTF-PEGCOOH was obtained after freeze drying as a red-orange solid 
(80 mg, 96% yield). 1H NMR (500 MHz, CD3OD, δ ppm): 8.50-7.35 (m, 50H), 4.50 
(br, m, 16H), 4.20 (br, m, 16H), 3.72-3.16 (m, 796H, PEG & Methanol solvent at 3.3 
ppm), 2.55 (br, m, 16H), 2.02 (br, m, 16H), 1.63 (br, m, 16H), 1.32-0.69 (br, m, 48H). 
Mass (MALDI-TOF, m/z): 10570. 
Pyrene4BTF-PEG-TAT: Pyrene4BTF-PEGCOOH (10 mg, 0.9 μmol), EDAC (1 
mg) and sulfo-NHS (1 mg) were mixed in borate buffer (5 mL, 0.2 M, pH 8.5) and 
DMSO (2 mL) and degassed. The mixture was allowed to activate for 30 min. HIV-1 
tat peptide (9 mg, 7.5 μmol) was then added into the solution. The mixture was stirred 
at RT for 24h before dialysis against MillQ water for 5 days using a 12 KDa molecular 
cut-off membrane to remove the unreacted tat peptide. Pyrene4BTF-PEG-TAT was 
obtained as yellowish orange fibres after freeze drying (10 mg, 60% yield). 1H NMR 
(500 MHz, CD3OD, δ ppm): 8.50-7.17 (m, 99H), 4.55 (br, m, 22H), 4.23-4.01 (br, m, 
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29H), 3.50 (br, m, 504H, PEG H), 2.80 (br, m, 16H), 2.70 (m, 10H), 2.50 (br, m, 16H), 
2.12-0.69 (br, m, 241H, tat H & alkyl H). Mass (GPC): Mn = 16900, PDI = 1.01. 
Cell Culture and Incubation 
Hela cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
medium containing 10% fetal bovine serum and 1% penicillin–streptomycin at 37 οC 
in a humidified environment containing 5% CO2. Before experiments, the cells were 
precultured until confluence was reached. 
Cell Viability 
MTT assays were performed to assess the metabolic activity of Hela cells. Hela 
cells were seeded in 96-well plates (Costar, IL, USA) at an intensity of 2 × 104 
cells/mL. After 48 h incubation, the medium was replaced by Pyrene4BTF-PEG-TAT 
solution at the concentrations of 1, 5 and 10 μM, and the cells were then incubated for 
24, 48 and 72 h, respectively. After the designated time intervals, the wells were 
washed twice with 1 × PBS buffer and freshly prepared MTT (100 μL, 0.5 mg/mL) 
solution in culture medium was added into each well. The MTT medium solution was 
carefully removed after 3 h incubation in the incubator. DMSO (100 μL) was then 
added into each well and the plate was gently shaken for 10 minutes at RT to dissolve 
all the precipitate formed. The absorbance of MTT at 570 nm was monitored by the 
microplate reader (Genios Tecan). Cell viability was expressed by the ratio of the 
absorbance of the cells incubated with Pyrene4BTF-PEG-TAT solution to that of the 
cells incubated with culture medium only. 
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One- and Two-Photon Fluorescence Imaging 
Hela cells were cultured in chamber (LAB-TEK, Chambered Coverglass System) 
at 37 °C for qualitative study. After 80% confluence, the medium was removed and 
the adherent cells were washed twice with 1 × PBS buffer. Pyrene4BTF-PEG-TAT 
solution (0.4 mL, 1 μM) was then added to the chambers. After incubation for 2 h, 
cells were washed three times with 1 × PBS buffer and then fixed by 75% ethanol for 
20 min, which was further washed with 1 × PBS buffer twice. The cells were then 
imaged by CLSM (Zeiss LSM 410, Jena, Germany) with imaging software (Fluoview 
FV1000). Pyrene4BTF-PEG-TAT was excited at 405 nm (3% laser power), and the 
fluorescence was collected > 610 nm. As negative controls, 1 μM 
Pyrene4BTF-PEGCOOH, or 1 μM Pyrene4BTF-PEGCOOH in the presence of 5 μM 
free tat peptide were used for incubation with Hela cells for 2 h, following the same 
procedure for CLSM imaging. 
To obtain two-photon images, the cells were imaged with multiphoton 
microscopes (Leica TCS SP5 X) with a Leica HCX PL APO 63x/1.20 W CORR CS 
objective lens. The probes were excited with a mode-locked Ti-Sapphire laser source 
(Chameleon Ultra ІІ) with ~25 mW average power in the focal plane. Internal PMTs 
were used to collect the signals > 610 nm in an 8 bit unsigned 1024 × 1024 pixels at 
400 Hz scan speed.  
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Chapter 4 Conclusion and Future Work 
In this PhD project, we have designed and synthesized a series of conjugated 
materials featuring star-shaped donor-acceptor structures and successfully tailored 
them into useful TPA materials with special secondary functionalities for TPEF 
cellular imaging applications. Firstly, the synthesis of a series of 
4,7,12,15-tatrasubstituted [2,2]PcPs with different combinations of donor and acceptor 
groups was attempted through the dithia[3,3]paracyclophane route for investigation on 
their TPA properties and potential non-linear optoelectronic applications. It was found 
that dithia[3,3]paracyclophanes bearing different patterns of donor-acceptor 
substitutions could be prepared under high dilution conditions. However, the 
desulfurization for dithia[3,3]paracyclophanes via photo irradiation underwent 
smoothly for the those substituted with only donor groups, while none of the 
dithia[3,3]paracyclophanes with acceptor groups could be converted into their 
corresponding [2,2]PcPs. The failure for the intraannular cyclization between radicals 
generated from dithia[3,3]paracyclophanes is due to the severely decreased reactivity. 
This could be further related to a decreased electron density of the neighbor aromatic 
ring, which is due to the substitution by electron withdrawing nitro groups. Hence, 
this study provides a reference for future design and synthesis of symmetrical and 
asymmetrical [2,2]PcPs based materials. 
A star-shaped glycosylated donor-acceptor based TPA material (TFBS) was then 
developed for living cells TPEF imaging. It was found that the glucose substitution 
molecular engineering strategy could yield a robust TPA material with higher quantum 
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yield (η) and larger TPA cross sections (δ) compared to its cationic counterpart. The 
enhanced TPA δ (~570-1200 GM at λ = 730-800 nm range) and η are ascribed to the 
formation of nanoparticles for TFBS in water, which provides relatively hydrophobic 
microenvironment for the molecular backbone of TFBS. As a result, the 
non-irradiative decay caused by interaction between water and TFBS was reduced. It 
was also found that TFBS nanoparticles could be effectively internalized by living 
human cervical cancer cells (Hela Cells) and the cells was successfully imaged using 
TPM. TFBS also showed negligible cytotoxicity, which makes TFBS a potential probe 
for long-term clinical applications. Thus, we have demonstrated an effective 
molecular engineering strategy of glycosylation to develop robust TPA materials with 
water-solubility, self-assembly ability and large TPA δ for TPM applications. 
Next, a glucopyranose functionalized star-shaped material was designed and 
synthesized for targeted TPEF imaging of cancer cells. The molecular backbone 
(TVFVBN) was linked via fluorene-vinylene, which possesses larger δ values (~3000 
GM vs ~2500 GM in toluene) and red-shifted emission wavelength as compared to 
TFBN from Chapter 3, Part I due to an increased co-planarity and elongated 
π-conjugation. The precursor TVFVBN-S-NH2 was found to self-assemble into 
spherical nanoparticles in water with η of 0.21 and a large TPA δ value of ~1100 GM 
at 740 nm based on molecules. Furthermore, TVFVBN-S-NH2 has reactive amine 
groups, which allows further conjugation to biorecognition moieties. For 
demonstration, folic acid was conjugated to TVFVBN-S-NH2 to yield 
TVFVBN-S-NH2FA, which was also found to possess similar self-assembly and 
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optical properties to TVFVBN-S-NH2. Due to the specific folic acid-folate receptor 
interaction on the cell membrane of MCF-7 cells, targeted TPEF imaging was 
successfully demonstrated using TVFVBN-S-NH2FA. As such, we have successfully 
synthesized a TPA material with red-shifted emission wavelength and larger TPA δ via 
replacement of the single bond linkers with vinylene linkers. Furthermore, we have 
improved the strategy of glycosylation to develop TPA materials for targeted cancer 
cells imaging.  
Finally, a star-shaped pyrene based material (Pyrene4BTF-PEG-TAT) with a 
push-pull system and red emission was designed and synthesized for one- and 
two-photon imaging applications. It was found that the donor-acceptor pair of 
pyrene-benzothiadizole was well matched to bring in advantageous optical properties 
in aqueous such as large Stokes shift of 181 nm, large TPA δ of ~500 GM in the NIR 
region and emission in the red spectra window. The large TPA cross section is due to 
the effective ICT from center to peripheries as visualized by DFT calculations. It was 
also found that Pyrene4BTF-PEG-TAT could self-assemble into nanoparticles in water 
and consequently provides a relatively hydrophobic microenvironment for the 
molecular backbone of the oligomer. Also, the Pyrene4BTF-PEG-TAT nanoparticles 
could be effectively internalized by Hela cells and give both one- and two-photon 
fluorescence images in a high contrast manner. This is the first example of 
water-soluble TPA materials based on a pyrene center. Thus, we have successfully 
tuned the emission wavelength into the red spectral window by carefully selecting the 
donor-acceptor pair and provided very useful information for future design and 
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synthesis of red emissive TPA materials for bioimaging applications. 
In summary, this PhD project not only dealt with synthetic methodologies, but 
also investigated molecular engineering strategies and unraveled the underlying 
mechanisms to provide useful guidelines for the future development of TPA materials 
in biological applications. 
The following studies are recommended for future improvements: 
In terms of molecular design, the donor-acceptor pairs adopted in this thesis were 
limited to triphenylamine, pyrene, benzothiazole and benzothiadizole. It is vital to 
search for more donor-acceptor pairs to develop materials with larger TPA cross 
sections and red-shifted emission wavelengths. Bridged triphenylamine is a planar and 
electron rich structure,204 and it is thus a good choice. 
In addition, only glucose and glucopyranose were investigated in this thesis due to 
the limited scope of the PhD study. However, there is a variety of sugar compounds, 
which show specific binding properties to receptors on cell membranes. For example, 
galactose could bind Hepatocyte205 and vimentin shows N-acetylglucosamine binding 
lectin like activity.206 As such, the synthesis of TPA materials with large TPA cross 
sections and intrinsic targeting properties from sugar moieties is plausible. 
Besides the in vitro cell imaging demonstrated in this thesis, further use of our 
conjugated molecules for in vivo biological applications, such as in vivo tumor 
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